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Stellingen 
1 . . Een suboptimale vitamine-D-voorziening kan bijdragen tot het ontstaan van 
osteoporose. 
Dit proefschrift. 
2. De Ca/P-verhouding, als maat voor de kwaliteit van de voeding, heeft slechts 
betekenis indien de absolute hoeveelheid van een der betrokken elementen 
bekend is. 
Dit proefschrift. 
3. De gunstige werking die het innemen van kalktabletten heeft tegen het 
optreden van botontkalking bij vrouwen na de menopauze, kan worden 
verklaard door de remmende invloed van calcium op de absorptie van fosfaat 
in de darm. 
Recker, R. R. et al., Effect of estrogens and calcium carbonate on bone loss in 
postmenopausal women. Ann. Int. Med. 87 (1977) 649-655. 
4. Het calciumgehalte van het bloed is niet of weinig geschikt als graadmeter 
voor de vitamine-D-status en de produktie van bi jschi ldkl ierhormoon. 
5. Het is zeer aannemelijk dat de aanwezigheid van lactose in melk bijdraagt tot 
de anti-rachitische werking van dit voedingsmiddel. 
Pansu, D. et al., Effect of lactose on duodenal calcium-binding protein and calcium 
absorption. J. Nutr. 109 (1979) 508-512. 
6. De uitdrukking „homeostasis of inorganic phosphate" komt voort uit een 
onjuiste woordkeuze. 
Fleisch, H. et al., Homeostasis of inorganic phosphate: an introductory review. 
Calcif. Tiss. Res. 21 (1976)Suppl. 327-331. 
7. Elke commissie van de Voedingsraad die een opdracht heeft op het terrein 
van de samenstelling van de voeding, dient, alvorens adviezen aan de Raad 
uit te brengen, in overleg te treden met de Commissie Voedingsnormen. 
8. Het reageren op de vaak verwarrende en deels onjuiste berichten die 
nieuwsmedia over voeding verspreiden, kan worden gecoördineerd door het 
Voorl ichtingsbureau voor de Voeding te Den Haag. 
9. De uitspraak van de voedingskundige E. H. Groot: „Voeding is geen wis-
kunde" , heeft nog onvoldoende ingang gevonden bij de gebruikers van de 
formules van Keys. 
10. Het zou de eerlijkheid en de oprechtheid van de zuivelindustrie benadrukken 
indien ze voor het produkt dat wordt verkregen door het microbiologisch 
aanzuren van zoete ondermelk een andere naam bedacht dan „karnemelk" . 
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11. Een lichtpunt in de achteruitgang van de economie in de ontwikkelde landen 
is dat men mag verwachten dat de voedingsgewoonten erdoor zullen verbe-
teren. 
12. De instelling van medezeggenschapsraden in het onderwijs, naar analogie 
van de ondernemingsraad in het bedrijfsleven, is overbodig waar ouder-
commissies en schoolraden goed functioneren. 
13. In tegenstelling tot wat de epitheta suggereren, zijn gewone, buitengewone 
en bijzondere hoogleraren meestal even gewoon. 
14. Indien het praktisch uitvoerbaar zou zijn, kon een verhoging van de ziekte-
kostenpremies voor rokers van sigaretten worden bekostigd uit een verla-
ging van de pensioenpremies voor deze mensen. 
15. Als de bal niet rond was, leek voetbal nóg meer op rugby. 
16. Bermtoerisme wordt bevorderd door het aanleggen van grote verkeerswe-
gen. 
17. Het moet dubieus worden geacht of het euvel van spookrijders op zowel 
autowegen als rijwielpaden kan worden verholpen door de algemene invoe-
ring van linkshoudend verkeer, of door deze categorie weggebruikers te 
verplichten bij duisternis een rood voorlicht te voeren. 
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Chapter 1 
Introduction and objectives 
Osteoporosis can be described as a disorder or group of disorders in which the 
density of the bone is reduced. In recent years a distinction is made between 
osteopenia and osteoporosis. Osteopenia is considered to be a non-pathological 
condition, which results from the normal physiological loss of bone which starts in 
the fifth decade of life. Osteoporosis is a metabolic bone disease, so a pathologi-
cal state, which involves an increased risk of bone fracture and which results from 
an imbalance between bone resorption and bone formation. Osteoporosis may 
occur either in women after the menopause (post-menopausal osteoporosis), in 
old men and women (senile osteoporosis), in young adults (idiopathic osteopo-
rosis) or in adolescent children (juvenile osteoporosis). Osteoporosis is, with 
good reason, a matter of great concern to public health authorities. It has been 
estimated that almost 25% of the female population in the USA of over 60 years 
have osteoporotic bones. An exponential increase in the collum fracture rate with 
advancing age, in males as well as in females, has been documented in the 
Netherlands and other countries. 
Several factors have been put forward in the etiology of osteoporosis. Among 
them are hormonal, physical and nutritional factors. Although it is well known that 
dietary calcium deficiency causes osteoporosis in laboratory animals, an asso-
ciation between dietary calcium and osteoporosis in man is not clear. Actually, 
there is no general agreement on the human calcium requirement. Experiments 
with aging rodents have indicated that diets containing an excess of phosphorus 
cause increased resorption of calcium from the bones and produce osteoporosis 
after mild but chronic stimulation of the parathyroid glands. 
According to several investigators, the calcium-to-phosphorus ratio in the 
average diet in the USA, which is substantially lower than that recommended in 
animal feeding practice, might contribute to the high prevalence of osteoporosis. 
Hence, restriction of dietary phosphorus has been advocated as a prevention of 
this disease. 
The possible relation between the amounts of calcium and phosphorus in the 
diet and human osteoporosis has given rise to the following questions. 
1. Are there any relations between dietary calcium and phosphorus on the one 
hand and bone mass and bone metabolism on the other in normal, healthy, 
elderly people, who subsist on their own customary diets? 
2. What influence have dietary calcium and phosphorus on bone mass and bone 
metabolism under controlled conditions in rats? 
In the first part of this thesis the literature is reviewed with regard to the 
regulation of bone mineral metabolism and to the effect of diets on bone and bone 
mineral homeostasis. In the second part experiments are described which we 
conducted in order to provide an answer to the questions mentioned above. 
These experiments comprised a cross-sectional study among 89 free-living el-
derly people in the community of Ede and three series of trials with rats. In short, 
the cross-sectional study consisted of a dietary survey, measurement of the bone 
mineral content by photon absorptiometry, and determination of biochemical 
parameters in serum and urine. It was investigated whether the estimated daily 
intake of calcium and phosphorus was related to bone mineral mass or to bio-
chemical data. In the trials with rats the effect of varying dietary levels of calcium 
and phosphorus on bone, calcium and phosphorus metabolism was investigated 
by means of balance studies, determination of biochemical parameters in serum 
and urine, and chemical analysis and histological investigation of bone samples. 
Chapter 2 
Bone, bone metabolism and homeostasis of bone minerals 
2.1 Introduction 
This chapter deals with the composition, structure and metabolism of bone tissue. 
It is not intended, however, as an extensive review of all aspects concerned with 
these subjects, because such a review would be outside the scope of this thesis. 
Instead of this, attention is drawn only to the essentials required for a general 
understanding of the'effects of endogenous and exogenous factors on bone 
metabolism. 
2.2 Chemical composition of the bone 
Like other supporting tissues, bone is derived from mesenchyme or, embryoni-
cally, from mesoderm. The bone tissue (amounting to 9 kg at a body weight of 65 
kg) provides elasticity and strength to the body. It consists of an organic matrix 
and a bone mineral phase. On a fresh-weight basis, about 28% is organic matrix, 
47% is mineral and 25% is water (Draper & Chalmers, 1971 ). 
About 90% of the organic matrix is collagen and roughly 10% is ground sub-
stance (Herring, 1970). The collagen is a unique type of protein with regard to its 
high content of hydroxyproline (13% of the weight). The ground substance of the 
bone matrix is made up of amino-polysaccharides, non-collagen protein and a 
small quantity of lipids. The amino-polysaccharides, mainly chondroitin-4-sul-
phate, chondroitin-6-sulphate and hyaluronic acid, are associated with protein. 
Because of their acid sulphate and carboxyl groups, the amino-polysaccharides 
have water- and ion-binding properties. The lipid in the ground substance con-
sists of triglycerides, phospholipids, cholesterol and cholesterol esters (Herring, 
1968). 
The bone mineral phase is present mainly in the form of hydroxy-apatite crys-
tals, Ca10 (P04)6(0H)2, varying quantities of amorphous calcium phosphate, and 
small but variable quantities of carbonate, citrate, sodium, potassium, magnesium 
and fluoride (Irving, 1973). 
2.3 Bone structure 
Macroscopically, two main structural forms of bone tissue can be differentiated: 
compact bone and cancellous bone. Both forms are deposited in lamellae which 
are characterized by the orientation pattern of the collagen fibres. 
Compact bone is present in the shaft of long bones (cortical bone). This type of 
bone is made up of units, called Haversian systems or osteons, which are 
rod-shaped and provided with a central canal surrounded by concentric lamellae. 
The osteons branch each with another and interweave. The central canal con-
tains vessels and nerve fibres. The direction of the long axes of the osteons runs 
concurrently with the lines of stress that have to be resisted. 
Cancellous or spongy bone is present in irregular and flat bones, such as the 
vertebrae, the pelvic bone and in the ends of long bones. Spongy bone is also 
called trabecular bone, as the lamellae are arranged in the form of trabeculae. 
These are laid down in such a pattern that optimum resistance to stress is 
obtained. 
2.4 Bone cells 
On morphological and functional grounds four types of bone cell can be identi-
fied: the undifferentiated mesenchyme cell (osteoprogenitor cell), the osteoblast, 
the osteoclast and the osteocyte. 
Osteoblasts orginate from the osteoprogenitor cells. They are involved in the 
synthesis of bone matrix, which is called the osteoid as long as it has not yet 
mineralized. The active cuboidal cells with basophilic cytoplasma and large nuclei 
cover the growing bone surfaces in a continuous layer. After the bone has formed, 
they have the appearance of flat spindles and are called lining cells. From this 
resting phase they can resume their osteogenic function. 
During bone formation some osteoblasts are trapped in new bone tissue, where 
they are lying as spindle-shaped cells in lacunae. These cells, called osteocytes, 
are conneced with tissue fluids at the bone surface by fine protoplasma offsets or 
canaliculi, which also interconnect these cells. The osteocytes are involved in the 
withdrawal and deposition of bone mineral, according to the biochemical needs 
of the body. 
Osteoclasts, originating presumably from the bone marrow, are involved in the 
resorption of bone mineral and in the removal of bone matrix. They are large cells 
with several nuclei and lie against the bone at sites of resorption. This resorption 
causes the so-called Howship's lacunae. Electron micrographs have shown that 
active osteoclasts have a ruffled border where they lie against the bone. 
2.5 Bone formation 
Two types of osteogenesis are recognized: endochondral ossification and intra-
membranous bone formation. The first involves calcification of previously gener-
ated cartilage. Soon after birth, endochondral ossification is restricted to epi-
physial cartilage plates, where it enables the long bones to grow in length, and to 
the articular surface of bone, where it contributes to the size of the epiphyses. 
Intramembranous bone formation proceeds under the influence of osteoblasts. It 
occurs beneath the periosteum, the membrane that covers the bone in places 
where no cartilage is present. Osteoblastic bone formation is responsible for the 
increase in bone diameter during the growing period. The periosteum is 
composed of two layers, an inner one consisting of osteoblasts and an outer one 
made up of fibrous tissue. The outer layer provides attachment for muscles and 
ligaments and carries part of the blood supply of the bone. 
The osteoblasts synthesize and secrete the osteoid. Procollagen molecules, 
which are formed within the osteoblasts are made up of three separate polypep-
tide chains which are spindled around a central axis. Each polypeptide chain 
contains about 1000 amino acids, mainly glycine, proline and hydroxyproline. 
After incorporation of proline molecules in the peptide chains, a proportion of 
these amino acids is hydroxylated to hydroxyproline (Kivirikko & Prockop, 1967). 
The procollagen is incorporated in the bone matrix, but part of it is lost in the 
blood stream, metabolized by the body or excreted in the urine as breakdown 
products (Laitinen, 1967; Weiss & Klein, 1969). The urinary hydroxyproline ex-
cretion is used for the study of collagen metabolism. Procollagen molecules 
arrange and assemble to form microfibrils from which the collagen is made up. 
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Mineralization takes place in spaces between the microfibrils along the collagen 
axis in an ordered fashion. It is not known why accumulation of minerals is 
specific for the collagen of bone. 
2.6 Bone mineralization 
The mechanism of bone mineralization has been the subject of many speculative 
theories (Irving, 1973) and is as yet not elucidated. An interesting theory is that of 
the process called epitaxy (Neuman & Neuman, 1958). This theory assumes the 
existence of a specific ionic configuration or nucleation centre similar to that of 
bone crystals in the organic matrix. In this centre, which is formed by components 
of the osteoid, either phosphate or calcium are bound, after which crystal forma-
tion can commence. Crystal growth can proceed since the serum is supersatu-
rated with respect to bone salts. Glycolysis appears to be a necessary accompa-
niment of bone salt formation, which indicates that the process is energy-depen-
dent. The question why mineralization is restricted to bone matrix and does not 
occur elsewhere in the body where collagen is present, has been explained by the 
existence of a crystal poison at the sites of crystal seeding. Inorganic pyro-
phosphate might be such a poison; it is split by alkaline phosphatase, an enzyme 
which is present in active osteoblasts (Fleisch, 1968). 
Another theory of bone mineralization, put forward by Bonucci, Anderson and 
others (see Jowsey, 1977), is that of the matrix vesicles. These vesicles have been 
demonstrated, by means of electron microscopy in zones of mineralization. They 
contain needle-like structures, which are probably calcium phosphate crystals 
since they are removed by EDTA. It has been found recently that electron-dense 
granules are present within the osteoblasts in areas of rapidly mineralizing bone. 
These granules, which are 20 to 80 nm in size, appeared to consist of agglomer-
ates of calcium phosphate molecules in sac-like envelopes. It has been suggested 
that these particles are extruded from the osteoblast down the caniculi to the 
mineralization front. 
Surface ions of the bone crystal bind water. This water forms an hydratation 
shell, which is an integral part of the hydroxy-apatite. This shell provides the 
possibility of ionic exchange taking place between bone salts and body fluids. 
Crystal growth is associated with a relative decrease in the amount of absorbed 
water, and with maturation of the bone its water content decreases. 
2.7 Bone resorption 
Two mechanisms of bone resorption are recognized: resorption by osteoclasts 
and resorption by osteocytes: the latter is called osteocytic osteolysis. 
Osteoclastic bone resorption occurs particularly at the endosteal surfaces of 
cortical and trabecular bone and also at the surfaces within the Haversian sys-
tems. On the inside of the shafts of long bones it causes widening of the cavity of 
the growing bone. One osteoclast can break down an amount of bone similar to 
that formed by 100 to 1000 osteoblasts in the same time (Frost, 1963). The 
osteoclasts are known to contain proteolytic enzymes and to produce organic 
acids such as citric acid and lactic acid. 
Osteolysis by osteocytes involves removal of mineral and matrix matter from 
around the lacunae. It has been suggested that osteolysis is an important factor in 
calcium homeostasis, in that it accounts for the acute release of calcium from 
bone due to increased secretion of parathyroid hormone (Belanger, 1969; Jow-
sey, 1968). 
2.8 B o n e remode l l i ng a n d b o n e t u rnove r 
Bone is a dynamic tissue that is formed and broken down continuously by the 
integrated action of osteoblasts and osteoclasts. This process is called bone 
remodell ing. During growth, bone formation dominates bone resorption. In peo-
ple over the age of about 45 years, bone resorption is no longer compensated by 
bone formation, which may lead to decalcif ication of the bones (Albanese, 1977). 
Compared with cortical bone, trabecular bone has a high surface-to-volume ratio 
and, as bone remodelling is a surface phenomenon, trabecular bone is 
considered to be more responsive to bone loss than is cort ical bone (Jowsey, 
1976). 
Kinetic studies with radio active tracer calcium have shown that about 500 mg 
calcium is exchanged for bone tissue each day (see Morgan, 1973); this value can 
be taken as a measure of the daily bone turnover rate. 
2.9 Calcium homeostasis 
The adult human body contains about 1200 g calcium, 99% of which is present in 
the skeleton. The remaining 1 % is found in the circulation and in soft tissues. A 
small proport ion (approx. 1%) of skeletal calcium is rapidly exchangeable for 
circulating calcium. The plasma calcium concentrat ion is homeostatically con-
trolled and kept within narrow limits, normally between 2.20 and 2.60 mmol / l . 
800 m g 650 mg 
*- faeces 
kidney ^ urine 
130 mg 
Fig. 1. Outline of calcium metabolism under balance conditions in adults (input = output). If 
the diet contains 800 mg of calcium per day, about 300 mg is absorbed from the intestinal 
tract to meet the daily endogenous losses: 150 mg in the faeces (from digestive juices and 
mucosal cells), 20 mg through the skin, 130 mg in the urine. Bone turnover is 500 mg per day. 
If the glomerular filtration is 100 ml/min and 60% of the plasma calcium is ultrafiltrable, the 
primary urine flow corresponds to 8510 mg/24 h, almost 99% of which is reabsorbed by the 
tubular cells, leaving a urinary excretion of 130 mg. Data were taken from Marshall et al. 
(1976), Heany et al. (1975), Lutwak et al. (1974), and Morgan (1973). 
10 
Calcium in plasma occurs in three different forms: (1 ) ionic or free calcium ( ± 
47%), (2) calcium bound to protein, particularly to albumin, ( ± 39.5%), and (3) 
calcium complexed with citrate, phosphate, bicarbonate, lactate and sulphate ( ± 
13.5%) (Moore, 1970). Protein-bound calcium is non-diffusable. The normal 
plasma calcium concentration is maintained by complex and integrated hormonal 
regulation of intestinal absorption, urinary excretion and deposition into or re-
sorption from the bone. Figure 1 shows an outline of the calcium metabolism as it 
takes place in adults. 
2.10 Phosphate metabolism 
The total amount of body phosphorus is about 600 to 900 g, more than 80% of 
which is present in the skeleton. The rest can be found in soft tissues and blood, 
either as organic phosphate (phospholipids and phosphate esters) or as inorga-
nic phosphate. In blood plasma the normal amount of organic (phospholi-
pid-)phosphorus ranges from 1.6 to 3.0 mmol/l and that of inorganic phosphate 
(Pj) from 0.8 to 1.6 mmol/l (Henry et al., 1974). 
It has been reported that about 53% of Pj in plasma is present as free ions, 
mainly as HP042" (43%) and H2P04~ (10%), the rest being bound to proteins (12%) 
or to other ions, especially sodium (29%), calcium (3%) and magnesium (3%) 
(Walser, 1961; see Van Paassen, 1979), Micropuncture studies of the kidney 
indicate that 90 to 95% of plasma Pj is ultrafiltrable (Fleisch et al., 1976). The 
kidneys play a major role in Pj metabolism by varying the tubular reabsorption. 
This reabsorption strongly depends on the amount of phosphate ingested with the 
diet. Under balance conditions the urinary Pj excretion equals the net intestinal 
phosphate absorption which amounts to more than 60% of the total intake 
(Spenceretal., 1965). 
2.11 Summary 
Bone is a dynamic tissue which is continuously formed by osteoblasts and broken 
down by osteoclasts. Osteocytes are involved in both processes. Together with 
the intestinal absorption and renal handling of calcium and phosphate, the de-
position of these minerals into the bone and their resorption from it (bone turn-
over) are important parameters in the maintenance of calcium homeostasis and in 
phosphate metabolism. 
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Chapter 3 
Hormonal control of bone mineral homeostasis 
3.1 Introduction 
Several hormones are involved in the complex mechanism of bone mineral ho-
meostasis. The following will be discussed: the parathyroid hormone (PTH), cal-
citonin (CT), vitamin D, thyroxine, glucocorticoids, growth hormone, somatome-
din, oestrogens and prolactine. 
3.2 Parathyroid hormone 
PTH is synthesized by four small glands which are situated beside the thyroid 
gland. It is a single-chain peptide, consisting of 84 amino acids. The hormone is 
secreted into the circulation after six amino acids have been detached from the 
N-terminal part of a pro-hormone (Hamilton etal., 1973). The biological activity of 
the native 1-84 molecule is located almost exclusively in the 1-34 N-terminal 
fragment. 
The native hormone is degraded (rapidly) by liver and kidney, some of its 
fragments remaining behind in the circulation. By means of a radio-immuno-assay, 
the native hormone, its degradation products, or both, can be determined, de-
pending on the type of antiserum used. Determination of the entire molecule or 
N-terminal fragments is useful if information is required about acute PTH-secre-
tion; the fact is that these peptides have a rapid turnover and are short-lived 
(minutes). Determination of carboxy-terminal fragments provides information 
about chronic PTH-secretion, because these fragments have prolonged turnover 
rates (hours) (Kenny & Dacke, 1975; Root& Harrison, 1976). 
The secretion of PTH and probably also its synthesis are directly stimulated by a 
low plasma-ionized calcium concentration, or inhibited by an elevated one. In 
vitro, PTH release appears to be enhanced by low serum magnesium levels, but 
severe hypomagnesemia inhibits the secretion of the hormone (Root & Harrison, 
1976). The main function of PTH is to maintain the plasma calcium concentration 
within narrow limits. The hormone acts upon bone, kidney and intestine. 
The well known effect that PTH has on bone is mobilization of calcium by: (1) 
increase in the number of osteoclasts, (2) rise in the metabolic activity of the 
osteoclasts and (3) increase in osteocytic osteolysis. It is generally agreed that 
PTH also acts upon the osteoblasts, initially inhibitory and subsequently stimula-
tory (Kenny & Dacke, 1975), but resorption dominates apposition. 
The effect of PTH on the kidney is that: (1) in the proximal tubule the reab-
sorption of phosphate and calcium is decreased, and (2) that in the distal tubule 
calcium reabsorption is enhanced. The results are that the renal phosphate 
clearance increases and the calcium clearance decreases. In addition, PTH 
stimulates the urinary excretion of sodium, potassium and bicarbonate by lowe-
ring the tubular reabsorption of these ions, and reduces the urinary excretion of 
hydrogen and magnesium ions by increasing the tubular reabsorption (Kenny & 
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Dacke, 1975; Massry étal., 1973; Root & Harrison, 1976). PTH activates the renal 
enzyme 25-hydroxycholecalciferol-1-alpha-hydroxylase, which stimulates the 
synthesis of 1,25-dihydroxycholecalciferol, a potent vitamin D metabolite (see 
Section 'Vitamin D'). 
The effect of PTH upon the intestine is probably indirect and is exerted through 
the medium of vitamin D. 
Regarding the effect of PTH on a cellular level, many observations are in line 
with a second messenger concept, as has been put forward by Borle and by 
Rasmussen & co-workers (see Root & Harrison, 1976). According to this concept, 
PTH directly or indirectly influences the concentration of cyclic AMP, cytosol-io-
nized calcium and monohydrogen phosphate, three intracellular second mes-
sengers which act in an interrelated manner and stimulate the cell to carry out 
characteristic functions. 
After PTH has been bound at the receptor site of the cell, membrane adenyl 
cyclase is activated. This results in the formation of 3,5-cyclic AMP from ATP, and 
in a change in the permeability of the cell membrane to ionized calcium, so that 
these ions enter the cell from the interstitial fluid, thereby increasing the cytosol 
calcium concentration. In bone cells these changes bring about stimulation of 
enzymes involved with resorption of bone, inhibition of osteoblast activity, and 
acceleration of osteoclast production from precursor cells. In renal cells they 
stimulate a mechanism that inhibits phosphate reabsorption. It is postulated that 
monohydrogen phosphate inhibits the metabolic activity of PTH by lowering the 
cytosol calcium concentration upon increasing deposition of calcium in mito-
chondria. In contrast, cyclic AMP is claimed to accelerate the transfer of calcium 
from mitochondria into cytosol, by which the cytosol calcium concentration is 
increased. This might inhibit the activity of adenyl cyclase, so that cyclic AMP 
production is partly autoregulatory. This theory explains why there is no respon-
siveness of bone cells to PTH in vitamin D deficiency, as has been reported by Au 
& Raisz (1967), who made experiments with rats. They state that, since in the 
vitamin-D-deficient animal intra- and extracellular calcium and phosphate con-
centrations are low, PTH is unable to increase cytosol-ionized calcium. 
3.3 Calcitonin 
Calcitonin is a linear peptide consisting of 32 amino acids, the entire structure 
being necessary for biological activity. The hormone is produced in the thyroid 
gland by the parafollicular cells, and its secretion is directly proportional to that of 
plasma calcium above the level of about 2.25 mmol/l; below this concentration 
the hormone is not detectable (Catt, 1970). 
Calcitonin has a hypocalcaemic action, mainly because it inhibits bone re-
sorption; it activates adenyl cyclase, as a result of which cellular levels of cAMP 
are increased, and stimulates active efflux of calcium from the cytosol to the 
interstitial fluid, thus antagonizing PTH (Root & Harrison, 1976). 
In the kidney, calcitonin is known to inhibit the tubular reabsorption of calcium, 
phosphate and sodium (Massry et al., 1973). No clear-cut direct effect of calcito-
nin on the intestine has been demonstrated (Root & Harrison, 1976). 
Human calcitonin has a low biological activity and is rapidly cleared from the 
circulation, probably by the kidneys. Its role in human calcium homeostasis has 
been questioned, since plasma calcium is essentially normal in patients with 
medullary carcinoma of the thyroid. These subjects have high circulating levels of 
the hormone. Moreover, administered calcitonin does not produce hypocalcae-
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mia in the normal adult to any marked extent, and thyroidectomy is not associated 
with a rise in plasma-calcium levels (Kalu & Foster, 1976). However, as postulated 
by Stevenson (1980), calcitonin might be of some importance in antagonizing the 
bone-resorptive action of 1,25-DHCC, the active vitamin D metabolite, and of 
PTH, during periods of calcium stress such as pregnancy and lactation. 
3.4 Vitamin D 
3.4.1 Introduction 
Vitamin D is known mainly in two forms, one from the animal and one from the 
plant kingdom. Provitamin D3 (7-dehydrocholesterol) is formed in the intestinal 
mucosa from cholesterol and is converted in the skin by ultraviolet irradiation 
(230-313 nm) into vitamin D3 (cholecalciferol); provitamin D2 (ergosterol) in 
foodstuffs of plant origin is similarly converted upon ultraviolet irradiation into 
vitamin D2 (ergocalciferol) in vitro. In both conversions the B-ring of the steroid 
molecule is opened. The difference between vitamin D2 is in the side chain (see. 
Fig. 2). The primary action of the calciferols is to prevent rickets in the young and 
provitamin D vitamin D 
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Fig. 2. Formation of vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) from their 
precursors by UV-irradiation. 
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osteomalacia in the adult. The physiological response to vitamin D2 and D3 is 
similar in rat and man, but in birds as well as in the green monkey vitamin D2 is 
much less active than vitamin D3 (Harrison, 1975). 
3.4.2 Metabolism of vitamin D 
It is now generally recognized, mainly on account of the work of DeLuca and 
co-workers (Ponchon et al., 1969) and of Fraser & Kodicek (1970), that vitamin D 
must be hydroxylated in liver and kidney before it obtains its full biological activity. 
After transport by an alpha-globulin protein from skin to liver, vitamin D3 is hy-
droxylated in liver cells by a microsomal 25-hydroxylase. The metabolite, 25-hy-
droxychoiecalciferol (25-HCC), is further hydroxylated to 1,25-dihydroxychole-
calciferol (1,25-DHCC) by a mitochondrial 25-hydroxy-1 -alpha-hydroxylase in the 
renal cortex. This 1,25-DHCC, the hormonal form of vitamin D, is known to be most 
active in the stimulation of intestinal calcium absorption and bone calcium mobi-
lization (see Fraser, 1975). The reported positive effect of 1,25-DHCC on renal 
calcium reabsorption is not specific and is probably related to the phosphataemic 
action of the hormone (Hugi et al., 1979). 
Plasma values of 25-hydroxy-vitamin D which depend on the vitamin D content 
of the diet and the degree to which the skin is exposed to the sun, serve as an 
excellent index of the vitamin D status; the normal concentration is about 30 
ng/ml, more than 80% of which has been reported to be 25-HCC (Edelstein et al., 
1974; Haussler & McCain, 1977). Plasma 25-HCC levels are subject to seasonal 
variation, because they depend on the degree to which the skin is exposed to the 
sun. Values are highest in August and lowest in February (Postkitt et al., 1979). 
The plasma concentration of 1,25-DHCC is less than 1/500th that of 25-HCC. 
Other circulating vitamin D metabolites are 24,25-DHCC and 25,26-DHCC, which 
are renal products of 25-HCC. Their plasma concentration is about 1/10th to 
1 /20th that of 25-HCC, but their function has not been completely defined yet 
(Root & Harrison, 1976; Haussler & McCain, 1977; Care et al., 1979). It has been 
suggested that 24,25-DHCC has a positive action on skeletal mineralization (Ka-
nis et al., 1979), possibly by occupying bone cell receptor sites for 1,25-DHCC. 
3.4.3 Regulation of the vitamin D metabolism 
The activity of renal 25-HCC-1-alpha-hydroxylase is known to be increased by 
PTH (Fraser & Kodicek, 1973; Garabedian et al., 1972; Rasmussen et al., 1972; 
Boyle & DeLuca, 1971), and this leads to an enhanced synthesis of 1,25-DHCC. 
PTH is not essential to the synthesis of this metabolite; in parathyroidectomized 
rats 1-alpha-hydroxylase is stimulated by a low-phosphorus diet (Tanaka & De-
Luca, 1973). According to DeLuca (1973) 1 -alpha-hydroxylase is stimulated if the 
inorganic phosphorus concentration in the renal parenchyma is below 400 fig/g 
tissue. It is now well established that either a low-calcium diet (via decreased 
plasma calcium and increased PTH secretion) or a low-phosphorus diet (inde-
pendently of PTH via hypophosphataemia) increases circulating levels of 
1,25-DHCC (Henry et al., 1974; Baxter & DeLuca, 1976; Hughes et al., 1975; Rader 
et al., 1979). On the other hand, another group of investigators (Maclntyre et al., 
1979) believe, mainly on the strength of results of experiments with renal cell 
culture, that, in addition to PTH, calcium itself can regulate the activity of 1-
alpha-hydroxylase; they found that elevation of calcium in the culture medium 
inhibited the activity of this enzyme and enhanced that of 24-hydroxylase. 
The PTH-induced stimulation of renal 1-alpha-hydroxylase operates through 
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the medium of cAMP, both in vivo (Horiuchi et al., 1977) and in vitro (Rasmussen 
et al., 1972). The common denominator in both the PTH- and hypophosphatae-
mia-stimulated 1-alpha-hydroxylation of 25-HCC may be a low intracellular, pos-
sibly mitochondrial, phosphorus content of the renal cortex. Rasmussen et al., 
(1975) (see Root & Harrison, 1976) believe that PTH has a major direct effect upon 
1-alpha-hydroxylase in that it increases the renal cell uptake of calcium and the 
cytosol concentration of ionized calcium. In the rat, the renal synthesis of 
1,25-DHCC declines and the synthesis of 24,25-DHCC increases when serum 
calcium rises above 2.25 mmol / l and serum phosphorus above 2.60 mmo l / l 
(Tanaka & DeLuca, 1973). Renal 1-alpha-hydroxylase is inhibited by 1,25-DHCC, 
whereas renal 24-hydroxylase is stimulated by it (Tanaka & DeLuca, 1974; Om-
dahl, 1976). 
24,25 DHCC - 25-HCC • 1,25 DHCC 
Fig. 3. Regulation of the conversion of 25-HCC by the intracellular phosphate concentration 
(Pj) in the renal cortex; Ca+ + and PTH are plasma concentrations of these regulators. 
PTH suppresses renal production of 25,26-DHCC (Tanaka et al., 1978). It is not 
known whether calcitonin influences the renal metabolism of 25-HCC; Rasmus-
sen et al. (1972) reported an inhibitory effect of this hormone on the product ion of 
1,25-DHCC, but this was not confirmed by others (Lorenc et al., 1977). 
3.4.4 Action of vitamin D metabolites 
The main target tissues of vitamin D metabolites are intestine, bone and kidney. It 
is known that the presence of vitamin D in the body is essential to the regulation of 
the intestinal calcium absorption. Active calcium absorption occurs in the upper 
portion of the small intestine against an electrochemical gradient; it is a vita-
min-D-dependent process which requires energy from the oxidative metabolism 
of mucosal cells (Schachter & Rosen, 1959). These cells contain cytoplasmic and 
nuclear receptor proteins which bind the 1,25-DHCC-hormone. After 1,25-DHCC 
has been bound to the nucleus, it induces the formation of a messenger RNA, 
which brings about the synthesis of an intracellular calcium-binding protein 
(CaBP). This protein, which was isolated for the first t ime by Wasserman et al. 
from chick intestine in 1966 (Wasserman & Taylor, 1968; Roo t& Harrison, 1976), 
may increase the permeability of the intestinal cell to calcium. The calcium-bin-
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ding activity of CaBP has been shown to correlate well with the efficiency of 
calcium absorption (Swaminathan et al., 1977). Vitamin D also increases the 
activity of intestinal alkaline phosphatase, a membrane-bound enzyme that exhi-
bits calcium-stimulated ATP-ase activity (Haussieret al., 1970). This enzyme may 
be involved in calcium transport, but its precise funct ion remains to be clarif ied. 
Active intestinal calcium transport is not stimulated by 25-HCC in anephric ani-
mals, which indicates that renal 1-alpha-hydroxylation is required for this effect 
(Boyle et al., 1972). Across the wall of the entire length of the intestine, vita-
min-D-facilitated diffusion of calcium has been established (Harrison, 1960). This 
transport is independent of the oxidative metabolism and is believed to be solely 
related to calcium intake (Heany et al., 1975). 
In normal individuals intestinal calcium absorption is positively correlated with 
serum levels of 1,25-DHCC (Gallagher et al., 1979; W i l ze ta l . , 1979). It has been 
reported that 25-HCC and 1,25-DHCC also augment intestinal phosphate trans-
port, independently of the presence of calcium (Chen et al, 1974; Walling & 
Kimberg, 1975). Brickman et al. (1977) reported that when patients suffering from 
advanced renal failure and normal individuals were treated with 1,25-DHCC or 
with its synthetic analogue, 1-alpha-HCC, intestinal absorption of phosphate was-
augmented. However, Wilz et al. (1979) noted that there was no signif icant cor-
relation between plasma levels of 1,25-DHCC and intestinal absorption of 
phosphate or magnesium in vitamin-D-replete humans. Any direct action of 
24,25-DHCC or 25,26-DHCC upon the intestine has not been reported. 
Regarding the action of vitamin D metabolites on bone, it is recognized that 
1,25-DHCC is most potent in stimulating bone resorption, and that this action 
requires the presence of PTH in vivo (Garabedian et al., 1974). PTH is not required 
for 1,25-DHCC-stimulated bone resorption in hypophosphataemic rats (Castillo et 
al., 1975). Although any action of 24,25-DHCC and 25,26-DHCC on bone has not 
been clearly defined, Queille et al. (1978) reported that both metabolites minera-
lized the osteoid in vitamin-D-deficient rats. 
1, 25-DHCC + " 24, 25-DHCC 
Fig. 4. Autoregulation of PTH secretion, as proposed by Canterbury et al. (1978). 
In the kidney, both 25-HCC and 1,25-DHCC decrease the excretion of fi ltered 
phosphate, sodium and calcium by increasing proximal tubular reabsorption of 
these ions (Puschett et al., 1972a and 1972b). 
Evidence is accumulating that vitamin D metabolites also act on the parathyroid 
glands. It has been demonstrated that 1,25-DHCC localizes selectively in the 
parathyroids (Henry & Norman, 1975) and that cytoplasmic and nuclear binding 
sites are present (Brumbaugh et al., 1975). Canterbury et al. (1978) observed that 
in an in-vivo canine model 25-HCC and 24,25-DHCC, in a near physiological 
concentrat ion, completely suppressed the secretion of PTH. They further dem-
onstrated that pharmacological, but not physiological doses of 1,25-DHCC sti-
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mulated PTH secretion. Care et al. (1979) reported that 24,25-DHCC and 
25,26-DHCC depressed PTH secretion and stimulated calcitonin secretion from in 
situ perfused goat parathyroid glands; 1,25-DHCC had an opposite action in this 
respect. 
3.5 Thyroxine 
Thyroxine increases the bone turnover rate, and this is particularly evident in 
thyrotoxicosis. In this condition serum levels of calcium and phosphorus are 
elevated, and there is a marked loss of bone minerals in urine consequent on an 
increased filtered load; since the increase in bone apposition does not fully 
compensate for the increase in bone resorption, thyrotoxicosis may lead to 
osteoporosis (Irving, 1973). 
3.6 Glucocorticoids 
Long-term administration or an increased synthesis of glucocorticoids (Cushing's 
syndrome) may cause loss of bone substance, resulting from a negative nitrogen 
balance. This loss of bone is associated with an increased loss of bone minerals in 
the urine (Massry et al., 1973). Glucocorticoids antagonize the effect of vitamin D 
on the intestinal calcium absorption (Root & Harrison, 1976). 
3.7 Growth hormone and somatomedin 
Growth hormone stimulates endochondral bone formation and increases skeletal 
mass by accelerating subperiostal bone apposition. Hypersecretion may lead to 
acromegaly with overgrowth of hands, feet and face, and to gigantism, whereas 
hyposecretion may give rise to dwarfism. The effect of growth hormone on bone is 
not a direct one, but is controlled by somatomedin, the synthesis of which is 
assumed to take place in the liver under the influence of growth hormone (Wie-
demann & Schwarz, 1972). The effect of somatomedin on bone is dependent on 
the presence of thyroxine. Regarding the renal handling of calcium and phos-
phate, growth hormone has an effect opposite to that of PTH (Massry et al., 1973) 
and this probably explains the higher levels of serum phosphate during growth. 
Spencer et al. (1979) reported that growth hormone, injected into hypophysec-
tomized rats, stimulated the renal conversion of 25-HCC into 1,25-DHCC. They 
proposed that this effect could be of importance to the long-term stimulation of 
renal hydroxylase during growth. 
3.8 Oestrogens and prolactine 
There is convincing evidence that oestrogens inhibit bone resorption; adminis-
tration of these hormones to postmenopausal women decreases bone loss (Riggs 
etal., 1969and 1972; Meema& Meema, 1976; Lindsday etal., 1976; Reckeretal., 
1977) and this effect appears to be associated with a decrease in the urinary 
excretion of calcium and hydroxyproline and in serum calcium, phosphorus and 
alkaline phosphatase. According to Heany (1965), sex hormones in women alter 
the responsiveness of bone to the action of PTH. Oestrogen deficiency, such as 
occurs in natural and artificial menopause, would increase the sensitivity of bone 
to PTH without the sensitivity of other PTH-target organs being changed. Indeed, 
Atkins et al. (1972) found that oestrogen inhibited the calcium-mobilizing action of 
PTH in an organ system of mouse calvaria. According to Van Paassen et al. 
(1978), however, the oestrogen concentration used in this experiment might have 
caused cell damage. The latter investigators were unable to demonstrate the 
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presence of a specific oestrogen receptor in the cell cytosol of the bone of rabbits, 
rats and humans, which would favour an indirect effect of oestrogens on bone. In 
his thesis, Van Paassen (1979) postulates that the effect of oestrogen adminis-
tration to postmenopausal females might result from an inhibitory effect of oe-
strogens on somatomedin synthesis in the liver (Wiedemann & Schwarz, 1972). 
There is evidence from in-vitro studies with chick renal tubules that prolactine 
directly stimulates the activity of renal 1-alpha-hydroxylase, but this might be 
specific to birds (Spencer et al., 1979; Maclntyre et al., 1979). 
3.9 Summary 
Calcium homeostasis is directed to the maintenance of the serum calcium con-
centration within narrow limits, mainly by the complex and integrated action of 
PTH and 1,25-DHCC, the active vitamin D metabolite, on three target organs: 
intestine, kidney and bone. 
Along the proximal part of the intestinal tract, active transport of calcium takes 
place against a concentration gradient. This process is dependent on the pres-
ence of 1,25-DHCC. More distally, passive calcium transport,.depending on the 
concentration gradient, has been established. 
In the kidneys diffusable calcium is filtered from the plasma into the primary 
urine and subsequently largely reabsorbed from the tubuli. This tubular reab-
sorption is influenced positively by PTH and 1,25-DHCC. 
The bone can be considered to be a closed system in which the intercellular 
calcium concentration is low (approx. 1.6 mmol/l) as compared with that in the 
blood (approx. 2.5 mmol/l). This gradient causes a diffusion transport of calcium 
from plasma to bone. On the other hand, transport of calcium from bone to plasma 
is an active process, which is influenced positively by PTH and 1,25-DHCC. 
The secretion of PTH, the main regulator of calcium homeostasis, is triggered 
by a low serum-ionized calcium concentration. PTH stimulates the renal synthesis 
of 1,25-DHCC from 25-HCC. The calcaemic action of PTH and 1,25-DHCC upon 
bone, kidney and intestine is accompanied by a Phosphaturie action of PTH to 
prevent hyperphosphataemia. The regulation of phosphate metabolism can be 
considered to be subservient to calcium homeostasis. 1,25-DHCC inhibits renal 
1-alpha-hydroxylase and stimulates 24-hydroxylase. This gives rise to the forma-
tion of 24,25-DHCC, which metabolite inhibits the secretion of PTH. 
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Chapter 4 
Effects of non-nutritional factors on bone and bone mineral 
metabolism 
4.1 Introduction 
In this chapter the effects of a number of non-nutritional, more or less physiolog-
ical factors on bone and bone mineral metabolism are discussed. It is felt that for a 
proper understanding or for an evaluation of the results of studies dealing with 
this subject, especially with reference to osteoporosis, the factors discussed 
below cannot be overlooked. Although merely referring to a pathological rather 
than to a physiological status, renal failure is given attention. The hyperparathy-
roidism and osteodystrophia associated with this disease resemble, at least to a 
certain extent, nutritional hyperparathyroidism, which subject will be discussed in 
Chapter 5. 
4.2 Age and sex 
As was already mentioned in Chapter 1, an important feature of aging is the 
associated loss of bone tissue, which may lead to osteoporosis. Cross-sectional 
studies in different populations have shown that bone loss starts in the fifth 
decade of life and proceeds about twice as fast in females as in males. In the 
former the rate of loss is about 12% of the bone mass per decade, as indicated by 
radiogrammatric measurements of the cortical thickness of the metacarpal bone 
(Garn et al., 1967). Newton-John and Morgan (1970) have collected considerable 
data from the literature on the loss of bone tissue with age; the process is 
approximately linear in both sexes; the inter-individual variation in the amount of 
bone does not increase with age, and within various age groups the amount of 
bone appears to be distributed normally. On the basis of their observations these 
investigators postulated that nearly all persons lose bone with age and that there 
is no large subgroup of persons who lose more bone than others. This interpre-
tation suggests that those who develop osteoporosis have not lost bone at a more 
rapid rate but just had a smaller amount of bone all the time. However, it should be 
recognized that results of cross-sectional studies, on which the above interpre-
tation is based, may give a false picture of reality since the effects of selective 
survival or differential mortality are not taken into account. Moreover, as stressed 
by Smith et al. (1975), models exist that allow inter-individual variation in the rate 
of loss without a change in the inter-individual variation in the amount of bone. 
The few longitudinal population studies that have been carried out as yet have 
indeed shown that inter-individual variation in the rate of bone loss exists (Garn et 
al., 1967; Adams et al., 1970; Dequeker, 1972). According to Garn étal., (1967), a 
small stature, resection of the stomach and early artificial menopause would 
favour the loss of minerals from the skeleton. Cohn et al. (1976) have analysed the 
amount of total body calcium in 40 women by means of neutron activation. These 
investigators reported that loss of calcium from the body can be characterized by 
two components, one with a rate of 0.37% per year and the other, a more rapid one 
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which starts postmenopausally, of 1.08% per year. The fast component was 
superimposed on the slow component and the latter continued throughout life. 
A second age-associated phenomenon is the reduced intestinal absorption of 
calcium in elderly people. It has been demonstrated by several groups of investi-
gators that calcium absorption gradually decreases with age, in males as well as 
in females (Gallagher et al., 1979; Aviolietal., 1965; Bullamoreetal., 1970; Nordin 
et al., 1976). Calcium absorption was found to be significantly lower than normal 
in postmenopausal osteoporotic patients when either age or dietary calcium was 
used as a co-variable (Gallagher et al., 1979). A decrease in calcium absorption 
with age, predominantly affecting the active transport component, has also been 
established in rats (Wilkinson, 1971; Armbrecht et al., 1979). Horst et al. (1978) 
reported decreased calcium absorption, low levels of 1,25-DHCC in serum and a 
decline in activity of renal 25-HCC-1-alpha-hydroxylase in aged rats. Gallagher et 
al. (1979) found that osteoporotic patients and elderly healthy subjects had nor-
mal serum levels of 25-HCC but lower levels of 1,25-DHCC. In addition to the 
observations made by Nordin et al. (1976) that malabsorption of calcium in elderly 
people can be corrected with pharmacological doses of vitamin D2, the above 
findings suggest that the decline in calcium absorption with age is the conse-
quence of reduced renal synthesis of the active vitamin D metabolite. This phe-
nomenon may be caused by decreases of PTH secretion in the absence of 
oestrogens or by diminished renal functioning, as has been postulated by Nordin 
et al. (1976). 
Other features of aging are a decrease in the urinary excretion of calcium, 
phosphorus and hydroxyproline, as has been reported by Dequeker (1973) on the 
basis of cross-sectional data on 59 normal females between 20 and 90 years. The 
decrease in mineral excretion was attributed to reduced intestinal absorption, and 
the decrease in hydroxyproline excretion to loss of bone mass. In females there is 
an increase in serum concentration of calcium and phosphorus and in the activity 
of alkaline phosphatase after the menopause. Values of these parameters return 
to pre-menopausal levels upon administration of oestrogens (Riggs et al., 1969 
and 1972; Van Paassen, 1979). 
During bone growth, when bone turnover is rapid, serum alkaline phosphatase 
activity, and the levels of serum phosphorus and urinary hydroxyproline are 
higher than during adulthood, when bone turnover has slowed down. 
It has been reported that women have lower plasma calcitonin levels than men, 
that during pregnancy and lactation plasma calcitonin levels are increased, and 
that women taking oestrogen/progesterone oral contraceptives show a similar 
increase in calcitonin levels (Stevenson, 1980). The physiological implications of 
these findings may be that calcitonin protects the bone against the resorptive 
action of PTH and 1,25-DHCC during periods of increased calcium requirements 
and that it provides the protective effect of oestrogens against bone resorption. 
Furthermore, the difference in plasma levels of calcitonin between sexes may be 
involved in the corresponding difference in rate of bone loss. 
4.3 Race 
There is convincing evidence that the prevalence of fracture and osteoporosis is 
much lower among people of African than among those of Caucasian back-
ground, that black males and females have a greater skeletal mass and that they 
lose less bone with age than their white counterparts (Moore et al., 1975; Cohn et 
al., 1977). The greater skeletal mass in black than in white women is associated 
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with a larger muscle mass (Cohn et al., 1977). It seems unlikely that these differ-
ences are due to factors other than genetic background. On the other hand, the 
earlier start and greater intensity of bone loss in Alaskan Eskimos, by 'white' 
standards, might be related to nutritional factors, such as low calcium, high 
protein and high phosphorus intake levels (Mazess & Mather, 1974). 
4.4 Pregnancy and lactation 
For the calcification of the human foetus 35 g calcium are required, most of which 
is delivered during the last trimester of pregnancy. As the amount of calcium in 
human milk ranges from 25 to 35 mg/100 ml and the daily output of breast milk is 
about 850 ml, up to about 50 g of calcium are required from the maternal body 
during a six-month lactation period. Plasma 1,25-DHCC levels are raised in early 
pregnancy, continue to increase throughout gestation, and remain elevated dur-
ing lactation (Kumar et al., 1979). Probably as a consequence, 25-HCC and 
24,25-DHCC concentrations in plasma decrease during gestation (Reiter et al., 
1979). It has also been reported that in late gestation plasma PTH levels tend to go 
up (Cushard et al., 1972). These changes in plasma levels of vitamin D metabolites 
and PTH undoubtedly reflect a physiological response to higher calcium 
requirements and explain why intestinal calcium absorption is increased in hu-
man pregnancy, as has been reported by Heany & Skillman (1971). Calcium 
balance may be negative during periods of high milk production in mammals as 
well as in the human species, in spite of large calcium intakes; it seems that during 
lactation bone calcium is more readily available than dietary calcium; the calcium 
balance again becomes positive when milk production declines and the maternal 
calcium stores are replenished (Irving, 1973). 
4.5 Physical activity 
It is wel known that bone adapts itself to environmental conditions. Stress and 
strain imposed upon the bone improve its trabecular structure, cortical thickness 
and density. Stress produces a piezo-electric response in bone, which stimulates 
osteoblastic activity. This effect, which may be an important factor with respect to 
increase of bone loss with age, is well illustrated by the observation that trabe-
c u l e subjected to the greatest stress and strain are the last to disappear as 
osteoporosis develops (Jowsey, 1977), and by the establishment that postmeno-
pausal bone loss can be prevented, at least on a one-year basis, by exercise 
programmes (Aloia et al., 1978). 
Resting in bed definitely increases the urinary excretion of calcium and 
phosphorus within a few days and this leads to a net loss of these minerals from 
the skeleton. Immobilization or denervation of a motor nerve of a limb is a com-
monly used technique for inducing disuse osteoporosis in laboratory animals 
(Kenny & Dacke, 1975). 
Aloia et al. (1978) observed that marathon runners had an 11% larger skeletal 
mass than that of more or less sedentary subjects. Furthermore it is known that 
manual labourers have more bone mass than sedentary workers (Jowsey, 1977). 
Emiola & O'shea (1978) found that young adults who were classified as highly 
active, on the basis of a questionnaire and a handgrip strength test, had denser 
finger bones than either moderately or lowly active groups. All these findings 
demonstrate the adaptive response of bone to muscular stress and strain. 
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4.6 Renal function 
Because the kidneys play an important role in the maintenance of calcium and 
phosphate homeostasis, it can be no matter of surprise that renal failure will upset 
this homeostasis. Indeed a complex disorder is known, called renal osteodys-
trophy, which occurs particularly in uremic patients suffering from end-stage 
renal failure, when the tubular function is less than about 30% of normal (glome-
rular filtration rate 40 ml/min) (Kumar, 1979). The bone lesions are mainly osteitis 
fibrosa and osteomalacia, the latter being more common in areas where vitamin D 
intake and/or exposure to sunshine are minimal; less frequently osteosclerosis is 
observed; osteoporosis is uncommon but is seen with increasing frequency 
among patients undergoing haemodialysis (David, 1975). It has been shown, for 
example by Juttman et al. (1979), that uremic patients lose bone and that this loss, 
as measured in the distal radius by 125l-photon absorptiometry, is roughly pro-
portional to the decrease in renal function (glomerular filtration rate between 5 
and 45 ml/min). 
The most important factor that contributes to the development of renal osteo-
dystrophy is secondary hyperparathyroidism. It is the first detectable abnormality 
in very early renal failure (glomerular filtration rate 70 to 80 ml/min). According to 
the 'Bricker hypothesis' (Bricker et al., 1969), a decline in the glomerular filtration 
rate leads to a small increase in plasma phosphate, as phosphate excretion is 
temporarily decreased. The rise in plasma phosphate depresses plasma-ionized 
calcium and it is this that triggers secretion of PTH, which in its turn decreases 
tubular reabsorption of phosphate and promotes a higher rate of phosphaturia 
per remaining nephron. In this way a new state of phosphate balance is obtained, 
but at the cost of a higher rate of PTH-secretion. In later stages of renal failure 
(glomerular filtration rate 30 ml/min) the body can no longer cope with the intake 
of phosphate, and hyperphosphataemia develops. 
Slatopolsky & Bricker (1973) have indeed found, from experiments with a ure-
mic dog model, that phosphate homeostasis is maintained at the cost of a higher 
rate of PTH secretion. They also showed that dietary phosphate restriction, in 
proportion to the reduction in glomerular filtration, could prevent the rise in 
hormone secretion. 
Patients with advanced renal failure have decreased circulating levels of 
1,25-DHCC (Eisman et al., 1976), which explains the decreased intestinal ab-
sorption of calcium, the low responsiveness of bone to PTH, the defective bone 
mineralization and the hyperparathyroidism, which have been observed in these 
patients (David, 1975; Duursma & Dorhout Mees, 1973). 
It is well known, from cross-sectional studies as well as from a longitudinal 
study, that the normal aging process is associated with a continuing linear decline 
in renal function; as measured by the creatinine clearance technique this decline 
amounts to about 30% in persons from 30 to 80 years (Rowe et al., 1976). Whether 
this loss of renal function has any consequences for the regulation of calcium and 
phosphate homeostasis remains to be established. 
4.7 Summary 
Several factors, directly or indirectly related to the metabolism of bone and bone 
minerals, appear to be associated with the normal aging process. These factors 
are: loss of bone mass, which may lead to osteoporosis, decrease in intestinal 
calcium absorption, decline in renal function and, probably, decrease in renal 
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synthesis of dihydroxylated vitamin D metabolites. It is not precisely known to 
what extent these features are interrelated. 
It is undoubtedly the hormonal status (oestrogen deficiency) in postmeno-
pausal females which makes them more predisposed to bone loss than males of 
the same age. Differences in race or genetic background are of significance in the 
etiology of osteoporosis as is illustrated by the fact that in black people this 
disease is relatively rare and bone loss with age proceeds at a lower rate than in 
whites. 
Physical activity is necessary for the maintenance of skeletal integrity. A de-
creased physical activity probably contributes to bone loss through age. 
The decrease in renal function with advancing age might be of importance from 
a nutritional point of view, since it has been shown that the adaptive response of 
the body to early renal failure is hyperparathyroidism. This disease can, as is 
apparent from an experimental study with dogs, be prevented by restriction of 
phosphorus intake levels. 
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Chapter 5 
Effects of nutritional factors on bone and bone mineral 
metabolism 
5.1 Introduction 
This chapter deals with the effect of nutritional factors on calcium and phosphate 
metabolism. Special attention is given to the influence of different amounts of 
calcium and phosphate in the diet, but first some remarks will be made on other 
dietary components which have indirect effects in this respect. 
5.2 Fat 
Dietary fat is a vehicle for vitamin D and facilitates its intestinal absorption, which 
in patients with fat malabsorption (steatorrhoea) is insufficient. The intestinal 
calcium absorption is depressed by the formation of insoluble calcium soaps in 
the more distal parts of the intestine (ileum) where conditions are more alkaline. 
The formation of these calcium soaps is increased as the digestibility of the 
dietary fat is lower. Depending on the sequence of the fatty acids in the glycerol 
molecule, their chain length and degree of saturation, triglycerides may differ in 
digestibility. In general the intestinal absorption of long-chain fatty acids ( > C18) 
is lower than that of short-chain, medium-chain and unsaturated fatty acids (La-
val-Jeantet & Laval-Jeantet, 1976). It has been shown that a triglyceride contai-
ning a long-chain fatty acid in the terminal position is more readily absorbed than 
a fat in which such a fatty acid is situated centrally (Barltrop, 1974). 
5.3 Lactose 
5.3.1 In laboratory animals 
It is well known that lactose (milk sugar) stimulates the intestinal absorption and 
retention of calcium, but the mechanism underlying this effect remains unresolv-
ed as yet (Ali & Evans, 1973). According to Vaughan & Filer (1960), lactose 
shares this property with other carbohydrates. These also have a low digestibility, 
with the result that they reach the ileum, where the effect referred to is exerted. 
Armbrecht & Wasserman (1976) obtained evidence that lactose interacts with the 
absorptive cells, which leads to an increase in the permeability to calcium. Pansu 
et al. (1979) observed that feeding of lactose to rats (30% in the diet) was asso-
ciated with a lower concentration of calcium-binding protein in the mucosa. It is 
therefore realistic to suggest that lactose depresses the synthesis of 
1,25-DHCC. 
5.3.2 In man 
The positive effect of lactose on calcium utilization has been confirmed by means 
of experiments with humans (Mills et al., 1940; Kobayashi et al., 1975; Condon et 
al., 1970). However, this effect has been found to be absent in lactase-deficient 
(lactose intolerant) people, who showed a diminished calcium absorption after 
lactose ingestion (Condon et al., 1970; Kocian et al., 1973). On the other hand, 
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Pansu & Chapuy (1970) reported calcium absorption to be enhanced by lactose in 
lactase deficient subjects. 
Flatz & Rotthauwe (1973) have postulated that the lactose tolerance (sufficient 
lactase activity in the intestine) in northern and western Europeans is a selective 
advantage in countries where vitamin D intake and exposure to sunshine are low 
and a tendency to develop vitamin D deficiency exists. The beneficial effect of 
lactose on calcium absorption would be of importance in the prevention of rickets 
and osteomalacia under these conditions. 
A high prevalence of lactase deficiency (47%) was observed by Birge et al. 
(1967) among patiens with osteoporosis. In patients who had undergone partial 
gastrectomy, Kocian et al. (1973) found significantly more thinning of the clavicle 
cortex in those who were lactase deficient than in those with normal lactase 
activity. More recently, Newcomer et al. (1978) reported in a well-controlled study 
that among 30 women with postmenopausal osteoporosis 8 were lactase defi-
cient, whereas among 31 control subjects without metabolic bone disease only 
one subject showed lactose intolerance. In this study, intakes of lactose and 
calcium were significantly lower in subjects with lactase deficiency than in those 
with normal lactase activity, because the former left dairy products out of their 
diets, even while they were not aware of their lactose intolerance. So it has been 
suggested that a low grade of calcium deficiency associated with lactose intoler-
ance contributes to the pathogenesis of osteoporosis (Anonymous, 1979). 
5.4 Proteins 
5.4.1 In laboratory animals 
As early as 1956, Wasserman et al. reported that the presence of certain amino 
acids, particularly lysine and arginine, in the intestinal tract improved calcium 
absorption. Engstrom & DeLuca (1963) investigated the effects of increasing 
amounts (from 18 to 36%) of three types of protein in the diet (egg-white, blood 
fibrin and casein) on calcium metabolism in growing rats fed a low-phosphorus 
diet (0.02%). In relation to egg-white, an increase in the net intestinal absorption 
and urinary excretion of calcium and a decrease in the femur-ash content were 
observed. Blood fibrin induced similar changes but had no effect on the fe-
mur-ash content, and casein increased the intestinal absorption of calcium and 
the femur ash content but had no effect on urinary calcium. The specific charac-
teristic of egg-white, its reducing effect on the femur-ash content, disappeared 
when conalbumin, ovomucoid and lysozyme were removed from it. Denis et al. 
(1973) reported that a rise in the protein content (blood fibrin) of a low-calcium, 
low-phosphorus diet of young growing rats from 3.3 to either 11 or 33%, increased 
the epiphyseal plates. These effects were found to be independent of PTH and 
calcitonin, as they also occurred in thyro-parathyroid- and parathyroid-ectomized 
rats. Bell et al. (1975) demonstrated, by means of experiments with adult rats fed 
adequate amounts of dietary calcium and phosphorus, that an increase in the 
prctein content of the diet from 10 to either 20 or 40% (by adding equal parts of 
lactalbumin and gelatin to a 10% casein diet) was associated with a shift in the 
route of endogenous calcium excretion from faeces to urine, and with an increase 
in intestinal calcium absorption. It was found to have no effect on the rate of bone 
resorption. 
More recently, Allen & Hall (1978), who worked with growing rats, reported that 
a high-protein diet (36% casein), as compared with a control diet (18% casein), 
resulted in a temporary increase (for the first two weeks) in urinary calcium 
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excretion. Other parameters of calcium metabolism (body calcium retention, 
intestinal absorption and intestinal calcium-binding protein content, bone turn-
over, bone development and plasma concentration) remained unchanged. En-
dogenous faecal calcium excretion, however, was reduced in animals fed the 
high-protein diet for 14 and 28 days, although this effect was not mentioned 
explicitly. A recent paper by Whiting & Draper (1980) shows that the degree of 
hypercalciuria seen with high-protein feeding in the rat depends on the duration 
of the diet period and on the type and level of protein used. A peak excretion 
occurs two days after feeding of the high-protein diet has started. The paper 
demonstrates the existence of positive correlations between the urinary excretion 
of calcium, that of sulphate and the content of sulphur-amino acids (methionine 
and cystine) of the diet. 
5.4.2 In man 
There is increasing evidence that the amount of dietary protein affects calcium 
metabolism. As early as in 1920, Sherman reported that a man who maintained 
calcium balance when given a diet supplying 390 mg calcium daily, lost body 
calcium when meat was added to his diet. McCance et al. (1942) observed that a 
raise in the protein content of the diet of three healthy subjects resulted in 
increased urinary excretion and intestinal absorption of calcium and magnesium. 
It was suggested that the primary action of dietary protein was that it increased the 
intestinal calcium absorption. More recent studies, carried out mainly by the 
group of Linkswiler and co-workers (Johnson et al., 1970; Walker & Linkswiler, 
1972; Anand & Linkswiler, 1974; but see Linkswiler et al., 1974), have confirmed 
the hypercalciuric effect of dietary protein and have shown that this effect is not 
secondary to an increased intestinal absorption. These investigators studied the 
effect of three levels of dietary protein (47, 95 and 142 g/day) in healthy young 
male adults during 15-day experimental periods at three levels of calcium intake 
(500, 800 and 1400 mg/day). Regardless of the level of calcium intake, urinary 
calcium increased with the protein content of the diet. If calcium intake was low 
(500 mg/day), the intestinal absorption of calcium was unaffected by the protein 
content of the diet, and calcium retention became negative if the protein content 
of the diet was raised from 47 to either 95 or 142 g /day. At higher levels of calcium 
intake an increase in the protein content of the diet was associated with an 
increase in the intestinal calcium absorption, the maximal effect being reached at 
the 95 g protein level. Almost all balances were negative at the highest level of 
protein intake. Kim & Linkswiler (1979) have shown that the calciuric effect of 
dietary protein is caused by a change in the renal handling of calcium: in a ten-day 
experimental study with six healthy adults, a 142 g protein diet, as compared with 
a control diet containing 47 g protein, resulted in an acceleration of the glome-
rular filtration, an increase in the filtered calcium load, and a reduction of the 
tubular reabsorption of calcium. These effects were associated with a slight, 
though not significant increase in the urinary excretion of hydroxyproline and 
were not related to parathyroid function. The calciuric effect of an increase in the 
amount of dietary protein from 47 to 112 g/day has recently been demonstrated 
by this group in older men and women (Schuette et al., 1980). In these people, 
who consumed about 800 mg calcium per day, the calcium balance became more 
negative whereas the circulating levels of 1,25-DHCC and PTH and the urinary 
excretion of cAMP remained unchanged. 
The findings described above were obtained in experiments with humans who 
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were given purified proteins, care being taken that other dietary components 
known to affect calcium metabolism were kept constant. This probably explains 
the somewhat different results obtained by Spencer et al. (1978 a). They found 
that an increase in the protein intake from 1 to 2 g/kg body weight by the ingestion 
of meat had no effect on urinary calcium when the calcium intake was either 200 
or 800 mg/day, and only had a temporary effect in this respect when calcium 
intake was 1100 or 2000 mg/day. It was assumed that the calciuric effect of 
protein was counteracted by a concomitant increase in the intake of phosphate 
(see Section 5.10.2). 
Licata et al. (1979) have stressed that the calciuric effect of dietary protein has 
to be taken into account with respect to evaluation and treatment of patients with 
hypercalciuria and urolithiasis. It has been hypothesized on the basis of a retro-
spective clinical and dietary survey that consumption of animal protein is a factor 
in the incidence of urinary calculi (Anonymous, 1980). 
5.5 Acid-base balance, dietary acidity 
When adult rats were subjected to acid stress by the addition of 1.5 or 2% NH4CI to 
their drinking water for 6 to 11 months, femur bone loss occurred independently 
of the level of dietary calcium (Barzel & Jowsey, 1969; Barzel, 1969). However, 
Newell & Beachene (1975) could not demonstrate any loss of bone mineral from 
the tibias in 13- and 25-month old rats which were fed diets containing 2% NH„CI 
with either 0.1 or 0.5% dietary calcium for nine months. But the acid-stressed 
animals, particularly those fed the low-calcium diet, had a decreased urinary pH, 
excreted more titratable acid with the urine and had an increased urinary excre-
tion of calcium, phosphorus and ammonia. In addition, the renal phosphate-de-
pendent glutaminase activity had increased in these animals and their serum 
calcium and phosphate levels tended to be depressed. These observations indi-
cate that rats may adapt themselves to an acid load and maintain acid-base 
balance without loss of minerals from the skeleton. This view is supported by the 
results of a study made by Bell et al. (1976), who demonstrated that rats fed acid 
diets excreted amounts of labelled calcium resorbed from the bones that were 
very similar to the amounts excreted by rats fed neutral diets. In the first 
mentioned animals the route of endogenous calcium excretion was found to have 
shifted from faeces to urine. Human subjects on acid diets showed increased 
urinary excretion of calcium, which appeared to be due to decreased calcium 
reabsorption from renal tubules (Lemann et al., 1979). According to these inves-
tigators, this phenomenon is not related to PTH or 1,25-DHCC. On the contrary, 
Wachman & Burnstein (1970) reported that NH„CI-acidosis in five healthy sub-
jects resulted in a higher serum PTH concentration associated with an increased 
excretion of calcium, phosphorus, magnesium and hydroxyproline in the urine, 
and negative calcium balances. The same investigators (Wachman & Burnstein, 
1968) have framed the hypothesis that the acid load associated with the con-
sumption of high-protein omnivorous diets in western communities is a contribu-
ting factor in the etiology of osteoporosis. 
5.6 Vitamin D 
The importance of vitamin D in the regulation of the calcium metabolism has been 
discussed in Chapter 3. Vitamin D deficiency causes rickets in the child and 
osteomalacia in the adult, with the well known classical symptoms: the histologi-
cal picture of the bone is characterized by failure of mineralization as it undergoes 
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remodelling, leaving wide zones of unmineralized osteoid at the junction of mi-
neralized bone and the layer of osteoblasts; serum calcium is normal or low, and 
serum phosphorus is reduced; alkaline phosphatase activity is increased and 
secondary hyperparathyroidism occurs. Hypervitaminosis D, a toxic condition 
resulting from excessive intake (more than 2000 units daily) over several weeks, is 
associated with hyperabsorption of calcium, hypercalciuria, renal calcinosis, 
progressive renal insufficiency and hypercalcaemia. The hypercalcaemia causes 
anorexia, nausea, obstipation, thirst and polyuria (Harrison, 1975). 
5.7 Dietary fibre, phytate and oxalate 
Dietary fibre (cellulose, lignin and non-cellulose polysaccharides) impairs the 
intestinal absorption of minerals, particularly calcium, magnesium, iron and zinc. 
Thus it is known that a high proportion of whole-wheat products in the diet may 
cause a negative calcium balance in man, despite calcium intakes as high as 1300 
mg/day (Cummings, 1978). Traditionally this effect is attributed to the cal-
cium-binding properties of phytic acid, a cell-wall constituent of cereals. Howev-
er, it has been shown by James et al. (1978) that uronic acids also have strong 
binding properties in this respect. These investigators estimate that a typical 
western diet, which contains on average 12.3 mmol uronic acids, can bind about 
3.8 mmol calcium ( = 152 mg). In tropical communities with a much higher intake 
of dietary fibre, the calcium binding capacity of uronic acids may exceed the 
calcium intake. However, microbial digestion of uronic acids in the colon will 
liberate the calcium, so that colonic absorption of calcium may occur, particularly 
since the transit time of food residues in the colon is about 20 times that in the 
small intestine. Experiments with rats suggest that the large intestine may play a 
role in calcium homeostasis by colonic calcium absorption, particularly when the 
calcium intake is restricted (Petith etal., 1976). 
Oxalate, present in foodstuffs such as rhubarb, spinach and purslane, binds 
calcium irreversibly in the intestinal tract. The calcium-oxalate complex formed is 
unavailable for absorption. 
5.8 Fluoride 
Fluoride is a 'bone-seeking' mineral: in rats 6% of a dose of radio-fluoride can be 
detected in the skeleton within two hours after administration. The incorporation 
of fluoride in bone and teeth results in a more stable mineral phase, the fluoro-
hydroxyapatite. Experiments showed that, when the fluoride content of the diet 
fed to weanling rats was increased from 0.2 to 200 mg/kg for a period of four 
weeks, the fluoride content of the bone was 200 times, that of plasma and liver 3 
times, and that of the kidneys 8 times as high as the corresponding levels in 
control animals (Deshmuth et al., 1970). Administration of fluoride has been 
reported to result in stimulation of osteoblasts and in formation of poorly minera-
lized osteoid; this leads to secondary hyperparathyroidism with increased bone 
resorption. By increasing the calcium and vitamin D content of the diet, the oste-
oid can be mineralized and hyperparathyroidism prevented (Jowsey et al., 1972). 
Excessive dietary fluoride causes fluorosis, the symptoms of which are mottled 
enamel and white patches on the teeth, and osteosclerosis, characterized by 
thickened and densely calcified bones and bony outgrowths (exostoses). It has 
been tested whether fluoride could prevent periodontal disease and osteoporosis 
in dogs which were fed diets with a low calcium and a high phosphorus content; 
the results were negative (Henrikson etal., 1970). 
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People living in areas where the fluoride content of the drinking water is high 
show a decreased incidence of both caries and osteoporosis; in the Netherlands 
Melman et al. (1973) found that in almost all age groups, people living in the town 
of Tiel, who received fluoride in their drinking water (1 mg/l), had a higher radial 
bone density than people living in the control town of Culemborg. Fluoride and 
vitamin D, used in the treatment of osteoporosis, were found to increase the 
amount of bone (Van Kesteren, 1978). 
5.9 Calcium 
5.9.1 In laboratory animals 
5.9.1.1 Calcium metabolism 
It is known that intestinal calcium absorption, expressed as a fraction of the 
calcium intake, decreases when calcium is added to the diet (Hansard & Plumlee, 
1954; Whittemore et al., 1973; Clark, 1969) or when body stores of calcium are 
filled (Nicolayson et al., 1953). It is now generally accepted that this adaptive 
response is regulated by the active intestinal transport system which is under the 
control of vitamin D metabolism (see Chapter 3). Hansard & Plumlee (1954) have 
shown that in the rat the endogenous faecal route of calcium is used as an 
excretory pathway when the dietary calcium content is varied. The cause of this 
phenomenon, which does not appear to occur in man to any significant extent, is 
that in the rat the urinary calcium excretion is very low (usually less than 1 mg/day 
or less than 1 % of the amount ingested). This remarkable species difference has 
been demonstrated by Wanner et al. (1956) by injecting 45Ca intravenously and by 
determining the ratio of faecal to urinary 45Ca in excreta collected for five days 
after injection of the tracer. In rat and dog this ratio was 22/1 and 10/1 respec-
tively, and in man and monkey it was 112. There is no information available as to 
whether this endogenous-faecal calcium excretion in the rat is under hormonal 
control. 
5.9.1.2 Phosphorus metabolism 
Hansard & Plumlee (1954) have demonstrated that an increase in the calcium 
content, from 0.013 to 0.5%, of the diet of rats stimulates the faecal excretion of 
injected 32P and diminishes the urinary excretion of this isotope. This effect may 
be attributed to depression of PTH secretion. Clark (1969) has shown that the 
intestinal absorption of phosphate is directly proportional to its intake, but 
inversely proportional to calcium intake. He also demonstrated that low dietary 
calcium increases the intestinal absorption of magnesium. 
5.9.7.3 Osteoporosis 
There is a lot of evidence showing that feeding rats calcium-free or calcium-defi-
cient diets (approx. 0.02% calcium) results in osteoporosis, irrespective of the age 
of the animals; in young rats bone formation is reduced and in older animals bone 
removal predominates (Volpin & Salomon, 1978). Similar observations have been 
made in chicks, rats, pigs and dogs (Sevastikoglou et al., 1977). Bone loss is 
accelerated in aging female mice after fertility and in adult ovariectomized rats, 
when they are given a low-calcium diet(Ambrusetal., 1978; Blanusaetal., 1978). 
The osteoporotic changes induced by dietary calcium deficiency are extreme in 
lactating rats: Rasmussen (1977 a and b) reported hypocalcaemia, slightly ele-
vated serum phosphorus and hydroxyproline, and reduction in the femur-ash 
content of the trabecular bone at the proximal and distal parts and, to a lesser 
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extent, of the cortical bone of the diaphyseal shaft. Histologically, there was 
reduced apposition of bone at the periosteal surface and increased resorption of 
bone at the endosteal surface of the diaphysis. Calcium deficiency is associated 
with increased circulating levels of PTH and 1,25-DHCC (Rader er al., 1979). 
Stauffer et al. (1973) reported that calcium deficient rats with hypocalcaemia 
develop a mineralization defect similar to that seen in hypocalcaemic vitamin 
D-deficient animals, but bone resorption is much higher in the former than in the 
latter. Whether the osteoporotic changes induced by dietary calcium deficiency 
are completely reversible remains a matter of debate; reversibility seems to de-
pend on the age of onset and on the length of the period during which the animal 
is subjected to calcium deficiency (Sevastikoglou et al., 1977). 
5.9.2 In man 
5.9.2.1 Calcium metabolism 
Heany et al. (1975) have confirmed the inverse relationship between intake and 
fractional absorption of calcium in man. They gave a mathematical equation for 
the absorption (y) versus intake (x), which consists of an exponential term, rep-
resenting a controlled active process, and a linear component, representing a 
passive process solely related to the level of intake: 
y = 0.3127 e"10539x+ 0.1541 x (x and y in g/day). 
Thus an enlargement of the calcium intake leads to increased net calcium ab-
sorption, which within 24 hours causes a rise in the filtered load of calcium and a 
drop in the circulation levels of PTH, and within 24 to 36 hours a decrease in 
serum levels of 1,25-DHCC. As can be expected from the equation described 
above, urinary calcium excretion depends slightly on calcium intake; at a given 
variation of calcium intake the urinary calcium changes by an average of only 6% 
(Lemann et al., 1979). Excretion of endogenous calcium in faeces is known to be 
largely independent of calcium intake, and amounts to about 150 mg/day. How-
ever, Spencer et al. (1964) found that endogenous-faecal calcium excretion in 
three osteoporotic subjects was 60 to 96 mg/ day during periods of a low calcium 
intake (75 to 177 mg/day) and 75 to 144 mg/day during periods of a high calcium 
intake (880 to 1505 mg/day). 
5.9.2.2 Phosphorus metabolism 
Dietary calcium increases the faecal excretion of phosphorus and decreases its 
urinary excretion. According to Spencer et al. (1964,1965 and 1978b), this shift is 
caused by the formation of insoluble calcium phosphates in the intestinal tract. 
5.9.2.3 Calcium requirement and allowance 
There is no general consensus of the calcium requirement of adult humans, which 
is illustrated by the fact that calcium allowances may differ substantially in various 
countries. For example, the FAO/WHO allowance for adults is 400 to 500 mg/day, 
whereas in the USA the Food and Nutrition Board recommends 800 mg/day for 
this group. The FAO/WHO committee on calcium requirements is of opinion that 
calcium intake may be low, since there are no clear-cut signs of calcium defi-
ciency in countries where calcium intake is supposed to be as low as 300 mg/day, 
and since man is able to adapt himself to low levels of calcium intake, as has been 
shown by Hegsted et al. (1952) and by Malm (1958). Proponents of a high level of 
calcium intake, however, point out that adaptation to low levels is not a desirable 
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Situation. One of their arguments is that Malm (1958) has shown that some people, 
particularly older ones, may find difficulties in such an adaptation or do not adapt 
at all, and another that cultural differences in dietary pattern (high intake of 
protein and phosphate) may increase calcium requirements. Anyhow, the results 
of calcium balance studies raise doubt of the general applicability of the 
FAO/WHO allowance. Thus Malm (1958) found that the average calcium requi-
rement of 25 prisoners in Norway, who were fully adapted to a low calcium intake, 
was 440 mg per day (range 337 to 617 mg). The calcium allowance for such 
people should largely exceed 400 to 500 mg/day. Marshall et al. (1976), in a 
recent review of 212 calcium balances in 84 subjects, found that most balances 
were negative at intakes below 600 mg calcium per day. These workers point out 
that the recommended intake that would preserve calcium balance in most of the 
population may be as high as 900 mg/day. 
Heany et al. (1977) found a weak but significant correlation between calcium 
intake and calcium balance in 130 perimenopausal women who had a mean 
calcium intake of 661 mg/day. On an average, the calcium balance in these 
women was slightly negative. On the basis of these findings, which indicate that 
the actual calcium intake was suboptimal, the investigators computed the calcium 
requirement (to maintain zero balance for the group as a whole) at 1.24 g/day. It 
should be recognized that balance studies are liable to large errors. The main 
reasons for this are the difficulties associated with the accurate measurement of 
intake and output, and the statistical fact that the small difference between intake 
and output cannot be determined with a high degree of precision. 
5.9.2.4 Calcium deficiency and osteoporosis 
Calcium deficiency in man is not well recognized. There are two case reports 
(Waltz et al., 1970; Kooh et al., 1977) in which the existence of dietary calcium 
deficiency in two infants is mentioned. The disease was characterized by rick-
ets-like symptoms, such as rachitic rosary, enlargement of the epiphyseal regions 
of the long bones, low serum levels of calcium and phosphorus, increased alka-
line phosphatase and aminoaciduria. Only in the report by Kooh et al. were 
vitamin D deficiency and resistance excluded. Recently Pettifor et al. (1979) 
described high incidence of hypocalcaemia, increased alkaline phosphatase and 
low urinary excretion of calcium in black schoolchildren living in a rural commu-
nity in South Africa. These abnormalities were attributed to a low calcium intake 
(125 mg/day) as they did not occur in children who consumed some milk (calcium 
intake 337 mg/day), and they disappeared after calcium supplementation. 
Whether osteoporosis in man is, in part, the result of dietary calcium deficiency 
is still a matter of discussion. Several groups of investigators have claimed to 
possess evidence, on the basis of retrospective studies, that a low calcium intake 
is more prevalent in osteoporotic patients than in control subjects, but other 
groups have reported negative results (Exton-Smith, 1972). In many studies in 
which calcium consumption is related to osteoporosis or to bone mass, the lack of 
a control group matched with the experimental group as regards sex, age, height 
and weight, ethnic background and geographic area is evident. Furthermore, a 
reliable estimate of the subject's individual habitual calcium intake is difficult to 
obtain. It is for these reasons that results of retrospective studies have to be 
interpreted with care. In this respect Reshef et al. (1971) found a negative corre-
lation between calcium intake and severity of osteoporosis. This correlation, 
however, was age-dependent, since calcium intake decreased with age and 
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osteoporosis was more common in the elderly than in the young. Nordin (1960), 
who revived the calcium deficiency theory, reported that 71 osteoporotic patients 
had a calcium intake of 13.4 mg/kg/day, whereas 69 control subjects consumed 
17.9 mg/kg/day. However, the control subjects differed markedly from the 
osteoporotic patients as their average body weight exceeded that of the latter by 
14 kg. 
There are other lines of evidence which indicate that a low calcium intake 
predisposes to osteoporosis. The high incidence of this disease in patients suf-
fering from lactose intolerance has already been stressed (see Section 5.3.). The 
administration of either calcium supplements alone (Lutwak, 1974; Recker et al., 
1977) or calcium supplements with vitamin D (Albanese et al., 1973; Riggs et al., 
1976) has proved to be effective in inhibiting bone loss with age. Cohn et al. (1968) 
have demonstrated in a study with seven osteoporotic patiens that calcium sup-
plements inhibit bone resorption. 
Matkovic et al. (1979), in a cross-sectional study among two rural populations in 
two Yugoslavian districts, found that in both men and women the relative cortical 
area of the second metacarpal bone was larger and the femur fracture rate was 
lower in a cattle raising district where dairy products were consumed than in a 
purely agricultural district where the consumption of these products was low. The 
difference in the amount of cortical bone which was already present at adult age, 
could not be attributed to genetic or geographic factors, tended to decrease with 
age, and was probably the consequence of a large difference in calcium con-
sumption between the two population groups (one group twice as much as the 
other). 
5.10 Phosphorus and the calcium-to-phosphorus ratio 
5.10.1 In laboratory animals 
5.10.1.1 Calcium and phosphorus metabolism 
Feeding rats phosphorus-deficient diets (approx. 0.03% P) leads to phosphorus 
depletion, cessation of growth and characteristic biochemical changes including 
hypercalcaemia, hypophosphataemia, hypercalciuria and hypophosphaturia 
(Lee et al., 1979). In addition, as demonstrated by Rader et al. (1979), circulating 
levels of 1,25-DHCC are increased and serum levels of PTH are decreased in rats 
fed 0.04% dietary phosphorus instead of 0.6%. 
In recent years a great deal of attention has been given to the effect on bone 
metabolism of diets with either a high phosphorus content or with a low 
Ca/P-ratio; according to Krook et al. (1975), such diets with their relative excess 
of dietary phosphorus slightly depress the serum-ionized calcium concentration, 
which stimulates the parathyroid glands and leads to nutritional hyperparathy-
roidism. Scott & Greaves (1961) induced a generalized osteitis fibrosa in young 
cats which were fed beef heart for six to eight weeks. As a result of this all-meat 
diet, with a Ca/P-ratio of 1/20, the parathyroids of the animals were enlarged, 
hypertrophic and hyperplastic. Addition of calcium carbonate, in amounts suffi-
cient to obtain a Ca/P-ratio of 1 /2, only delayed the osteopathy, whereas addition 
of calcium carbonate and gluconate until a Ca/P-ratio of 1/1 was reached, 
prevented the skeletal lesions. More recently Clark & Brashear (1976) induced 
osteitis fibrosa cystica and nephrocalcinosis in adult rats by feeding them a diet 
with a normal calcium content (0.4%) and a very high phosphorus content (3.2%) 
for two months. Very interesting in this respect is the extensive work, mainly on 
aging rats and mice, carried out by the group of Draper and co-workers. Initially 
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they showed (Shah et al., 1967) that the femur-ash content of aged mice was 
significantly influenced by feeding them diets with different Ca/P-ratios for 14 
months. A ratio of 2/1 always resulted in higher bone-ash contents than did a ratio 
of 1/1 at levels of dietary calcium that varied between 0.1 and 1.2%. A further 
study of mice which were fed diets high in calcium (1.2%) (Krishnaro & Draper, 
1972) showed that in animals of 11 months and over a reduction of dietary 
phosphorus from 1.2 to 0.6% lowered bone loss during the following seven 
months. Draper and co-workers, in a series of experiments with adult rats, inves-
tigated the effect of dietary phosphorus upon the mobilisation of calcium from 
bone by monitoring the excretion of 45Ca that had been injected one month before 
the start of the dietary studies (Anderson & Draper, 1972; Draper et al., 1972; Sie 
et al., 1974). It was demonstrated that high-phosphorus diets (1.2%) with a normal 
(0.6%) or a high (1.2%) calcium content stimulated bone resorption, that this 
effect could be eliminated by parathyroidectomy and that the high-phoshorus 
diets stimulated PTH-synthesis and reduced urinary excretion of calcium. 
Meal-fed rats on a high-phosphorus diet exhibited depressed serum-calcium 
concentrations in postprandial as well as in fasting blood samples. The bone mass 
of these rats was reduced, but the chemical composition of the bones was found 
to be normal. Even a diet with 0.6% dietary phosphorus and 0.6% calcium gave, 
during a six-month period, a 16% higher excretion of 45Ca than did a similar diet 
with 0.3% dietary phosphorus. A 1.8% phosphorus diet (0.6% calcium) produced 
calcification of soft tissues (kidneys and heart). Although the technique of moni-
toring the excretion of stable 45Ca from the skeleton is very sensitive as regards 
the resorption of calcium from bone, it cannot be used for differentiating between 
net loss of bone and increased bone turnover. 
The observations made by the group of Draper regarding aging bone loss in 
rats rely on determinations of bone ash, since differences in the retention of 
calcium could not be demonstrated. 
Another group of investigators, Jowsey and co-workers, studied the effects of 
dietary phosphate supplements in rabbits (Jowsey & Balasubramanian, 1972) and 
in adult dogs (Laflamme & Jowsey, 1972). In rabbits a decrease in the Ca/P-ratio 
from either 1.7 to 0.55 or from 1.1 to 0.42 by the addition of phosphate resulted in 
increased porosity of the bones, as shown by microradiography, and in calcifi-
cation of soft tissues (kidneys and thoracic aorta). In dogs, long-term dietary 
phosphate supplementation (forten months) led to higher bone resorption, loss of 
bone tissue, increased bone porosity and raised circulating levels of PTH. In 
addition, calcification of soft tissues (kidneys, thoracic aorta, tendon and 
eye-lens) was observed in animals fed the high-phosphorus diets. The feeding of 
these diets was further associated with a post-prandial decrease in serum-ionized 
calcium and an increase in serum phosphorus. In fasting serum samples, 
however, calcium was normal and phosphorus slightly depressed. Serum 
phosphorus was found to correlate negatively with the bone resorption rate. 
Increased PTH-activity in serum was reflected by a 40 to 60% decrease in urinary 
calcium excretion. Urinary phosphorus increased by a factor of 2 to 3, which 
illustrates the lack of a barrier against intestinal phosphate transport. The 
phosphate-supplemented dogs had a phosphorus intake of about 0.22 g/kg/day, 
roughly three times the amount fed to the control animals. 
In contrast to the findings described above, Anderson et al. (1977) reported that 
diets with a low dietary Ca/P-ratio (0.30% Ca and 1.20% P, or 0,95% Ca and 2.0% 
P) had no significant effects on either the skeleton or plasma calcium, phospho-
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rus and alkaline phosphatase in young growing and maturing Cebus monkeys. 
This observation might indicate that a species difference exists with respect to the 
response to changes in dietary calcium and phosphorus content, or that this 
response depends on the age of the animal. 
5.10.1.2 Nephrocalcinosis 
Of particular interest is the dietary induction of nephrocalcinosis. It is clear that 
this condition can be induced by means of diets with a high phosphorus content, 
particularly if these diets are semi-purified with highly available inorganic phos-
phates (Woodard, 1971; Goulding & Malthus, 1969; Van Beek et al., 1974). In 
female rats fed a semi-purified diet even 0.5% dietary phosphorus appeared to be 
sufficient to induce nephrocalcinosis (Hitchman et al., 1979). The significance of 
the calcium content of the diet in this respect remains indistinct. According to 
Woodard (1971 ), increasing dietary calcium worsens the lesions, but Hitchman et 
al. (1979) reported decreased severity of renal calcification in rats on an 0.5% 
phosphorus diet when the dietary calcium content was raised from 0.5 to 1.0%. 
Among rats of different strains the susceptibility to nephrocalcinosis varies, and 
female rats are more susceptible than male animals (Du Bruyn, 1970). 
5.10.2 In man 
5.10.2.1 Phosphorus requirement 
Phosphorus nutrition in man has never received considerable attention, because 
nutritionists are generally of opinion that phosphorus is no problem as long as 
calcium intake is satisfactory. Phosphates are so ubiquitous in foods that the 
occurrence of a state of deficiency is very unlikely. An estimate of the average 
level of phosphorus intake, based on Dutch market figures, is1520mg/day, butin 
a sub-population of farmers the intake averaged about 2200 mg/day (El-Shaara-
wy, 1971 ). On the basis of balance studies, collected from the literature, Marshall 
et al. (1976) have reported that the intake is very close to the output of phosphorus 
down to levels of 400 mg/day. These investigators commented that balance 
studies below this level will be needed to define a phosphorus requirement. In the 
USA 800 mg is the recommended daily allowance for adults, and this seems a 
generous amount. 
5.10.2.2 Calcium metabolism 
According to Irving (1973), it might be concluded on the strength of evidence that 
in healthy subjects large increases in phosphorus ingestion, either as phosphoric 
acid or as neutral phosphate, do not affect the calcium balance or the absorption 
of calcium to any significant extent. This conclusion is based on the results of 
calcium balance studies, such as those made by Malm (1953) and Spencer et al. 
(1965). More recent studies by Spencer et al. (1975 and 1978b) have confirmed 
this conclusion. 
On the other hand, dietary phosphorus affects several parameters of calcium 
metabolism. Thus Reiss et al. (1970) reported that an oral dose of phosphate (1 g 
P) to five healthy adult subjects resulted in a 60 tot 125% increase in serum PTH, 
initiated by a small decrease in total and ionized serum calcium. This observation 
is consistent with the well known phenomenon that an increase in phosphorus 
intake diminishes urinary calcium excretion (Malm, 1953; Spencer et al., 1965, 
1975,1978a, 1978b; Bell et al., 1977a). Bell et al. (1977a) studied the physiological 
response in eight students to foods containing phosphate additives. Commer-
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cially available foods containing phosphate additives were substituted for natural 
foods. As a result of this substitution, phosphorus intake was increased from 979 
mg/day during the four-week control period to 2124 mg/day during the four-week 
experimental period, whereas calcium intake only changed from 677 to 715 
mg/day in these eight weeks. The high-phosphorus diets significantly depressed 
the urinary excretion of calcium (by 37% on average), and increased the urinary 
phosphorus excretion (by 112% on average). Also the urinary hydroxyproline 
excretion increased, whereas six subjects out of eight showed a larger urinary 
cAMP excretion. Serum calcium was found to be depressed up to three hours 
after the high-phosphorus evening meal, whereas no such depression was ob-
served after the control evening meal. The depression of serum calcium was 
associated with an increase in the post-prandial serum-phosphorus concentra-
tion. These observations are consistent with the view, based on studies with 
laboratory animals, that high-phosphorus diets stimulate PTH-secretion and bone 
resorption. 
With regard to the effect of low-phosphorus diets on calcium metabolism, it has 
been shown by Dominguez et al. (1976), in an investigation concerning eleven 
healthy adults, that phosphate depletion (phosphorus intake about 90 mg/day) is 
associated with an increase in urinary calcium, and in intestinal calcium absorp-
tion, and with negative calcium balances (particularly in females), hypophospha-
taemia (in females but not in males), depressed serum PTH-levels and increased 
turnover of the serum 25-HCC-pool, probably as a consequence of enhanced 
renal synthesis of 1,25-DHCC. In addition, urinary phosphate excretion was re-
duced to less than 3 mg/day. 
5.10.2.3 Relation to osteoporosis 
Although there is no doubt that phosphorus intake is generally far above the 
amount required to maintain phosphorus balance, there is no conclusive or direct 
evidence that a high phosphorus intake or a low dietary calcium-to-phosphorus 
ratio contributes to the high incidence of osteoporosis in western communities. 
However, in addition to the observations made by Bell et al. (1977a) and Reiss et 
al. (1970) (see Section 5.10.2.2), which strongly support the evidence from stu-
dies with laboratory animals that diets with either a low calcium-to-phosphorus 
ratio or a high phosphorus content lead to nutritional secondary hyperparathy-
roidism, there are several indications which link a high phosphorus intake or a low 
dietary Ca/P-ratio with osteoporosis in man. Thus a study of bone density in 25 
elderly ovo-lacto-vegetarians, reported by Ellis & Ellis (1972), revealed that these 
people had significantly denser bones and lost less bone with age than did sex-
and age-matched omnivorous control subjects. These differences could be due 
to a more favourable Ca/P-ratio in the diets of the vegetarians. Mazess & Mather 
(1974) measured the bone mineral content in Alaskan Eskimos and found a 
greater bone loss with age and an earlier start of this loss in these mainly 
meat-eating people, as compared with standard values in white humans. Again a 
low dietary Ca/P-ratio (in the Eskimo diet) may be implicated. Jowsey et al. (1972) 
observed in eleven osteoporotic patients a significant correlation between pre-
vious phosphorus intake and the rate of bone resorption. 
The discrepancy between the fact that studies in both man and laboratory 
animals failed to show that high-phosphorus diets affect calcium retention and 
the hypothesis that dietary phosphorus is a factor in osteoporosis, can be ex-
plained by taking into consideration that the result of phosphate-stimulated bone 
36 
turnover depends on the physiological status. If a positive calcium balance exists 
(during growth), increased bone turnover will tend to accelerate this positive 
balance. On the other hand, if there is a negative calcium balance (during the 
aging process), increased bone turnover will also tend to accelerate this negative 
balance. A second factor which might explain the discrepancy mentioned above 
is that the degree to which bone turnover is stimulated by dietary phosphorus 
depends on the renal ability to handle the phosphorus load, and this ability may 
have a connection with age. The normal aging process in the human kidney leads 
to a decrease in the glomerular filtration rate and this will be associated with a 
decrease in the tubular reabsorption of phosphate per remaining nephron, pos-
sibly control led by increased circulating levels of PTH. It has been found that 
serum PTH-levels increase with age(Riggs et al., 1978; Berlyn et al., 1974). 
5.11 Conclusion 
Calcium, phosphorus, vitamin D and protein are nutrients which have an impor-
tant influence on the calcium and phosphate metabolism. It is well established 
that the influence of the first three dietary components is exerted to a large extent 
through the medium of parathyroid hormone (PTH). This hormone plays a major 
role in calcium homeostasis. As far as dietary protein is concerned, its relation 
with PTH is not very clear. On the basis of the available literature it is possible to 
compose a model which gives an outline of the pathogenesis of secondary hy-
perparathyroidism. In this model (see Figure 5) dietary calc ium, phosphorus, the 
vitamin D status and the renal function are the variables which influence the 
secretion of PTH. In normal condit ions, an equil ibrium exists between serum-
low vitamin D status renal function \ diet 
(due to aging process)' P-excess Ca-deficiency low Ca/P ratio 
(Ca-malabsorption) 
1, 25-DHCC synthesis! glomerular 
bone 
resorption t 
turnover t 
kidney 
Ca-reabsorption t 
P-reabsorption \ 
loss of bone t 
urinary hydroxyproline f 
serum alkaline phosphatase 1 
serum P 1 
urinary Ca | 
urinary P | 
Fig. 5. Outline of the pathogenesis of secondary hyperparathyroidism. 
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ionized calcium and PTH. Either a low vitamin D status, diminished renal function, 
excess of dietary phosphorus, dietary calcium deficiency (or calcium malab-
sorption) or a low dietary CA/P-ratio depresses (temporarily) the serum-ionized 
calcium concentration. This results in the secretion of PTH being stimulated. The 
parathyroid hormone acts on bone and kidney, in order to restore the serum-io-
nized calcium concentration. In that new situation, again an equilibrium between 
a normal level of serum-ionized calcium and an increased amount of PTH is 
reached. The action of PTH on bone may proceed at the expense of skeletal 
calcium, so that osteoporosis develops. 
5.12 Summary 
Many dietary components influence the calcium and phosphate metabolism, the 
most important being calcium, phosphorus, vitamin D and protein. 
Though adaptation to low-calcium diets is, in the presence of vitamin D, quite 
normal, results of epidemiological and clinical studies suggest that, at least in 
western societies, an ample intake of calcium (800 mg/day or more) is desirable 
with a view to prevention and treatment of osteoporosis. 
From studies witx laboratory animals it appears that feeding high-phosphorus 
diets results in secondary hyperparathyroidism, calcification of soft tissues 
(nephrocalcinosis), and stimulation of bone resorption. The amount of phospho-
rus normally consumed by man largely exceeds the amount required to maintain 
the phosphorus balance. It is not precisely known whether a high phosphorus 
intake is without risks. Restriction of dietary phosphorus might be valuable in the 
prevention and treatment of osteoporosis. 
Dietary protein increases the urinary excretion of calcium, which may lead to 
negative calcium balances, especially when protein intake is high and calcium 
intake is low. 
In the evaluation of effects of dietary components on calcium metabolism the 
phenomenon of adaptation has to be accounted for, and in this respect a differ-
ence must be made between short-term and long-term studies. Short-term studies 
(duration less than a few weeks) are useful only for studying mechanisms of 
calcium homeostasis. Long-term studies (duration more than four weeks) are 
needed if information is required about the influence of dietary components on 
the genesis of osteoporosis. 
On the basis of the available literature a model was composed which gives an 
outline of the pathogenesis of secondary hyperparathyroidism. According to this 
model, either a calcium-deficient diet (or calcium malabsorption) or a 
high-phosphorus diet or a diet with a low calcium-to-phosphorus ratio stimulates 
the secretion of parathyroid hormone (PTH), especially when the renal function 
has decreased and/or the vitamin D status is low. By its action on bone, PTH may 
cause osteoporosis. 
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Chapter 6 
Cross-sectional study in elderly people 
6.1 Introduction 
On a long-term basis a low calcium intake, a high phosphorus intake or a low 
dietary Ca/P-ratio might cause osteoporosis in man via a mechanism which 
involves secondary hyperparathyroidism. This mechanism might particularly oc-
cur when renal function has declined (diminished glomerular filtration rate and 
diminished synthesis of 1,25-DHCC). A schematic presentation of causes and 
consequences of this so-called nutritional secondary hyperparathyroidism is 
shown in Figure 5 (Section 5.11). Given the fact that the human calcium require-
ment is subject to much debate and that the level of phosphorus intake in western 
countries is considered to be excessive, we found it necessary to investigate 
whether such a mechanism as described above is operative in man on his ususal 
diet. Since the prevalence of osteoporosis is high among the aged and since renal 
function is known to decrease with advancing age, we planned a study in a group 
of normal healthy elderly people. The aim of this study was to investigate whether 
the existence of relationships between dietary calcium and phosphorus on the 
one hand and the development of hyperparathyroidism on the other could be 
demonstrated. 
6.2 Methods 
The study was carried out between March and December 1976 in the community 
of Ede. Four hundred addresses of elderly people living in their own homes were 
kindly provided by a service centre in Ede (director Mr. S. J. H. Hartsema). Contact 
persons from this centre visited the elderly people at home and invited them to 
participate in the study on a voluntary basis. In a brochure the aim of the study and 
the study procedure were explained. From a response population of 25%, 89 
normal healthy elderly people (53 women and 36 men) were selected according to 
criteria discussed below (see under 'Medical investigation'). The study procedure 
consisted of three parts: (1) dietary (history) survey by a dietitian; (2) medical 
investigation by a physician, and (3) laboratory investigation of serum and urine. 
6.2.1 Dietary survey 
Food consumption was estimated by a trained dietitian who used the cross-check 
method during a visit at home. By this method habitual rather than actual food 
intake is estimated. The cross-check method has been recommended as the 
method of choice for the estimation of individual food consumption in scientific 
studies in which nutrient intake levels will be correlated with physical and phys-
iological parameters (Loo-Bunnik & Van Staveren, 1973). After the dietitian has 
interviewed the participant about the daily food consumption pattern, including 
possible variation during the weekend, and has listed the varieties and quantities 
of food items, the list is checked with a table of commonly consumed food 
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products to make sure that one or more items are not forgotten. The estimated 
quantities are compared with the contents of cups, spoons etc. which are used in 
that particular household. Finally as a cross-check the list is compared with the 
weekly food purchases. In spite of all checks the cross-check method has the 
essential limitation that it cannot be completely free of subjectivity and, since it is 
merely based on interview, only a rough estimate of the habitual food intake is 
obtained. Furthermore there is no guarantee as to whether the dietary habit is 
life-long or has been adopted fairly recently. 
The recorded food consumption pattern was translated into nutrient intake with 
the aid of a computer programme, which is based on figures of the Dutch Food 
Composition Table (Hautvast, 1975). It was found by El-Shaarawy (1971) that 
figures in this table of the calcium and phosphorus content of food products 
correlate well with results of chemical analyses and can be used for the estimation 
of calcium and phosphorus intake in Dutch diets. In addition we have tested the 
suitability of the Dutch Food Composition Table for this purpose by the determi-
nation of calcium and phosphorus contents of 15 food items obtained from local 
stores. The items were selected as representative of dairy products, meat, vege-
tables and luxury foods. After homogenization in a mortar or a Waring Blendor a 
sample of 1 gram was wet-ashed according to the method of Clarkson (1967). 
After proper dilution with distilled water, calcium and phosphorus were estimated 
according to the methods of Ripoll (1976) and Griswold et al. (1951 ) respectively. 
Table 1 shows the results of these estimations as well as the corresponding 
figures taken from the Dutch Food Composition Table. The figures compare 
Table 1. Calcium and phosphorus content (mg/100 g) of 15 food items by 
analysis and by the Dutch Food Composition Table1). 
food item 
milk (full cream) 
Gouda cheese (young) 
processed cheese (full cream) 
pork (lean) 
beef (lean) 
minced meat (beef) 
liver (cooked) 
ham 
potato 
onion 
endive 
chicory 
cola drink 
salted peanuts 
salted potato crisps 
analysis 
Ca 
121 
803 
541 
45 
51 
24 
17 
12 
10 
47 
90 
20 
13 
58 
51 
P 
97 
510 
767 
212 
175 
152 
449 
308 
38 
36 
44 
27 
17 
364 
103 
Ca 
125 
600 
450 
10 
10 
6 
10 
10 
10 
30 
20 
20 
5 
60 
25 
DFCT 
P 
90 
350 
800 
200 
200 
125 
225 
300 
60 
40 
70 
20 
20 
350 
150 
') The Spearman rank-order correlation coefficients (rho) between values obtained from 
analyses and those obtained from the Dutch Food Composition Table are 0.82 for 
calcium and 0.98 for phosphorus. 
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favourably. The Spearman rank-order correlation coefficient was found to be 
good for calcium (rho = 0.82) and excellent for phosphorus (rho = 0.98). 
Physical activity was estimated by interview and classified according to the 
five-point scale as defined in the Dutch Food Composition Table (Edition 1978). 
6.2.2 Medical investigation 
All participants visited the physician, to judge whether they could be regarded as 
'apparently healthy'. Special attention was given to medical history, prescription 
of medicines and to complaints related to health. The occasional use of medicines 
and/or vitamin supplements was considered to be normal. Persons who used 
blood pressure-lowering drugs or diuretics were not excluded from participation. 
Blood pressure (systolic and diastolic) was measured in the sitting position, body 
height (to the nearest mm) in upright position and body weight (to the nearest 100 
g) with indoor clothing but without shoes. The ratio W/H 2 (Quetelet index) was 
used as an index of obesity: W is the measured body weight (in kg) reduced by 2 
and 3 kg for women and men respectively (to account for clothes) and H is the 
standing height (in metres). 
For the measurement of the skeletal mass the non-invasive sensitive technique 
of photon-absorptiometry was chosen. With the Norland-Cameron Bone Mineral 
Analyzer (BMA type 178) the bone mineral content (BMC) and bone width (BW) at 
the distal third of the radius were measured. With regard to the radiation dose, a 
set of 4 scans is computed to be 1/100 of the dose delivered to a patient for a 
radiograph of the forearm if radiation area and exposure time are taken into 
account (communications from Norland Instruments). The principle of this meth-
od is as follows. A low-energy gamma-beam from a collimated 200 mCi125l 
source and a Nal-detector are moved by an electromotor across the arm with a 
speed of 2 mm/sec. The translated energy, not absorbed by the radius, is 
detected and a built-in computer module computes the BMC (in g/cm) and the 
BW (in cm). Both values are read out digitally. During the measurement the lower 
arm is immobilized by a limb-holder and, at the site of the scan, surrounded by a 
tissue bag equivalent (a rubber bag filled with distilled water). This bag has similar 
characteristics to those of soft tissue with respect to photon-absorption and 
makes sure that the bone is equally surrounded by 'soft tissue' so that a straight 
base line is obtained. The BMA is calibrated before each series of measurements 
against an aluminium phantom with a mineral content similar to that of an average 
radius. The radius was measured as the second bone (after the ulna), which has 
the advantage that the base line is set between ulna and radius where only a small 
amount of adipose tissue is present. Adipose tissue has a lower photon-absorp-
tion coefficient than lean soft tissue and may disturb the measurement. The scan 
site was at the point 1 /3 the distance from the distal end of the radius (the distal 
third). Here the region is quite uniform and repositioning has little effect on the 
measurement. Each participant was measured 4 times in one session and the 
mean value was computed. The precision (reproducibility) of the method has 
been reported to be between 2 and 3% and the accuracy is about 5% (Mazess et 
al., 1964; Smith et al., 1972). In our hands the variation coefficient between 
measurements in one session was well below 2% for both BMC and BW. In-normal 
subjects BMC-values of the radius at the distal third correlate well (r = 0.973) with 
values of total body calcium as measured by neutron activation analysis. In 
osteoporotic patients this correlation is somewhat lower (r = 0.826; Cohn et al., 
1974). The ratio BMC/BW has been used in many studies to correct BMC-values 
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for differences in skeletal size. Normal values for BMC, BWand BMC/BW depend 
on sex, age and race. A BMC-value for females less than 0.68 g/cm is suspect of 
clinical osteoporosis*). 
6.2.3 Laboratory investigation 
Haemoglobin, haematocrit, mean cell haemoglobulin concentration (MCHC), pH 
and bicarbonate in blood, and urea, creatinine, cholesterol, uric acid, alkaline 
phosphatase, acid phosphatase and proteins in serum were estimated as a check 
of the general status of health. Inorganic phosphorus, ionized calcium, bone 
alkaline phosphatase, PTH and 25-HCC in serum and calcium, phosphorus and 
total hydroxyproline in urine were estimated as indicators of the calcium and bone 
metabolism. 
Serum was prepared within one to two hours after venapuncture (blood was 
drawn during the medical investigation) by centrifuging the clot at room temper-
ature for 20 minutes at 2000 g. Serum was frozen (-18°C) or refrigerated (4°C, less 
than 4 days), until analyzed. The phosphatases, urea, creatinine and uric acid 
were estimated in fresh or refrigerated samples. 
Participants were instructed in detail (verbal and on paper) to collect a com-
plete 24-hour urine sample including the morning urine of the day on which the 
blood was drawn. The procedure for this collection was according to Henry et al. 
(1974). Urine volume was measured and the urine was checked for presence of 
glucose, protein, nitrite, ketones, bilirubin, blood and urobilinogen by the Com-
bur-8-test (Boehringer, Mannheim). Urine was frozen (-18°C) until analyzed. 
Blood pH, bicarbonate (Astrup-apparatus) and haematocrit were estimated by 
standard procedures (Henry et al., 1974). The determination of haemoglobin was 
according to the cyan methaemiglobin method (reagent test combination, Boeh-
ringer, Mannheim). MCHC values were computed from the ratio between blood 
haemoglobin and haematocrit. 
Serum proteins (albumin, alpha 1, alpha 2, beta and gamma globulins were 
separated by cellulose acetate electrophoresis (Helena Laboratories, Beaumont, 
Texas). Bands were stained with Ponceau-S dye and measured densitometrically 
in transmission with a Shimadzu CS-900 dual wavelength densitometer at 525 nm. 
The reference beam was set at 635 nm. The scans were inspected visually for 
abnormalities. The serum albumin concentration was computed by multiplying 
the relative area of the albumin peak by the serum total-protein concentration. 
The inter-assay variation coefficient of the relative area of the albumin peak in an 
electropherogram of proteins in a control serum was found to be 5.1%. 
Total cholesterol, uric acid and urea in serum were estimated enzymatically, 
creatinine in serum and urine with the Jaffé reaction (in serum after precipitation 
of the proteins with 2N trichloroacetic acid), acid and alkaline phosphatase with 
para-nitrophenol-phosphate as a substrate and serum total protein with the Biuret 
reaction. All these methods were carried out using commercial reagent kits 
(Boehringer, Mannheim). 
Alkaline phosphatase isoenzymes (liver, bone and intestine) were separated by 
Polyacrylamide gel electrophoresis (Ames, division Miles, Indiana). Bands were 
visualized by incubation of gels in a solution containing 5-bromo-4-chloro-3-in-
dolyl-phosphate, a substrate which is specific for alkaline phosphatase. Bands 
*) Smith & Cameron, Interpretation of Fracture Index Charts, University of Wisconsin, Bone 
Mineral Laboratory Communication from Norland Instruments. 
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were measured densitometrically in transmission with the sample beam set at 620 
nm and the reference beam at 550 nm. The activity of the bone isoenzyme was 
computed by multiplying the relative area of the bone isoenzyme peak by the total 
alkaline phosphatase activity in the serum. The inter-assay variation coefficient of 
the relative area of the bone isoenzyme peak of a control serum was 4.5% 
Calcium in serum and urine was determined by atomic absorption. Serum-io-
nized calcium was computed using a modification of the formula of Zeissler as 
proposed by Pottgen & Davis (1976). This formula accounts for serum concen-
trations of albumin and globulin. Phosphorus in serum and urine was estimated by 
a molybdenum blue method according to Griswold et al. (1951). Urinary total 
hydroxyproline was estimated according to the method of Kivirikko et al. (1967). 
Within each of the above-mentioned series of determinations a control serum or 
urine sample was run and the inter-assay variation coefficients were found to be 
below 6%. 
PTH in serum was measured by radio-immunoassay by Dr. R. Bosch (University 
of Utrecht). Results are expressed in fiEq/l PTH-135, a bovine standard. The 
antiserum used is specific to carboxyterminal PTH-fragments and was developed 
by Dr. R. Bouillon (University of Leuven, Belgium). The inter-assay variation 
coefficient of this assay is 8%. 25-hydroxycholecalciferol (25-HCC) was measured 
by a competitive protein-binding assay by Dr. J. H. Schade (CIVO-TNO, Zeist) 
according to a modified method of Edelstein et al. (1974). The inter-assay varia-
tion coefficient of this assay is 10%. 
As, in spite of detailed instructions, errors in collection time of urine could be 
expected, urinary calcium, phosphorus and hydroxyproline were expressed as 
their ratios to creatinine which are much less dependent on the accuracy of the 
collection period. 
6.2.4 Statistics 
To investigate correlations between biochemical, physical and dietary parame-
ters, data were classified according to nutrient intake levels, age groups and bone 
mineral content values. Although this method has the disadvantage that some 
information is lost because individual data are pooled, it was given preference 
over simple linear regression as a primary evaluation since grouping of data 
provides readable tables. Students t-test was used to test the significance of 
differences between group means. If variances differed significantly (P < 0.05), 
as shown by the F-test, the modified t-test of Cochran & Cox was used (Downie & 
Heath, 1965). As a secondary evaluation of data correlational techniques (multi-
ple-linear or simple-linear regression analysis) were applied (Snedecor & Coch-
ran, 1973). A Hewlett Packard model 9830A table computer and a Hewlett Pac-
kard model 9866A printer were used for the processing of the data. Three levels of 
significance were applied: P < 0.01; P < 0.05; P < 0.10, one-tailed, unless 
otherwise indicated. The latter level was used as an indicator of a trend effect. 
6.3 Results 
6.3.1 Basic data in males and females (Tables 2 to 5) 
The medical investigation revealed complaints related to old age (sleeplessness 
and obstipation), histories of gastric resection (1 woman), hysterectomy (5 wom-
en), ovariectomy (1 woman) and of mastectomy (1 woman). Moreover 1 woman 
had achlorhydria and 2 women and 1 man were non-insulin-dependent diabetics. 
Diuretics were used by 13 women and 2 men. No significant abnormalities were 
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found in urine by the Combur-8-test. These data together with those of Tables 2 to 
5 indicate that we deal with a rather healthy group of elderly people. 
Table 2 shows data on age and somatometry and reference values (normative 
data) of U.S. whites, reported by Mazess & Cameron (1973). The mean value for 
the Quetelet index for females was high. In 23 women the index exceeded the 
value 27.0 which indicates 20% overweight or more for women with a normal 
frame (James et al., 1976). Mean values for BMC, BW and BMC/BW and their 
standard deviations compare with the U.S. normative data. Our values for BW are 
slightly higher and those for BMC/BW slightly lower than these normative values. 
In the study of Van Paassen (1979) the mean values for BMC, BW and BMC/BW of 
44 postmenopausal women in Utrecht (mean age 54 years) were 0.87 g/cm, 1.31 
cm and 0.65 g/cm2 respectively. If the line is taken that postmenopausal bone loss 
proceeds with an annual rate of 1%, than these values compare favourably with 
those of the present study. An osteopenic BMC-value (BMC < 0.68 g/cm) was 
found in 9 women (18%). 
Table 2. Age and somatometric data. 
age 
weight 
height 
Quetelet 
index 
BMC 
BW 
BMC/BW 
(years) 
(kg) (cm) 
(kg/m2) 
(g/cm)2) 
(cm)2) 
(g/cm2)2) 
females (n = 53) 
mean sd range 
69.9 
70.2 
159.6 
26.7 
0.78 
1.39 
0.56 
5.5 
10.4 
6.3 
3.3 
0.12 
0.14 
0.07 
57 
51 
146 
19.6 
0.53 
1.02 
0.39 
- 89 
- 107 
- 173 
-38 .9 
-1 .06 
-1 .71 
-0 .69 
mean 
70.4 
75.6 
171.8 
24.6 
1.19 
1.63 
0.73 
males (n = 36) 
sd 
4.7 
10.9 
5.7 
3.2 
0.15 
0.14 
0.08 
range 
64 -
56 -
162-
16.6-
0.88-
1.26-
0.55-
- 82 
- 101 
- 184 
-31.9 
-1.50 
-1.92 
-0.85 
reference val 
9 
60 
62.8 
159.1 
24.8 
0.77 
1.26 
0.61 
+ 
+ 
- t -
-*-
+ 
70 
11.3 
6.9 
0.14 
0.13 
0.09 
u e s ( i 
60 
75.9 
175.2 
24.7 
1.23 
1.57 
0.79 
sd) 
cf 
± 1 
± 
± 0 
± 0 
± 0 
Reference values are normative data of U.S. whites, reported by Mazess & Cameron (1973); 
reference values for U.S. whites in the age group of 70 - 80 years are very similar, with the exceptio 
of BMC-and BMC/BW-values for females, which are 0.72 ± 0.13 g/cm and 0.58 ± 0.09 g/cm2 
respectively. 
Measured on 51 females and 35 males. 
Table 3 shows the data on blood pressure and biochemical parameters in blood 
(plasma). No participants had a diastolic blood pressure exceeding 110 mm Hg. In 
5 women and 1 man systolic blood pressure exceeded 170 mm Hg. Mean values 
for both systolic and diastolic blood pressure are quite acceptable for this age 
group (Kitchin & Julian, 1971). Anaemia did not occur in women whereas only 3 
men had haemoglobin values below 14 g/100 ml. In 2 of them haematocrit was 
below 40% but their MCHC was normal. In 6 women and 2 men plasma bicarbo-
nate was below 21 mEq/l, but their blood pH was normal. In 1 woman and 2 men 
blood pH was slightly below 7.35 but their plasma bicarbonate was normal. 
Table 4 shows the biochemical parameters in serum and urine. Mean values for 
females and males are well within the range of normality, although for several 
parameters the observed ranges are broader. As far as calcium and bone 
metabolism are concerned, the following comments can be made. The bone 
fraction of serum alkaline phosphatase (APB) was moderately increased (activity 
> 24 U/1) in 5 women and 1 man. Mean serum calcium values are rather low. For 
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instance, van Paassen (1979) reported a mean value of 10.3 mg/100 ml in post-
menopausal women. The cause of this difference might be of methodological 
origin. The mean value of serum phosphorus is significantly lower ( P < 0.01) in 
males than in females; 6 men, but no women, had values below 2.5 mg/100 ml. In 
the study by van Paassen a lower mean value (3.16 ± 0.47 mg/100 ml) for serum 
phosphorus was found in postmenopausal women who were on average 15 years 
younger. These observations are consistent with the sex difference in serum 
phosphorus and with an increase in serum phosphorus with advancing age 
(Section 4.2). Serum 25-HCC was subnormal ( < 12 ng/ml) in 5 women and 1 man. 
In 16 women (31%) and 8 men (22%) PTH exceeded the upper limit of normality, 
and this is consistent with an increase in serum PTH with age (Section 4.2). 
Hypercalciuria occurred in 2 women. No excessive values were found for the 
urinary excretion of hydroxyproline. Regarding renal function, mean values for 
serum creatinine were at the upper limit of normality and in 17 subjects (20%) 
serum urea values exceeded this limit. These findings are consistent with a 
slightly diminished renal function in elderly people. 
Table 5 shows data on dietary parameters and physical activity. If a comparison 
is made with recommendations by the Dutch Nutrition Board (see the Dutch Food 
Composition Table, edition 1978), the following comments can be made. Energy 
intake is in conformance with the recommendation. The intake level of protein 
exceeds the amounts recommended for women and men with 13 and 15 g/24 h 
respectively. Fat intake is within the recommended range but the contribution of 
the saturated fat to the total fat intake is relatively high. Calcium intake largely 
exceeds the recommendation of 0.8g/24 h. Nevertheless 13 women (25%) and 6 
men (17%) had an intake below that level. In spite of an ample intake of phosphate 
(25% of the women and men had an intake exceeding 1.6 and 2.0 g phosphorus 
daily respectively) the dietary Ca/P-ratio was more favourable than that of the 
general Dutch population (0.76 and 0.71 versus 0.58, Bosman & Kosten-Zoethout, 
1978). The mean intake of vitamin D is well above the level of 100 IU/24 h below 
which osteomalacia has been reported to occur in moderate climates (Dent & 
Smith, 1968). Physical activity of the women was low and this might relate to the 
high frequency of obesity among them. 
6.3.2 Evaluation of the data in females (Tables 6 to 12) 
6.3.2.1 Factors associated with the bone mineral content 
Table 6 shows the results of grouping data according to different BMC-values. 
With the exception of the value of 0.68 g/cm (osteopenic BMC) these values were 
chosen arbitrarily. If the means of somatometric, biochemical and nutritional 
parameters in group I are compared with those in group III, significant differences 
can be observed with respect to age, height, weight, the Quetelet index, BW, 
BMC/BW, serum phosphorus, serum 25-HCC and dietary protein and phospho-
rus. The positive correlations between BMC on the one hand and BW, BMC/BW, 
height and weight on the other are related to either differences in skeletal size or 
to the loss of bone and height with advancing age. The latter is indicated by the 
high mean age in subgroup I (osteopenic BMC). Since the oestrogen oestrone is 
produced in adipose tissue (Vermeulen & Verdonck, 1978), the high-value of the 
Quetelet index in the subgroup with the highest BMC-value might reflect the 
protective effect of oestrogen against postmenopausal bone loss. The high serum 
phosphorus concentration in subgroup I (low BMC-value) might reflect a loss of 
renal function as a consequence of the aging process. The positive correlation 
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Table 6. BMC in relation to age and somatometric, biochemal and nutritional parameters 
females. 
mean 
somatometry: 
age 
height 
weight 
Quetelet index 
BW 
BMC/BW 
serum:*) 
Ca+ + 
P 
25-HCC 
PTH 
creat 
APB 
urine:5) 
Ca/cr 
P/cr 
hypro/cr 
diet: 
energy 
protein 
Ca 
P 
Ca/P 
vit. D 
physical activity6) 
(years) 
(cm) 
(kg) 
(kg/m2) 
(cm) 
(g/cm2) 
(mg/100ml) 
(mg/100ml) 
(ng/ml) 
OiEq/l) 
(mg/100ml) 
(U/l) 
(mg/g) 
(mg/g) (mg/g) 
(MJ/24 h) 
(g/24 h) 
(energy %) 
(g/24 h) 
(g/MJ) 
(g/24 h) 
(g/MJ) 
(IU/24h) 
I 
< 0.68 
0.61 (n 
74.6 ± 
155.6 ± 
65.6 ± 
26.2 ± 
1.22 ± 
0.51 ± 
4.42 ± 
3.82 ± 
18.9 ± 
0.35 ± 
1.06 ± 
12.9 ± 
130 ± 
708 ± 
31.7 ± 
6.8 ± 
58 ± 
14.3 
0.91 ± 
0.13 
1.16 ± 
0.17 
0.79 ± 
121 ± 
1.0 ± 
= 9) 
6.1 
7.8 
9.7 
3.1 
0.12 
0.06 
0.39 
0.21 
7.5 
0.18 
0.16 
4.3 
763) 
188 
11.2 
1.7 
11 
0.13 
0.14 
0.17 
71 
0.9 
BMC(g/cm) 
II 
0.68-0.85 
0.77 (n 
69.5 
158.7 
66.3 
25.6 
1.42 
0.54 
4.49 
3.39 
21.3 
0.32 
1.01 
16.1 
132 
764 
26.5 
8.5 
70 
13.8 
1.04 
0.12 
1.40 
0.17 
0.74 
198 
1.9 
+ 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
+ 
+ 
± 
+ 
+ 
± 
± 
+ 
+ 
= 27) 
5.3 
5.3 
6.9 
2.6 
0.12 
0.05 
0.40 
0.52 
8.3 
0.12') 
0.18 
6.1 
633) 
322 
9.8 
1.7 
18 
0.35 
0.40 
0.12 
85") 
1.0 
II 
>0.85 
0.91 
67.7 
163.0 
77.6 
28.4 
1.44 
0.64 
4.45 
3.36 
24.1 
0.36 
0.99 
13.8 
127 
691 
28.5 
7.4 
70 
15.9 
1.07 
0.15 
1.41 
0.19 
0.75 
150 
1.3 
(n 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
± 
+ 
+ 
± 
+ 
+ 
± 
± 
+ 
± 
± 
+ 
+ 
= 15) 
4.5 
5.7 
8.1 
2.3 
0.11 
0.03 
0.50 
0.38 
7.1 
0.152) 
0.13 
6.0 
57 
201 
8.9 
1.5 
12 
0.38 
0.36 
0.12 
64 
0.6 
t-tes 
l-lll 
P-val 
<o. 
<o. 
<o. 
<o. 
<o. 
<o. 
<o. 
= 0. 
r 
r 
r 
r 
<o. 
r 
<o. 
r 
r 
r 
1
 ) One value not available 
2) With exclusion of one abnormal value (1.12/xEq/l). 
3) With exclusion of one (hypercalciuric) value. 
4) With exclusion of one woman who used vit. D supplements. 
5) For abbreviations see subscript to Table 4. 
6) See subscript to Table 5. 
between serum 25-HCC and BMC indicates that the vitamin D status is a factor 
associated with BMC. The lower intake of protein and phosphorus in subgroup I 
can be attributed mainly to a lower intake of food. 
6.3.2.2 Factors associated with age 
Since age is an important variable with regard to bone mass and calcium metab-
olism (Section 4.2), differences in age have to be taken into account if the effect of 
diet on calcium metabolism and bone mass is studied. Table 7 shows the results of 
grouping data according to different age categories. From this table it can be seen 
that body height, BMC, BMC/BW, and the urinary excretion of calcium decrease 
with age. Correlation and regression coefficients are shown in Table 8. The 
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average loss of height with age of 0.35 cm per annum exceeds that of 0.2 cm 
reported by Mazess & Cameron (1973) for US females after the thirties. Our value 
for the loss of height with age may be an overestimation since it does not take into 
account a possible secular trend. The loss of bone with age is 0,8% per annum as 
computed from the ratio between the regression of BMC/BM on age and the 
BMC/BM value of Table 2. This rate of loss harmonizes with the literature on the 
rate of postmenopausal bone loss (Smith etal., 1976). The decrease in the urinary 
excretion of calcium with age (about 3.5% per annum) occurred without any 
decrease in calcium intake and may therefore be attributed to a decrease in the 
intestinal calcium absorption. There was a positive correlation between se-
rum-ionized calcium and age. This is in harmony with observations by Dequeker 
(1973), who reported an increase in serum calcium in females after the age of 
about 50 years. This increase might be attributed to an increase in the 
responsiveness of bone to the calcium-mobilizing action of PTH as a conse-
quence of oestrogen deficiency. The increase in the dietary Ca/P-ratio with age is 
of interest since it might obscure a positive effect of this ratio on bone. 
6.3.2.3 Effect of calcium and phosphorus intake on bone parameters 
From Table 6 it cannot be concluded that BMC-values are related to dietary 
parameters. However, since Tables 6, 7 and 8 indicate that age and skeletal size 
(height and weight) correlate with bone parameters and that the dietary 
Ca/P-ratio increases with age, it was found necessary to account for differences 
in age and skeletal size in the possible relation between diet and bone parame-
ters. To account for differences in skeletal size the parameter body height x body 
weight V 2 was used. It appeared from linear regression analysis that this para-
meter gave the same correlation coefficients with the bone parameters as did 
linear combinations of height and weight. 
Table 9 shows a matrix of correlation coefficients between age, somatometric 
and nutritional parameters. It can be seen that H.W1/2 correlates significantly 
positive with BMC, BW and BMC/BW. The latter correlation shows that the ratio 
BMC/BW does not completely correct BMC-values for differences in skeletal size. 
The negative correlation between H.W1/2 and the Ca/P-ratio is probably related 
to the observation that the older females, who have a smaller stature, have a 
higher dietary Ca/P-ratio. The positive correlation between dietary phosphorus 
and BW as well as the negative correlation between dietary Ca/P and this bone 
parameter will be referred to below. The correlations between dietary calcium, 
phosphorus and the Ca/P-ratio are explained by the fact that dairy products, the 
main source of dietary calcium, contain much phosphorus and have a high dietary 
Ca/P-ratio. 
Table 10 shows partial regression coefficients of multiple linear regression of 
bone parameters (dependent variables) on age, H.W1/2, Ca, P and Ca/P as 
independent variables. It can be seen that the inclusion of either Ca, P or both or 
the inclusion of Ca/P in the regression of BMC on age and H.W1/2 does not 
improve the multiple correlation coefficient. In addition, partial regression coeffi-
cients (b3, b4 and b5) are not significant. The same procedure applied to BW 
resulted in a significant partial regression coefficient for dietary P and in an 
improvement of the multiple correlation coefficient. With reference to BMC/BW 
there was an increase in the multiple correlation coefficient if both Ca and P were 
included in the regression equation, whereas partial regression coefficients (b3 
and b4) for Ca and P were significantly positive and negative respectively. These 
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Table 7. Age in relation to somatometric, biochemical and nutrit ional parameters in female; 
Somatometry: 
height 
BMC 
BW 
(cm) 
(g/cm) 
(cm) 
BMC/BW (g/cm2) 
serum:5) 
Ca+ + 
P 
25-HCC 
PTH 
creat 
APB 
urine:5) 
Ca/cr 
P/cr 
hypro/cr 
diet: 
energy 
protein 
Ca 
P 
Ca/P 
vit. D 
(mg/100ml) 
(mg/100ml) 
(ng/ml) 
OiEq/l) 
(mg/100ml) 
(U/l) 
(mg/g) 
(mg/g) 
(mg/g) 
(MJ/24h) 
(g/24h) 
(g/24 h) 
(g/24h) 
(IU/24h) 
Physical activity6 
I 
< 66 yr 
62.6 (n = 
161.3 ± 
0.88 ± 
1.42 ± 
0.62 ± 
4.26 ± 
3.43 ± 
21.7 ± 
0.38 ± 
1.00 ± 
16.9 ± 
161 ± 
715 ± 
27.8 ± 
7.1 ± 
70 ± 
0.93 ± 
1.32 ± 
0.70 ± 
170 ± 
1.4 ± 
 11) 
4.9 
0.10 
0.12 
0.05 
0.29 
0.42 
5.8 
0.16 
0.15 
6.5 
69 
258 
7.5 
1.8 
17 
0.30 
0.35 
0.11 
56 
0.7 
II 
age 
66-71 yr 
68.0 (n 
161.1 
0.80 
1.44 
0.56 
4.50 
3.38 
25.9 
0.29 
1.02 
14.6 
140 
757 
26.6 
8.3 
71 
1.08 
1.44 
0.74 
177 
1.6 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
± 
= 18) 
4.9 
0.09') 
0.131) 
0.08') 
0.50 
0.48 
7.2 
0.112) 
0.15 
6.0 
60 
294 
10.2 
1.6 
14 
0.39 
0.36 
0.14 
63 
0.9 
71 
II 
-76 yr 
73.5 (n 
157.3 
0.72 
1.34 
0.54 
4.52 
3.47 
19.6 
0.34 
1.02 
13.5 
116 
701 
29.0 
7.7 
64 
1.06 
1.33 
0.81 
152 
1.4 
+ 
+ 
+ 
+ 
± 
± 
+ 
± 
± 
± 
+ 
± 
+ 
± 
± 
+ 
+ 
± 
+ 
+ 
= 18) 
7.6 
0.11') 
0.14') 
0.07') 
0.43 
0.56 
7.8 
0.17 
0.21 
5.5 
573) 
274 
11.0 
1.9 
18 
0.31 
0.37 
0.12 
79 
1.0 
IV 
> 7 6 y r 
78.7 (n = 6) 
156.7 
0.73 
1.34 
0.54 
4.73 
3.55 
14.7 
0.44 
1.07 
15.1 
85 
742 
25.3 
8.3 
68 
1.08 
1.35 
0.81 
185 
2.0 
± 8.0 
± 0.10 
± 0.17 
± 0.04 
± 0.27 
± 0.33 
± 5.5 
± 0.11 
± 0.20 
± 2.13) 
± 43") 
± 237 
± 9.3 
± 1.0 
± 18 
± 0.31 
± 0.43 
± 0.06 
± 81 
± 0.9 
t-test 
I-
iii + H 
P-valui 
<0 .1 
<0.C 
< 0 . 1 
<0.C 
<0.C 
n 
n 
n 
n 
n 
<0.C 
n 
n 
n 
n 
n 
n 
<0.C 
n 
n 
') n = 17. 
2) with exclusion of one abnormal value (1.12 nEq/l). 
3) n = 4. 
") With exclusion of one (hypercalciuric) value. 
5) For abbreviations see subscript to Table 4. 
6) See subscript to Table 5. 
Table 8. Linear regression of somatometric, biochemical and nutritional 
parameters with age (y = b0 + b,x) in females (n = 51). 
y 
BMC 
BMC/BW 
height 
serum Ca 
urinary Ca/cr 
dietary 
(g/cm) 
(g/cm2) 
(cm) 
(mg/100ml) 
(mg/g) 
Ca/P 
b0 
1.54 
0.86 
184 
3.19 
444 
0.23 
b, 
-0.0110 
- 0.0043 
- 0.350 
0.0186 
- 4 . 4 9 
0.0076 
r 
- 0 . 5 3 
- 0 . 3 5 
- 0 . 3 1 
0.24 
- 0 . 4 0 
0.33 
P (t-test) 
< 0.01 
< 0.01 
<0.01 
< 0.05 
< 0.01 
<0.01 
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Table 9. Matrix of correlation coefficients between age, somatometric and nu-
tritional parameters in females (n = 51). 
age 
H.W.1/2 
dietary Ca 
dietary P 
dietary Ca/P 
BMC 
BW 
BMC/BW 
age 
1.00 
- 0 . 2 3 " ' 
0.13 
- 0 . 01 
0.34*** 
- 0 . 5 3 * * * 
- 0 . 3 3 * * * 
- 0 . 3 4 * * * 
H.W.y' 
1.00 
0.01 
0.16 
- 0 . 3 2 * * 
0.60*** 
0.50*** 
0.32** 
dietary 
Ca 
1.00 
0.88*** 
0.49*** 
0.06 
0.06 
0.03 
dietary 
P 
1.00 
0.03 
0.15 
0.24** 
0.00 
dietary 
Ca/P 
1.00 
- 0 . 2 0 
- 0 . 2 8 * * 
- 0 . 0 3 
P < 0.05; P < 0.01. 
Table 10. Partial regression coefficients ( ± SEM) of multiple linear regression (y 
= b0 + b,x, + b2x2 + . . . b n x n ) of bone parameters (y) on age 
(x,), H.W>(x2), Ca (x3), P(x„) and Ca /P (x5) in females (n = 51 ). 
y 
BMC 
(mg/cm) 
BW 
(cm 10"2) 
b« 
765 
753 
751 
771 
691 
115 
113 
110 
107 
120 
BMC/BW 631 
(mg/cm2) 
626 
636 
660 
565 
b, 
(age) 
_
 8 4 * » * 
± 2.1 
_ 8.7*** 
± 2.1 
_
 8 ]4*** 
± 2.1 
- 9.0*** 
± 2.2 
- 9.0*** 
± 2.2 
- 0 . 5 7 * * 
±0.31 
- 0 . 6 0 * * 
±0.31 
— 0.58** 
±0.30 
- 0 . 4 8 * * 
±0.31 
- 0 . 5 2 * * 
±0.33 
- 3.5*** 
± 1.7 
— 3.6*** 
± 1.7 
- 3.5*** 
± 1.7 
_
 4 3 * s , ä , 
± 1.7 
- 4 . 1 * * * 
± 1.7 
regression 
b2 (H.W.^) 
45.2*** 
± 9.3 
44.8*** 
± 9.3 
4 4 2 * * -
± 9.5 
46.7*** 
± 9.7 
48.1*** 
± 9.6 
4.8*** 
± 1.4 
4 8*** 
± 1.4 4.5*** 
± 1.3 
4 . 1 * * * 
± 1.4 
4 6*** 
± 1.4 
13.5** 
± 7.3 
13.4** 
± 7.4 
14.0** 
± 7.5 
17.0*** 
± 7.5 
16.1*** 
± 7.6 
± 
+ 
± 
— 
+ 
+ 
± 
coefficients 
b, 
(Ca) 
38.6 
34.6 
— 
88.3 
77.6 
3.7 
5.0 
— 
13.6 
11.0 
13.2 
27.6 
— 
108.7*s 
60.2 
b« 
(P) 
— 
21.4 
±32.0 
- 5 1 . 2 
±71.4 
— 
6.6* 
± 4.6 
17.8** 
±10.1 
— 
- 8.9 
±25.4 
-98 .2** 
±55.3 
b5 (Ca/P) 
— 
— 
— 
111 
±101 
— 
— 
— 
8.2 
±14.7 
— 
— 
— 
98.2 
±79.2 
multiple P 
r 
0.72 
0.73 
0.72 
0.73 
0.73 
0.55 
0.55 
0.57 
0.59 
0.55 
0.42 
0.42 
0.42 
0.48 
0.45 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
<0.01 
<0.01 
< 0.01 
<0.01 
< 0.01 
= P < 0.10; = P < 0.05; = P < 0.01. 
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observations indicate that dietary calcium has a positive effect on BMC/BW if 
differences in age, skeletal size and P-intake are taken into account and that 
dietary phosphorus has a negative effect on BMC/BW if differences in age, 
skeletal size and calcium intake are taken into account. 
The dietary Ca/P-ratio did not give a significant partial correlation with any of 
the bone parameters. This might be explained by the fact that information is not 
fully utilized when, instead of calcium and phosphorus separately, the ratio be-
tween them is taken. 
6.3.2.4 Effect of calcium and phosphorus intake on biochemical parameters 
Table 11 shows the results of classification of biochemical data into groups 
according to intake levels of Ca, Pand Ca/P. These levels (low, medium and high) 
were chosen arbitrarily. Comparison of group means (low-high) shows that there 
are no significant relations between diet and serum parameters. Serum P tends to 
increase with the intake of Ca and with the Ca/P-ratio and this trend is associated 
with a significant increase in urinary P. These effects may be a reflection of high 
availability of dietary P derived from dairy products being rich in calcium. Se-
rum-ionized calcium (not mentioned in Table 11) was not related to dietary para-
meters. The positive trend between Ca intake and urinary Ca is in harmony with 
literature data (Section 5.9). A positive trend between the dietary Ca/P-ratio and 
urinary Ca is obscured by the age-associated decrease in urinary Ca and increase 
in dietary Ca/P. Regarding P-intake, the positive relation with urinary P indicates 
that the use of the cross-check method and that of the Dutch Food Composition 
Table for the estimation of P-intake have their value. The positive relation between 
P-intake and urinary Ca has no physiological basis and is probably the conse-
quence of the fact that diets rich in P contain much calcium and protein, which 
nutrients increase urinary Ca. The increase in the excretion of hydroxyproline 
with P-intake might indicate an increase in bone turnover. However, bone alkaline 
phosphatase (APB) and PTH were not significantly influenced by P-intake. 
6.3.2.5 Correlations between biochemical parameters and BMC/BW 
Since correlations between biochemical parameters and bone might provide 
information about the possible existence of nutritional secondary hyperparathy-
roidism, a correlation matrix was computed between biochemical parameters and 
BMC/BW (Table 12). For this purpose we had to exclude women whose data set 
was not complete (n = 6), women with hypercalciuria (Ca/cr > 280 mg/g, n = 2) 
and one woman who had an abnormal urinary P-excretion (P/cr = 1620 mg/g). 
Table 12 shows a positive correlation (r = 042; P < 0.01) between P and hydro-
xyproline in urine and a negative one (r = — 0.32; P < 0.05) between urinary P 
and BMC/BW. These correlations, which are in striking harmony with the positive 
relation between P-intake and urinary hydroxyproline (Table 9) and with the 
negative partial correlation between P-intake and BMC/BW (Table 10), support 
the concept of nutritional secondary hyperparathyroidism. This concept is also 
supported by the negative correlation (r = — 0.32; P < 0.05) between serum 
ionized Ca and urinary hydroxyproline. We have no satisfactory explanation for 
the negative correlation (r = — 0.40; P < 0.01, two tailed) between bone alkaline 
phosphatase in serum and urinary hydroxyproline. Serum P showed a weak 
negative correlation with serum PTH (r = 0.20; P = 0.10) and BMC/BW (r = 
0.20; P = 0.10) and a positive correlation with serum creatinine (r = 0.32; P < 
0.05). These correlations might reflect a slight loss of renal function with loss of 
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Table 11 . Intake level of dietary variables in relation to biochemical parameters in females. 
mean Ca-intake 
range 
serum;5) 
P 
PTH 
APB 
urine:5) 
Ca/c r 
P/cr 
hypro /c r 
mean P-intake 
range 
serum: 
P 
PTH 
APB 
urine: 
Ca/c r 
P/cr 
hypro /c r 
mean C a / P 
range 
serum: 
P 
PTH 
APB 
urine: 
Ca/c r 
P/cr 
hypro/cr 
(g /24 h) 
( m g / 1 0 0 m l ) 
(MEq/l) 
(U / l ) 
(mg /g ) 
( m g / g ) 
(mg /g ) 
(g /24 h) 
( m g / 1 0 0 m l ) 
OxEq/l) 
(U / l ) 
(mg /g ) 
(mg /g ) 
(mg /g ) 
(mg /100ml ) 
(MEq/l) 
(U/ l ) 
(mg /g ) 
(mg /g ) 
(mg /g ) 
intake level of dietary 
low 
0.66 (n 
< 0.8 
3.34 ± 
0.33 ± 
15.8 ± 
118 ± 
615 ± 
26.7 ± 
1.02 (n 
< 1 . 2 
3.41 ± 
0.36 ± 
16.0 ± 
111 ± 
639 ± 
25.3 ± 
0.61 (n 
< 0 . 7 
3.34 ± 
0.30 ± 
15.3 ± 
138 ± 
616 ± 
27.5 ± 
= 13) 
0.52 
0.18 
6.1 
57 
1093) 
10.1 
= 19) 
0.52 
0.17 
4.8 
63 
154 
7.3 
= 16) 
0.51 
0.1-8 
6.9 
57 
1083) 
8.4 
medium 
calcium 
0.98 (n = 26) 
0 . 8 - 1.2 
3.48 ± 0.45 
0.34 ± 0.14 
15.8 ± 6.6 
127 ± 652) 
678 ± 197 
28.1 ± 9.4 
phosphorus 
1.37 (n = 21) 
1 . 2 - 1.6 
3.51 ± 0.44 
0.32 ± 0.13 
14.3 ± 6.7 
132 ± 582) 
665 ± 1923) 
28.8 ± 1 1 . 8 
variable 
high 
1.49 (n 
> 1 . 2 
3.61 ± 
0.38 ± 
14.0 ± 
149 ± 
867 ± 
30.1 ± 
1.87 (n 
> 1 . 6 
3.55 ± 
0.37 ± 
15.2 ± 
151 ± 
882 ± 
31.6 ± 
calcium to phosphorus 
0.76 (n = 15) 
0 . 7 - 0.8 
3.45 ± 0.49 
0.38 ± 0.13 
15.6 ± 5.7 
106 ± 48") 
674 ± 2 1 5 
27.4 ± 9.9 
0.88 (n 
> 0 . 8 
3.56 ± 
0.35 ± 
14.3 ± 
142 ± 
799 ± 
30.4 ± 
= 14) 
0.46 
0.12') 
4.9 
62 
318 
10.6 
= 13) 
0.48 
0.14') 
5.7 
68 
320 
9.0 
= 22) 
0.39 
0.13') 
5.0 
72") 
289 
11.9 
t-test 
low-hiqh 
P-value 
< 0.10 
n s 
n s 
< 0 . 1 0 
< 0 . 0 5 
n s 
n s 
n s 
n s 
< 0.05 
< 0.01 
< 0.05 
< 0 . 1 0 
n s 
n s 
n s 
< 0 . 0 5 
n s 
') One value not available, one abnormal value 
excluded (1.12 ftEq/l). 
') Two hypercalciuric values excluded. 
3) One abnormal value excluded (1620 mg/g). 
') One hypercalciuric value excluded. 
5) For abbreviations see subscript to Table 4. 
"able 12. Matrix of correlation coefficients between biochemical parameters 
and BMC/BW in females (n = 44). 
1. Ca /c r 1 ) 
2. P/cr 
3. hypro /c r 
4. Ca+ + 
5. P 
6. PTH 
7. APB 
8. 25-HCC 
9. creat 
I0. BMC/BW 
* = P < 0.10; 
1 
1.00 
2 
0 .35* * * 1.00 
0.13 
0.02 
0.12 
- 0 . 0 4 
0.17 
0.01 
- 0 . 0 3 
- 0 . 1 4 
0 4 2 * * * 
0.01 
0.19 
- 0 . 0 2 
- 0 . 0 2 
- 0 . 1 0 
- 0 . 1 2 
- 0 . 3 2 * * 
P < 0.05; 
3 
1.00 
- 0 . 3 2 * * 
0.03 
- 0 . 0 4 
- 0 . 4 0 * * 
0.07 
- 0 01 
- 0 . 0 9 
* ** _ 
4 
1.00 
0.12 
0.10 
- 0.01 
- 0 . 0 6 
0.11 
- 0 . 0 7 
P < 0.01 
5 
1.00 
- 0 . 2 0 * 
0.03 
- 0 . 1 8 
0 .32** 
- 0 . 2 0 * 
6 
1.00 
0.05 
- 0 . 1 4 
0.09 
0.12 
7 
1.00 
- 0 . 1 7 
- 0 . 0 5 
0.04 
8 9 10 
1.00 
- 0 . 0 4 1.00 
0 . 2 7 * * - 0 . 0 3 1.00 
' ) For abbreviations see subscript to Table 4. 
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bone as a consequence. The positive correlation (r = 0.27; P < 0.05) between 
serum 25-HCC and BMC/BW which was also found with BMC (Table 6) probably 
indicates a suboptimal vitamin D status. 
6.3.3 Evaluation of the data in males (Tables 13 to 20) 
For reasons of systematics and simplicity, evaluation of the data in males was 
done according to the procedures applied to the data of females. 
6.3.3.1 Factors associated with the bone mineral content 
Table 13 shows that BMC values correlate positively with height and weight, BW, 
BMC/BW, and thus with skeletal size. The positive correlation between BMC and 
Table 13. BMC in relation to age and somatometric, biochemical and nutritional parameters 
in males. 
mean 
somatometry: 
age 
height 
weight 
Quetelet index 
BW 
B M C / B W 
serum.") 
Ca+ + 
P 
25-HCC 
PTH 
creat 
APB 
urine:") 
Ca/c r 
P/cr 
hypro /c r 
diet: 
energy 
protein 
Ca 
P 
C a / P 
vit.D 
physical activity5) 
(years) 
(cm) 
(kg) 
(kg /m 2 ) 
(cm) 
(g /cm 2 ) 
(mg /100ml ) 
( m g / 1 0 0 m l ) 
(ng /ml ) 
OxEq/l) 
(mg /100ml ) 
(U/ l ) 
(mg /g ) 
(mg /g ) 
(mg /g ) 
( M J / 2 4 h ) 
( g / 2 4 h ) 
(energy %) 
( g / 2 4 h ) 
(g /MJ) 
(g /24 h) 
(g /MJ) 
< 1 
0.99 (r 
70.4 
166.4 
69.5 
24.0 
1.56 
0.64 
4.45 
3.01 
21.5 
0.36 
1.04 
17.0 
123 
535 
20.9 
10.7 
70 
11.0 
1.03 
0.10 
1.49 
0.14 
0.68 
237 
2.0 
+ 
+ 
+ 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
+ 
± 
+ 
+ 
± 
+ 
+ 
+ 
± 
+ 
.10 
= 8) 
4.7 
3.0 
7.2 
2.5 
0.16 
0.06 
0.291) 
0.55 
5.6 
0.23 
0.10 
4.8 
51 
142 
5.0 
3.0 
10 
0.33 
0.28 
0.17 
152 
0.8 
BMC ( g / c m ) 
1 
II 
.10-1.25 
1.17(n = 17) 
70.3 
172.4 
76.0 
24.5 
1.61 
0.74 
4.37 
2.96 
23.8 
0.36 
1.14 
13.8 
122 
652 
22.5 
11.0 
91 
13.9 
1.31 
0.12 
1.79 
0.16 
0.73 
246 
2.8 
± 4.7 
± 5.1 
± 1 1 . 9 
± 3.5 
± 0.14 
± 0.06 
± 0.44 
± 0.58 
± 7.22) 
± 0.12 
± 0.14 
± 5.7 
± 63 
± 1793) 
+ 7.1 
± 2.82) 
± 212) 
± 0.46 
± 0.442) 
± 0.172) 
± 1682) 
± 1.32) 
III 
> 1.25 
1.37 (n = 10) 
69.6 
175.4 
80.5 
25.3 
1.74 
0.79 
4.54 
3.06 
23.5 
0.26 
1.20 
11.8 
121 
583 
21.2 
11.9 
86 
12.1 
1.20 
0.10 
1.71 
0.14 
0.70 
254 
3.2 
± 3.7 
± 5.6 
± 10.1 
± 3.4 
± 0.08 
± 0.04 
± 0.19 
± 0.58 
± 5.2 
± 0.07 
± 0.14 
± 3.8 
± 48 
± 159 
± 5.4 
± 2.8 
± 26 
± 0.29 
± 0.33 
± 0.10 
± 76 
± 0.9 
t-test 
l-lll 
P-value 
n s 
< 0.01 
< 0.01 
n s 
< 0 . 0 1 
< 0.01 
n s 
n s 
n s 
n i 
< 0.01 
< 0 . 0 1 
n i 
n i 
n ! 
n ! 
< 0 . 1 ( 
n ! 
< 0.K 
n s 
n ! 
< 0 . 0 ' 
1) n = 7, one value not available. 
2) n = 16, one value not available. 
3) n = 16, one extreme value (1752 mg/g) excluded. 
4) For abbreviations see subscript to Table 4. 
5) See subscript to Table 5. 
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serum creatinine and that between BMC and physical activity probably reflect the 
association between skeletal and muscle mass. The relatively low consumption of 
protein and phosphorus in the subgroup with the low BMC-values (subgroup 1) 
can be attributed to a lower intake of food. The absence of-a negative correlation 
between BMC and age is attributable to the lower rate of bone loss with aging in 
males than in females (Section 4.2) as well as to the rather small age range of the 
males (Table 2). The negative correlation between bone alkaline phosphatase 
activity in serum and BMC will be referred to below. 
6.3.3.2 Factors associated with age 
Table 14 shows a remarkable decrease of height with age. On average this height 
loss amounted to 0.45 cm per annum (Table 15). It undoubtedly represents bone 
loss from the vertebrae (trabecular bone) but it could be in part the consequence 
of a secular trend. Between 1920 and 1930 the average height of conscripts in the 
Netherlands increased by 1.5 cm (den Hartog, 1972). This trend is insufficient to 
account for the observed height loss in the present study. The decrease in the 
urinary phosphorus excretion with age parallels a decrease in food intake. The 
decrease in the urinary excretion of hydroxyproline with age is attributable to a 
decrease in either protein intake, bone collagen metabolism or bone mass. 
6.3.3.3 Effect of calcium and phosphorus intake on bone parameters 
Table 16 shows significant positive correlations between skeletal size (H.W1/2) 
and bone parameters. A positive correlation between calcium intake and skeletal 
size can also be seen in this table. This correlation was investigated further using 
body height as a bone parameter (see Table 18). The positive correlations be-
tween calcium and phosphorus intake and dietary Ca/P are attributable to the 
consumption of dairy products. The positive trend correlation between BW on the 
one hand and dietary calcium and Ca/P on the other appeared insignificant if 
differences in skeletal size and age were taken into account by multiple linear 
regression (Table 17). 
From Table 17 it can be concluded that nutritional parameters did not give any 
partial correlation with bone parameters. However, if body height was used as a 
bone parameter, which seems justified because of the remarkable loss of height 
with age, the inclusion of calcium intake as an independent variable in the re-
gression of height on age improved the correlation coefficient from 0.37 (Table 
15) to 0.49 and the partial regression coefficient for calcium intake was significant 
(P< 0.05). The partial correlation between height and calcium intake was supe-
rior to that between either height and phosphorus intake or height and dietary 
Ca/P (Table 18). This suggests that the positive relation between calcium intake 
and body height is specific. 
6.3.3.4 Effect of calcium and phosphorus intake on biochemical parameters 
Table 19 shows there are no significant correlations between serum parameters 
(P, PTH and APB) and dietary variables (Ca, P and Ca/P). 
Mean serum PTH tended to be higher in the low-calcium than in the high-cal-
cium intake subgroup but this correlation was not consistent. Serum Ca (not 
tabulated) was unaffected by dietary variables. With respect to the urinary para-
meters, an increase in either Ca or P intake was associated with an increase in 
both the excretion of P and that of hydroxyproline. These observations in males 
are more or less similar to those in females. 
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Table 14. Age in relation to somatometric, biochemical and nutrit ional parameters in males 
mean 
somatometry: 
height 
BMC 
BW 
BMC/BW 
serum:5) 
Ca+ + 
P 
25-HCC 
PTH 
creat 
APB 
urine:5) 
Ca/cr 
P/cr 
hypro/cr 
diet: 
energy 
protein 
Ca 
P 
Ca/P 
vit.D 
(cm) 
(g/cm) 
(cm) 
(g/cm2) 
(mg/100ml) 
(mg/100ml) 
(ng/ml) 
GiEq/l) 
(mg/100ml) 
(U/l) 
(mg/g) 
(mg/g) 
(mg/g) 
(MJ/24 h) 
(g/24 h) 
(g/24 h) 
(g/24h) 
(IU/24h) 
physical activity6) 
< 68 years 
65.8 (n 
174.4 
1.17 
1.63 
0.72 
4.42 
2.86 
22.4 
0.32 
1.14 
15.5 
133 
638 
23.8 
12.4 
95 
1.24 
1.85 
0.67 
292 
2.9 
+ 
+ 
+ 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
+ 
= 12) 
6.1 
0.17 
0.18 
0.08 
0.452) 
0.62 
7.0 
0.10 
0.14 
6.4 
68 
177 
5.3 
3.2 
21 
0.31 
0.40 
0.13 
208 
1.6 
68-73 
69.8 (n 
170.9 
1.22 
1.62 
0.75 
4.47 
3.05 
25.0 
0.33 
1.10 
13.4 
102 
610 
21.2 
10.7 
84 
1.26 
1.70 
0.74 
222 
2.9 
± 
+ 
± 
+ 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
+ 
+ 
± 
+ 
± 
+ 
± 
age 
I 
years 
= 14) 
6.2 
0.16 
0.15 
0.08 
0.28 
0.60 
6.33) 
0.15 
0.17 
3.1 
36 
182") 
7.4 
1.6 
17 
0.40 
0.35 
0.15 
70 
1.2 
III 
> 73 years 
76.9 (n 
169.7 
1.15 
1.65 
0.70 
4.36 
3.14 
21.3 
0.35 
1.16 
13.5 
124 
535 
18.9 
9.7 
75 
1.15 
1.52 
0.73 
212 
2.1 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
+ 
+ 
+ 
= 10) 
3.4 
0.11') 
0.10') 
0.08') 
0.41 
0.41 
5.2 
0.18 
0.10 
5.6 
64 
139 
3.8 
2.0') 
14') 
0.52') 
0.361) 
0.171) 
89') 
0.8') 
t-test 
I-III 
P-valu 
<o. 
r 
r 
r 
r 
r 
r 
r 
r 
r 
r 
<o. 
<0.( 
<0 . ( 
<0 . ( 
n 
<0 . ( 
n 
n 
n 
1) n = 9, one value not available. 
2) n = 11, one value not available. 
3) n = 13, one value not available. 
") n = 13, one extreme value (1752 mg/g) excluded. 
5) For abbreviations see subscript to Table 4. 
6) See subscript to Table 5. 
Table 15. Linear regression of 
parameters on age (y = 
somatometric, biochemical and nutritional 
= b0 + b,x) in males. 
y 
height 
urinary hypro/cr 
diet: 
energy 
protein 
phosphorus 
(cm)') 
(mg/g)') 
(MJ/24 h)2) 
(g/24 h)2) 
(g/24h)2) 
bo 
204 
51.8 
26.4 
194 
3.31 
b, 
- 0.45 
- 0.43 
- 0.22 
- 1.54 
-0.023 
r 
-0.37 
-0.34 
-0.41 
-0.38 
-0.28 
P-value 
(t-test) 
<0.05 
<0.05 
<0.01 
<0.05 
<0.05 
') n = 36. 
2) n = 35, one value not available. 
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Table 16. Matrix of correlation coefficients between age, somatometric, and 
nutritional parameters in males (n = 34). 
age H.W.'/° dietary Ca dietary P dietary Ca/P 
age 
H.W.* 
dietary Ca 
dietary P 
dietary Ca/P 
BMC 
BW 
BMC/BW 
* = P < 0.10; 
1.00 
-0.09 
-0.14 
-0 .38** 
0.14 
-0.15 
-0.06 
-0.14 
** = P < 0.05; 
1.00 
0 4") *** 
0.23 
0.36** 
0.54*** 
0.50*** 
0.24* 
1.00 
Q 74a*a 
Q v T * * a 
0.20 
0.25* 
0.04 
*** = P < 0.01. 
1.00 
0 32** 
0.23 
0.13 
0.15 
1.00 
0.08 
0.24* 
-0.06 
Table 17. Partial regression coefficients ( ± SEM) of multiple linear regression (y 
= b0 + b,x, + b2x2 + . . . b n x n ) of bone parameters (y) on age (x,) 
H.W.*(x2), Ca (x3), P (x4) and Ca /P (x5) in males (n = 35) 
y 
BMC 
(mg/cm) 
BW 
(cm10-2) 
BMC/BW 
(mg/cm2) 
b0 
591 
593 
495 
310 
558 
90 
90 
89 
97 
92 
634 
687 
644 
514 
661 
(age) 
- 3.7 
± 5.3 
- 3.8 
± 5.3 
- 2.7 
± 5.8 
1.4 
± 6.1 
- 3.0 
± 5.4 
- 0 . 0 5 
±0.53 
- 0 . 0 3 
±0.53 
- 0 . 0 3 
±0.51 
- 0 . 0 9 
±0.57 
- 0 . 0 9 
±0.55 
- 2.0 
± 3.0 
- 2.2 
± 3.2 
- 1.6 
± 3.3 
- 0.7 
± 3.5 
- 1.6 
± 3.2 
regression coefficients 
b2 ( H.W.* ) 
57.2*** 
±16.2 
58.9*** 
±17.9 
55.6*** 
±16.8 
61.3*** 
±18.1 
61.6*** 
±17.6 
5 .1 * * * 
± 1.6 
4.9*** 
± 1.8 
5 -i * * * 
± 1.7 
4 g * * * 
± 1.8 
4 g * * * 
± 1.7 
12.7* 
± 9.5 
14.6* 
±10.4 
12.0 
± 9.8 
16.0* 
±10.5 
15.8* 
±10.2 
b3 (Ca) 
- 1 5 . 6 
±64.0 
— 
- 8 2 . 6 
±95.4 
2.1 
± 6.3 
— 
3.9 
± 9.5 
- 17 .1 
±37.3 
— 
- 5 7 . 8 
±55.6 
b4 
(P) 
-
30.4 
±66.3 
93.8 
±99.0 
-
0.48 
±6.58 
- 2.5 
± 9.8 
-
12.6 
±39.0 
57.0 
±57.8 
b5 (Ca/P) 
-
— 
— 
- 112 
± 167 
-
— 
— 
6.7 
±16.5 
-
— 
— 
- 7 9 . 1 
±97.8 
multiple 
r 
0.55 
0.55 
0.56 
0.57 
0.56 
0.50 
0.50 
0.50 
0.51 
0.51 
0.27 
0.28 
0.27 
0.33 
0.30 
! P 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
< 0.01 
<0.01 
<0.01 
<0.01 
<0 .10 
<0 .10 
<0.05 
< 0.05 
P < 0.10; * ** = P < 0.01. 
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Table 18. Partial regression coefficients ( ± SEM) of multiple linear regression of 
body height (y) on age (x,), dietary Ca (x2), P (x3) and Ca /P (x4) in 
males (n = 35). 
regression coefficients 
y 
height 
(cm) 
bo 
195.5 
194.8 
188.4 
202.3 
* = P < 0.10; 
b, 
— 0.42** 
±0.22 
- 0 . 4 2 * * 
±0.24 
- 0.34* 
±0.24 
—0.53** 
±0.22 
** = P < o.oe 
b2 
5.07** 
±2.35 
4.90* 
±3.60 
— 
b5 
0.24 
±3.99 
4.30* 
±2.66 
b. 
— 
— 
9.62* 
±6.50 
multiple r 
0.49 
0.49 
0.44 
0.43 
P-value 
<0.01 
<0.01 
<0.01 
<0.01 
Table 19. Intake level of dietary variables in relation to biochemical parameters in males. 
intake level of dietary variable t-test 
mean Ca-intake 
range 
serums) 
P 
PTH 
APB 
urine: 
Ca/cr 
P/cr 
hypro/cr 
mean P-intake 
range 
serum: 
P 
PTH 
APB 
urine: 
Ca/cr 
P/cr 
hypro/cr 
mean Ca/P 
range 
serum: 
P 
PTH 
APB 
urine: 
Ca/cr 
P/cr 
hypro/cr 
(g/24 h) 
(mg/100 
(MEq/l) (U/l) 
(mg/g 
(mg/g) 
(mg/g) 
(g/24 h) 
(mg/100 
(MEq/l) (U/l) 
(mg/g) 
(mg/g) 
(mg/g 
(mg/100 
0»Eq/l) 
(U/l) 
(mg/g) 
(mg/g) 
(mg/g) 
low 
0.76 (n 
< 1 . 0 
ml) 3.07 ± 
0.42 ± 
13.7 ± 
94 ± 
517 ± 
18.5 ± 
1.31 (n 
< 1 5 
ml) 2.97 ± 
0.36 ± 
13.7 ± 
117 ± 
539 ± 
19.1 ± 
0.55 (n 
< 0 . 6 
ml) 3.01 ± 
0.37 ± 
13.5 ± 
124 ± 
551 ± 
22.1 ± 
= g) 
0.45 
0.18 
6.1 
32 
93 
4.6 
= 12) 
0.47 
0.20 
5.1 
46 
147 
5.4 
= g) 
0.35 
0.18 
4.3 
71 
1573) 
4.1 
medium 
calcium 
1.16(n = 15) 
1.0 - 1.4 
2.93 ± 0.58 
0.26 ± 0.12 
13.9 ± 5.5 
134 ± 72 
608 ± 1702) 
22.2 ± 5.8 
phosphorus 
1.67 (n = 11) 
1 .5 - 1.9 
2.82 ± 0.57 
0.29 ± 0.09 
14.3 ± 6.5 
125 ± 68 
611 ± 1342) 
20.9 ± 6.0 
high 
1.68 (n 
> 1 . 4 
3.04 ± 
0.33 ± 
15.5 ± 
118 ± 
657 ± 
23.7 ± 
2.13(n 
> 1 . 9 
3.10 ± 
0.32 ± 
14.5 ± 
115 ± 
651 ± 
25.0 ± 
calcium to phosphorus 
0.67 (n = 12) 
0 .6-0 .75 
3.05 ± 0.58 
0.32 ± 0.14 
15.4 ± 7.9 
102 ± 52 
637 ± 152 
21.7 ± 6.2 
0.86 (n 
>0 .75 
3.04 ± 
0.30 ± 
13.6 ± 
130 ± 
595 ± 
21.4 ± 
= 11) 
0.64 
0.09 
3.4 
46 
207 
7.0 
= 12) 
0.61 
0.11 
3.9 
61 
212 
5.8 
= 14) 
0.58 
0.12 
3.4 
52 
197 
7.2 
P-valu( 
n 
<0 .1 
n 
= 0.1 
<0.C 
<0.C 
n 
n 
n 
n 
<0 .1 
<o.c 
n 
n 
n 
n 
n 
n 
1
 ) For abbreviations see subscript to Table 4. 
2) n = 14, one abnormal value (1752 mg/g) is excluded. 
3) n = 8, see footnote 1. 
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6.3.3.5 Correlations between biochemical parameters and BMC/BW 
Table 20 shows a correlation matrix based on data of 33 males. Because of 
incomplete data sets (2 cases) and hyperphoshaturia (1 case; 1753 mg/g creati-
nine), 3 males were excluded from this matrix. There was a significant correlation 
(r = -0.34; P < 0.05) between urinary Ca and serum PTH and this is consistent 
with the positive effect of the hormone on renal tubular reabsorption of calcium. 
Table 20. Matrix of correlation 
males (n = 33). 
1 2 
LCa /c r ' ) 1.00 
2. P/cr 0.22 1.00 
3. hypro/cr 0.07 0.27* 
4. Ca** -0.12 0.21 
5. P -0.05 -0.39* 
6. PTH -0 .34** -0.08 
7. APB -0.12 0.04 
8.25-HCC -0.21 -0.05 
9. creat -0.06 -0.34* 
10. BMC/BW -0.09 0.12 
coefficients between biochemical parameters and BMC/BW in 
3 
1.00 
-0.01 
' 0.13 
0.19 
0.21 
-0.07 
5
 -0.05 
0.04 
4 
1.00 
0.07 
-0.02 
-0.05 
0.05 
-0.04 
0.06 
5 
1.00 
-0.03 
0.01 
0.07 
0.27* 
0.03 
6 
1.00 
0.09 
0.07 
-0.03 
0.09 
7 8 9 10 
1.00 
-0.15 1.00 
-0.01 0.03 1.00 
-0.36**0.42***0.13 1.00 
* = P < 0.10; 
** = P < 0.05; 
*** = P < 0.01. 1) For abbreviations see subscript to Table 4. 
The positive correlation (r = 0.27; P < 0.10) between urinary P and hydroxypro-
line is consistent with the concept that excess dietary phoshorus stimulates PTH 
secretion and bone turnover. The negative correlations between urinary P and 
serum P (r = -0.39; P < 0.05) and between urinary P and serum creatinine (r = 
0.34; P < 0.05) as well as the positive correlation between serum creatinine and 
serum P (r = 0.27; P < 0.10) point to a slightly diminished renal function. The 
positive correlation (r = 0.42; P < 0.01) between serum 25-HCC and BMC/BW 
may indicate that the vitamin D status of the group as a whole is not optimal. This 
is supported by the negative correlation (r = -0.36, P < 0.05) between bone 
alkaline phosphatase (APB) in serum and BMC/BW. 
6.3.4 Abstract of results 
Calcium intake largely exceeded the Dutch recommendation of 0.8 g/24 hours for 
adults and averaged 1.04 g/24 hours in the women and 1.22 g/24 hours in the 
men. In spite of an ample phosphorus intake (25 % of the men and the women had 
an intake exceeding 1.6 and 2.0 g phosphorus daily respectively), the dietary 
Ca/P-ratio (0.76 in the women and 0.71 in the men) was more favourable than that 
of the general Dutch population (0.58). 
In the women BMC/BW-values clearly decreased with advancing age (0.8% per 
year) and this bone loss was associated with loss of height (0.35 cm per year). The 
BMC/BW-ratio showed a significant positive partial correlation with calcium in-
take and a negative one with phosphorus intake (both P < 0.05). An increase in 
phosphorus intake was associated with an increase in the urinary excretion of 
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phosphorus and that of hydroxyproline, and the urinary phosphorus excretion 
showed a significant negative correlation (P < 0.05) with the BMC/BW-ratio. The 
urinary excretion of calcium slightly but significantly decreased with advancing 
age (P < 0.01), probably as a consequence of a decrease in the intestinal 
absorption. 
In the men there was no loss of radial bone with advancing age. However, a 
marked loss of height was established (0.45 cm per year). This decrease of body 
height with age probably reflects, at least in part, loss of trabecular bone from the 
vertebrae. BMC-values as well as BMC/BW-values increased with the degree of 
physical activity but did not show any relation with either calcium or phosphorus 
intake. In contrast body height showed a significant positive partial correlation 
with calcium intake (P < 0.05). As in the women, an increase in phosphorus 
intake was associated with an increase in the urinary excretion of phosphorus and 
that of hydroxyproline. A significant negative correlation was observed between 
the urinary excretion of phosphorus and the serum phosphorus concentration (P 
< 0.05). 
In both the men and the women serum concentrations of PTH and creatinine 
were at the upper limit of normality, and this is in line with a slightly diminished 
renal function. In both sexes positive correlations (P < 0.05) were found between 
BMC/BW values and the serum concentrations of 25-HCC. These correlations 
existed despite serum concentrations of this parameter of the vitamin D status 
were within normal limits. 
6.3.5 Discussion of results 
For several reasons the interpretation of the results has to be done with great 
care. In the first place the study was carried out among a rather small and selected 
group of elderly people. So extrapolation of results to the population of elderly 
people in Ede or in The Netherlands as a whole is not permissible. In the second 
place it should be recognized that in an observational study like this it is not 
possible to have all the interfering variables sufficiently under control. In the third 
place it should be recognized that in an observational study the change of one 
variable is mostly associated with that of many others. These two latter consider-
ations imply that the study cannot provide conclusive evidence. At best the results 
can support an hypothesis or give rise to further study. 
Although significant correlations were found, they were generally low and, as a 
consequence explained only a small part of the variation. In this respect the 
marked inter-individual variation of biological parameters which normally occurs 
should be stressed. It should also be stressed that the cross-check method yields 
somewhat rough estimations of habitual rather than actual nutrient intake. Fur-
thermore there is no guarantee as to whether the constancy of food habits on 
which the cross-check method is based really occurred in all participants. For 
these reasons the correlation between nutrient intakes and biochemical param-
eters in a single urine or serum sample cannot be high. 
One complication of a cross-sectional study among aged subjects is that ef-
fects of selective survival or differential mortality might give a false picture of 
observed relationships. A significant point in this study is that observed differen-
ces in bone mass may be the consequence of either differences in bone mass 
already present at maturity or to differences in the rate of bone loss after maturity 
or to both. 
The results will be discussed further within the scope of the pathogenesis of 
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hyperparathyroidism as outlined in Figure 5 (Section 5.11). Both in women and 
men there was evidence of a slightly diminished renal function and this might have 
been expected in subjects of this age group (Rowe et al., 1976). The positive 
correlation, found in both sexes, between creatinine and phosphorus in serum 
also points to early loss of renal function, and the negative correlation in women 
between serum phosphorus and BMC or BMC/BW is consistent with the view that 
loss of renal function is a factor in bone loss with aging. 
Regarding the effect of diet on bone in women, the positive correlation between 
calcium intake and BMC/BW and the negative correlation between phosphorus 
intake and this bone parameter are consistent with the hypothesis of nutritional 
hyperparathyroidism. However, since these correlations were only significant if 
differences in age and skeletal size were taken into account and since they could 
not be demonstrated in men, the chance of an artefact should not be overlooked. 
In men bone loss with advancing age was not detected but there was a marked 
loss of height with age, probably reflecting a loss of trabecular bone. It is therefore 
possible that the photon-absorptiometric measurement of the BMC of the radius 
at the distal third (almost completely cortical bone) is not representative of the 
bone status of the entire body. In this respect differences in manual labour 
affecting the muscle and bone mass of the right (often dominating) forearm might 
have interfered. It is also possible that, particularly in men, loss of trabecular bone 
dominates that of cortical bone. In this sense the positive correlation in men 
between calcium intake and body height is remarkable. 
Regarding the effect of diet on biochemical parameters in both women and 
men, an increase in P intake was found to be associated with an increase in the 
urinary excretion of phosphorus and hydroxyproline. In addition, these latter 
parameters were correlated positively with each other. Since diets which are rich 
in phosphorus usually contain much protein, possibly including collagen-protein 
and hydroxyproline, these correlations might be of dietary rather than of physio-
logical origin. It should be remembered, however, that urinary phosphorus, which 
is mainly determined by the amount of phosphorus consumed, correlated nega-
tively with BMC/BW in women. This correlation is consistent with the partial 
negative correlation between dietary phosphorus and this bone parameter. In 
men urinary phosphorus correlated negatively with serum phosphorus, suggest-
ing hyperparathyroidism. This latter phenomenon was not observed in the wom-
en. The possible cause of this sex difference will be referred to in the General 
Discussion (Chapter 9). The observed correlations between either dietary or 
urinary phosphorus and hydroxyproline excretion and serum phosphorus in the 
men and hydroxyproline excretion and BMC/BW in the women, are in line with the 
concept that high-phosphorus diets stimulate PTH secretion and bone turnover 
(Figure 5, Section 5.11). 
An important observation was that in the elderly people, serum 25-HCC corre-
lated positively with BMC/BW despite the fact that the concentrations of this 
metabolite in serum were normal. This correlation probably reflects a diminished 
conversion of 25-HCC to 1,25-DHCC or 24,25-DHCC consequent to renal aging 
(Section 4.6), an increased need for vitamin D and a sub-optimal vitamin D status 
of the elderly. A diminished synthesis of 1,25-DHCC consequent to renal aging 
was also outlined in Figure 5 (Section 5.11). This corresponds with the decline in 
the urinary calcium excretion with age which was observed in the women, and 
with the negative correlation between bone alkaline phosphatase and BMC/BW 
in the men. 
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It can be concluded that the observed relations, discussed above, fit into the 
outline of the pathogenesis of hyperparathyroidism (Figure 5, Section 5.11 ). This 
suggests that in elderly people either a low-calcium or a high-phosphorus diet 
contributes to the development of hyperparathyroidism, which may cause osteo-
porosis. 
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Chapter 7 
Nutritional interrelationships between calcium, phosphorus 
and lactose in rats 
7.1 Introduction 
This Chapter, in which an experiment with rats is reported, deals with the effect of 
dietary calcium, phosphorus and lactose on calcium and bone metabolism. It was 
published in the 'Journal of Nutrition' in 1980 and is reproduced in its entirety on 
the following pages. 
Although it was not intended that this thesis should deal with lactose as a 
dietary factor which influences calcium metabolism (Section 5.3), the observa-
tions made in this experiment, as far as the effect of dietary calcium and phos-
phorus on calcium and bone metabolism is concerned, are relevant to the subject 
of this thesis. The study at issue preceded the experiments described in Chapter 8. 
Before the reader loses himself in the article, some remarks have to be made. 
First, it should be mentioned that rat plasma alkaline phosphatase, in contrast to 
human plasma alkaline phosphatase, could not be separated by Polyacrylamide 
gel electrophoresis into its isoenzymes in a satisfactory way. It appeared that the 
bone isoenzyme did not separate from the intestinal isoenzyme. For this reason, 
only total alkaline phosphatase activity has been reported in the experiments with 
rats. Secondly, attention is drawn to a few errors in the text: 
page 64 Abstract, line 11: 'excretion' should read: 'exception'. 
Abstract, line 21 : 'in line' should read: 'are in line'. 
page 65 first column, line 15: 'calcium phosphorus ratio' should read: 'cal-
cium-to-phosphorus ratio'. 
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ABSTRACT From the age of 3 months, six groups of rats consisting of 
six animals each were fed one of three types of diet with either 15% 
lactose or dextrose. The diets used were a control diet containing 0.6% 
calcium and 0.45% phosphorus and two high-phosphorus ( 1.3% ) diets with 
either a normal (0.6%) or a low (0.2%) calcium content. Whereas calcium 
retention and femur mass appeared to be unaffected, feeding the high-
phosphorus diets resulted in significant ( P ^ 0.05 or P ^ 0.01 ) biochemical 
changes including: decreased plasma phosphorus almost throughout the 
whole of the study; increased plasma alkaline phosphatase and urinary 
total hydroxyproline after 17 and 42 weeks; nephrocalcinosis; depressed 
urinary calcium, and reduced femur density. With the excretion of nephro-
calcinosis and depressed urinary calcium, these changes were more marked 
if the calcium content of the diet was low than when it was normal, and 
this difference was associated with a significant ( P < 0.01 ) inhibiting effect 
of dietary calcium on the intestinal absorption and urinary excretion of 
phosphorus. Although lactose, as compared with dextrose, significantly 
( P < 0.01 ) improved the intestinal absorption and retention of calcium 
during body weight gain, which was reflected by an increased femur mass 
after 42 weeks, this sugar did not reduce the detrimental effects on bone 
and soft tissue resulting from feeding the high-phosphorus diets. The results 
of the study in line with the induction of nutritional secondary hyperpara-
thyroidism and increased bone turnover in rats fed high-phosphorus diets 
and indicate that lactose-stimulated calcium absorption will not prevent or 
diminish the biochemical changes associated with this disease; the results 
also stress the significance of the calcium content of the diet as a factor that 
may protect the body against excessive dietary phosphorus. J. Nutr. 110: 
1101-1111, 1980. 
INDEXING KEY WORDS calcium phosphorus • lactose • 
calcium balance • bone parameters 
It is well known ( 1 ) that diets contain- cially of kidneys. According to Krook et al. 
ing either a phosphorus excess or a low ( 5 ) the underlying mechanism is secondary 
calcium:phosphorus ratio induce acceler- hyperparathyroidism, initiated by a depres-
ated bone resorption in experimental ani- sion of the plasma calcium concentration 
mals. This bone resorption may, depending following an increased phosphate flow 
on age of onset, animal species and dietary through the blood. Osteoporosis ( dimin-
manipulation, result in osteoporosis (2) , ished amount of bone) has been reported 
osteitis fibrosa (3) and periodontal disease by Draper and co-workers (2, 6) in aging 
(4). These bone lesions are sometimes as-
SOciated with soft tissue calcification, espe- Received for publication 5 October 1979. 
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TABLE 1 
Composition of the diets (gl 100 g) 
Diets 
Basal diet12 
CaCCV 
KH2P(V 
Washed sea 
Total 
sand 
CC 
93.24 
1.50 
1.32 
3.94 
100 
CH 
93.24 
1.50 
5.28 
100 
LH 
93.24 
0.50 
5.28 
0.98 
100 
ingredients (g/kg total diet): casein, 195; DL-
methionine, 5; palm oil, 149; wheat starch, 298 
cellulose, 100; lactose or dextrose, 150; KCl, 10 
NaCl, 15; MgS04-7H20, 6.2; FeS04-7H20, 0.5 
CuSO,-5H20, 0.1; MnSO,-4H20, 0.1; ZnSO,-7H20, 
0.1, and KIO3, 0.001. Vitamins per kilogram of total 
diet: thiamin-HCl, 3 mg; riboflavin, 4 mg; pyridox-
ine, 3 mg; niacin, 25 mg; pantothenic acid, 20 mg; 
biotin, 0.12 mg; cyanolcabalamin, 0.04 mg; folic 
acid, 0.84 mg; myo-inositol, 84 mg; choline chlo-
ride, 1.5 g ; dextrose, 360 mg; retinol, 12.5.103iu; 
cholecalciferol, 2.9 X 103 iu ; alpha tocopherol, 51 
mg; Phyllochinone, 2 mg, and soy oil, 1 g. 2 Die-
tary mineral composition and the supplementation 
with CaC03 and KH2PO.i adapted from Whittemore 
et al. (9). 
rats fed diets containing 1.2 or 1.8% versus 
0.3 or 0.6% phosphorus with 0.67c calcium, 
as well as in rats fed 1.2 versus 0.6% di-
etary phosphorus with 1.2% calcium. Al-
though in both studies an increased loss of 
labeled calcium from the bones of rats fed 
the high-phosphorus diets was observed, 
neither intestinal absorption nor retention 
of calcium was affected, which is difficult 
to reconcile with the development of osteo-
porosis. Increasing the dietary calcium con-
tent did not prevent accelerated bone 
resorption induced by feeding high-phos-
phorus diets, and it was therefore postu-
lated that the dietary calcium phosphorus 
ratio loses significance at high phosphorus 
intake levels (6) . 
However, as it has been shown that di-
etary calcium has a marked inhibiting effect 
on intestinal phosphate absorption, ( 2, 6, 7 ) 
one might expect that lowering the calcium 
content of the diet would aggravate the 
detrimental effects of a high phosphorus 
load. It might also be expected that the 
effects of excess dietary phosphorus would 
be counterbalanced if the stimulus to para-
thyroid stimulation were reduced by an in-
creased intestinal calcium absorption. A 
factor that has long been known to increase 
intestinal absorption and retention of cal-
cium is the presence of lactose in the diet 
(8). The aim of the subsequent study was 
therefore to investigate the effects of high-
phosphorus diets with or without lactose on 
calcium metabolism and bone and the ef-
fects of different levels of calcium in high-
phosphorus diets on phosphate metabolism 
and bone. 
METHODS 
Thirty-six male lean Zucker rats (Rattus 
norvegicus) 3 months old and weighing 
about 270 g were divided into six groups 
of six which were fed one of three types of 
diet with either 15% lactose or dextrose. 
The diets used were a control diet (diet 
CC) containing 0.6% calcium and 0.45% 
phosphorus and two high-phosphorus 
(1.3%) diets with either a normal (0.6%) 
or a low (0.2%) calcium content (diets 
CH and LH, respectively). The diets of 
which the composition is shown in table 1 
were fed for a period of 42 weeks. The ani-
mals were housed individually under con-
ditions of controlled lighting, temperature 
and humidity, and deionized water and 
food were provided ad libitum. Food con-
sumption was recorded daily and body 
weights were measured biweekly. During 
weeks 4, 8, 30 and 42, 96-hour collections 
of feces and urine were made. Fasting 
blood samples were drawn under light 
ether anesthesia (orbita puncture) after 
these collection periods and also after 17 
weeks. 
After 42 weeks of feeding, the rats were 
killed by N 2 0, and heart, kidneys and right 
femur were removed from their bodies. 
Feces, dry fat-free femurs, heart and kid-
neys were dry ashed in a muffle furnace 
for 16 hours at 600°. The ash was dissolved 
in 1 ml 4 N HCl and diluted with distilled 
water for the determination of calcium and 
phosphorus. Femurs were cleaned of adher-
ing tissue, weighed under water for deter-
mination of bone volume, defatted for 48 
hours in ethanol (95%) and for 48 hours 
in petroleum ether (b.p. 30-60°), dried for 
16 hours at 105° and weighed. Calcium was 
estimated by a methylthymol blue method 
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( 10 ) and phosphorus by a molybdenum 
blue method (11). Urinary total hydroxy-
proline was assayed according to the 
method of Kivirikko et al. (12). Plasma 
alkaline phosphatase activity was estimated 
using nitrophenylphosphate as a substrate 
(commercial reagent kit, Boehringer, Mann-
heim, W. Germany). 
Two-way analysis of variance was ap-
plied to test the significance of main and 
interaction effects. If F-values reached sta-
tistical significance ( P ^ 0.05 ) or indicated 
a trend effect (P^O. IO) , differences be-
tween group means of rats fed the same 
type of diet (lactose versus dextrose) were 
further investigated using Student's t-test 
(one-sided). Differences due to the type of 
diet and/or carbohydrate X diet interaction 
effects were further investigated using 
Sheffe's test to prevent loss of confidence 
due to multiple comparison ( 13 ). If in-
homogeneity of variances was apparent, the 
parameter-free Kruskal-Wallis test was 
used. Three levels of significance were ap-
plied: P s$ 0.01, P s£ 0.05 and P ^ 0.10. 
RESULTS 
Body weight gain and jood consumption 
(table 2). Body weight gain was almost 
linear during the first 12 weeks and slowed 
down thereafter in all groups. Rats fed the 
dextrose diets with the normal calcium 
content gained faster than did rats fed these 
diets with lactose ( P < 0.05 ), whereas food 
consumption was not significantly different 
between these animals. Body weight gain 
as well as food consumption was higher in 
rats fed the control diets than in rats fed 
the high-phosphorus diets ( P < 0.01 ). 
Plasma parameters and urinary total 
hydroxyproline ( fig. 1 ) 
Calcium. There were no significant main 
effects of dietary variables on plasma cal-
cium, which was within the normal range 
in all groups. After 42 weeks, values tended 
to be lower in rats fed the normal calcium 
high-phosphorus diets than in rats fed the 
control diets (mean difference ± SEM: 0.30 
±0.14 mg/100 ml; P < 0.10). 
Phosphorus. In all groups plasma phos-
phorus decreased with advancing age. The 
type of dietary carbohydrate did not in-
TABLE 2 
Body weight gain and food consumption1 
Diets 
Lactose 
Dextrose 
SEM4 
ANOV' 
Main« 
contrast 
C C ' 
CH 
LH 
CC 
CH 
LH 
CHO 
C a / P 
CHO X C a / P 
CC -
CC -
CC -
CH -
CH 
LH 
J(CH + LH) 
LH 
Body wt 
gain 
g/42 weeks 
129 
88 
118 
162' 
126» 
111 
13 
P < 0.10 
P < 0.01 
N.S. 
38.5 ±13.4'.« 
31 .0±13.4 ' 
34 .7±11.6 ' 
- 7 . 5 ± 1 3 . 4 
Food 
consumption 
g/week 
116 
105 
113 
117 
110 
110 
2 
N.S. 
P < 0.01 
N.S. 
9.0 ±2.4 / 
5.0±2.4 
7.0 ± 2 . 1 / 
- 4 . 0 ± 2 . 4 
1
 Values shown are means of six rats. * CC, CH and LH in-
dicate control, normal-calcium, high-phosphorus and low-cal-
cium, high-phosphorus diets, respectively. ' Indicates signi-
ficance of difference from value in rats fed the corresponding 
diet with lactose: « P $ 0.10; ' P $ 0.05; 'P Ç 0.01, by 
Students (-test. * SEM derived from pooled error variance. 
s
 Analysis of variance : CHO, C a / P and CHO X C a / P indicate 
effects of dietary carbohydrate, calcium/phosphorus ratio and 
carbohydrate X calcium-phosphorus ratio interaction effect, 
respectively. fl Values of lactose-fed and dextrose-fed rats 
combined. 'Mean±BEM; * P ^ 0.10, • P i 0.05, ' F $ 
0.01 by Scheffe's test. 
fluence the concentration in four of the five 
occasions that it was measured; after 30 
weeks levels were slightly higher in rats 
fed lactose: mean differences ± SEM were 
0.55±0.33 in rats fed the control diets, and 
0.48±0.33 and 0.50±0.33 mg/100 ml (all 
P ^ 0.10) in those fed the high-phosphorus 
diets with the normal and low calcium con-
tent respectively. Throughout the study rats 
fed the high-phosphorus diets had lower 
concentrations than did those fed the con-
trol diets; the lowest values were observed 
on the low-calcium, high-phosphorus diets. 
These values differed significantly from 
those of rats fed the control diets for the 
first 30 weeks: mean differences ± SEM 
were 1.09 ± 0.37, 1.39 ± 0.32, 0.69±0.23 
and 0.84 ±0.23 mg/100 ml (all PsSO.01) 
after 4, 8, 17 and 30 weeks, respectively. 
After 42 weeks the difference was smaller 
(mean value 0.48±0.23 mg/100 ml; P < 
0.10). Consistent intermediate values which 
were not significantly different from those 
in rats fed either type of other diet were 
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plasma alkaline phosphatase (U/l) 
25 
0 8 16 24 
urinary total hydroxyproline (mg/day) 
32 40 
weeks 
Fig. 1 Plasma calcium, phosphorus and alkaline phosphatase and urinary total hydroxy-
proline. Lactose-fed and dextrose-fed rats combined: O O = control groups (CC diets); 
A A normal-calcium, high-phosphorus groups (CH diets); • O low-calcium, high-
phosphorus groups (LH diets). 
observed in rats fed the normal-calcium, 
high-phosphorus diets. 
Alkaline phosphatase. Enzyme activity 
was not significantly influenced by the type 
of dietary carbohydrate throughout the 
study. After 17, 30 and 42 weeks the activ-
ity was higher in rats fed the low-calcium, 
high-phosphorus diets than in those fed the 
control diets, (mean difference ± SEM: 2.01 
±0.79, P = 0.05; 0.81±0.55, P < 0.10, and 
2.99±0.66, P < 0 . 0 1 , respectively). After 
17 and 42 weeks intermediate values were 
measured in rats fed the normal-calcium, 
high-phosphorus diets, which were not sig-
nificantly different from values in rats fed 
either type of other diet. 
Hydroxyproline. No significant carbohy-
drate effect was detected throughout the 
study. After 17 weeks rats fed the control 
diets had lower values than rats fed either 
the normal-calcium, high-phosphorus diets 
(mean difference ± SEM: 0.20±0.08 mg/24 
hours, P < 0.05) or the low-calcium, high-
phosphorus diets ( mean difference ± SEM : 
0.49±0.08 mg/24 hours P < 0.01). Of the 
rats fed these high-phosphorus diets, those 
fed low dietary calcium had higher values 
than those fed normal dietary calcium 
(mean difference ± SEM: 0.30±0.08 mg/100 
ml, P < 0.01 ). These differences were not 
observed after 30 weeks but reappeared, 
though to a smaller extent, after 42 weeks. 
At that time rats fed the low-calcium, high-
phosphorus diets excreted more than rats 
fed either the control diets or the normal-
calcium, high-phosphorus diets (mean dif-
ferences ± SEM: 0.14±0.04, P < 0.01, and 
0.11±0.04, P < 0.05, respectively). 
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Calcium and phosphorus balance ( tables 
3 and 4). Data on balances obtained after 
3 and 7 weeks, when body weight gain was 
almost linear ( designated as period 1 ) and 
after 29 and 41 weeks when body weights 
were almost constant ( designated as period 
2) were pooled, since the results obtained 
during each of these periods were similar. 
Results obtained during period 1 are shown 
in tables 3 and 4, and those achieved dur-
ing period 2 appear in the text as far as 
they differed from those achieved during 
period 1. 
Urinary calcium. Effects of dietary treat-
ment on urinary calcium were identical 
during periods 1 and 2. Rats fed lactose ex-
creted more calcium in urine than did rats 
fed dextrose ( P < 0.01 ), this effect being 
greater in rats fed the control diets than in 
those fed either type of the high-phos-
phorus diet ( P . < 0.01). Rats fed the con-
trol diets excreted more than did rats fed 
the high-phosphorus diets ( P < 0.01 ), and 
in rats fed these latter diets excretion was 
slightly higher when the calcium content 
of the diet was low than when it was nor-
mal ( P < 0 . 0 5 ) . 
Calcium retention. Calcium retention in 
all groups was positive during period 1. 
Lactose improved retention during this pe-
riod in rats fed either the control diets 
( P < 0.01 ) or the low-calcium, high-phos-
phorus diets ( P < 0.05 ). This positive effect 
was not observed during period 2. There 
was no significant effect of the dietary 
Ca/P ratio on retention during period 1. 
When body weights were almost constant 
(period 2), a positive calcium retention 
was only observed in rats fed the normal-
calcium, high-phosphorus diets, which 
amounted to 4.4±1.8 mg/24 hours for both 
lactose-fed and dextrose-fed rats, whereas 
in the remaining groups retention was not 
significantly different from zero —0.05± 
0.91 mg/24 hours). 
Percentage net intestinal calcium absorp-
tion. During period 1 lactose improved ab-
sorption in rats fed either the control diets 
TABLE 3 
Parameters on calcium balance and percentage net intestinal calcium absorption1 
Diets 
Lactose 
Dextrose 
SEM 
ANOV 
Main 
contrast 
Interaction 
contrast2 
CC 
CH 
LH 
CC 
CH 
LH 
CHO 
Ca/P 
CHO X Ca/P 
CC -
CC -
CC -
CH -
CC -
CC -
CC -
CH -
CH 
LH 
*(CH + LH) 
LH 
CH 
LH 
i(CH + LH) 
LH 
Intake 
89.0 
80.3 
31.8 
85.3 
81.8 
27.2 
2.1 
— 
— 
— 
Urine 
mg/24 hours 
2.1 
1.1 
1.3 
1.3' 
0.86 
1.0" 
0.1 
P < 0.01 
P < 0.01 
P < 0.01 
0.8±0.1' 
0.6±0.1> 
0.7±0.1' 
0.2±0.1« 
0.6±0.2' 
0.5±0.2' 
0.6±0.1' 
0.1±0.2 
Retained 
9.7 
8.8 
8.5 
2.7' 
7.5 
4.1* 
1.3 
P < 0.01 
N.S. 
P < 0.10 
— 
5.6±2.6 
2.6±2.6 
4.1±2.2 
-3 .1±2.6 
Absorption 
% 
13.1 
12.3 
30.8 
4.8« 
10.1 
18.8' 
1.6 
P < 0.01 
P < 0.01 
P < 0.01 
- 2.1±1.6 
- 1 5 . 9 Ü . 6 
- 9.1±1.4' 
-13.6±1.6 ' 
6.2±3.2 
- 3.8±3.2 
1.2±2.8 
- 9.9±3.2> 
1
 Average of mean values of six rats during weeks 3 and 7. See footnotes to table 2. 
contrast on lactose and contrast on dextrose diets. 
2
 Difference between 
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TABLE 4 
Parameters on phosphorus balance and percentage net intestinal phosphorus absorption1 
Diets 
Lactose 
Dextrose 
SEM 
ANOV 
Main 
contrast 
Interaction 
contrast* 
CC 
CH 
LH 
CC 
CH 
LH 
CHO 
Ca/P 
CHO X Ca/P 
CC -
CC -
CC -
CH -
CC -
CC -
CC -
CH -
CH 
LH 
i(CH + LH) 
LH 
CH 
LH 
i(CH + LH) 
LH 
Intake 
68.9 
174.1 
188.0 
66.5 
177.5 
168.2 
4.6 
— 
— 
— 
Urine 
mg/24 hours 
32.1 
113.8 
159.1 
30.9 
124.5 
145.9 
5.5 
N.S. 
P < 0.01 
N.S. 
- 87.6±5.5' 
-121.0±5.5 ' 
-104.3±4.8 ' 
- 33.4±5.5' 
— 
Retained 
4.7 
7.9 
6.2 
-1 .1 
-2.7» 
-53.» 
4.1 
P < 0.01 
N.S. 
N.S. 
— 
— 
Absorption 
% 
53.2 
69.8 
87.9 
44.8' 
68.5 
83.6' 
0.9 
P < 0.01 
P < 0.01 
P < 0.01 
-20.2±0.9 ' 
-36.8 ±0.9 ' 
-28 .5±0.8 ' 
-16 .6±0.8 ' 
7.1±1.8' 
4.1±1.8 
5.6±1.4' 
- 3.0±1.8 
1
 Average of mean values of six rats during weeks 3 and 7. See footnotes to table 2. 
contrast on lactose and contrast on dextrose diets. 
2
 Difference between 
( P < 0.01 ) or the low-calcium, high-phos-
phorus diets ( P < 0.01 ), and in rats fed 
the high-phosphorus diets the positive ef-
fect of lactose was significantly greater 
when the calcium content of the diet was 
low than when it was normal ( P < 0.01 ). 
The positive effect of lactose was not ob-
served during period 2. Rats fed the low-
calcium, high-phosphorus diets had higher 
values than rats fed either type of the other 
diet during period 1 (P < 0.01) but not dur-
ing period 2. During this latter period ab-
sorption tended to be higher in rats fed the 
normal-calcium, high-phosphorus diets than 
in those fed the other diets (7.2±1.5 versus 
3.0±1.0%, P < 0.10). 
Urinary phosphorus. During periods 1 
and 2 there was no significant carbohydrate 
effect, but rats fed the high-phosphorus 
diets excreted much more phosphorus in 
urine than did rats fed the control diets 
( P < 0.01 ). In rats fed the high-phosphorus 
diets excretion was markedly higher when 
the calcium content of the diet was low 
than when it was normal ( P < 0.01 ). 
Phosphorus retention. During period 1, 
but not during period 2, rats fed lactose 
retained more phosphorus than did rats fed 
dextrose. This effect was significant on 
either type of the high phosphorus diet 
(P < 0.05). Retention was not significantly 
influenced by the dietary Ca/P ratio dur-
ing period 1, but during period 2 positive 
retention occurred in rats fed the normal-
calcium, high-phosphorus diets (12.0±3.1 
mg/24 hours), whereas in rats fed the other 
diets retention was not significantly dif-
ferent from zero (1.4±2.2 mg/24 hours). 
Percentage net intestinal phosphorus ab-
sorption. During period 1 but not during 
period 2, rats fed lactose had higher ab-
sorption values than did rats fed dextrose. 
This effect was significant in rats fed the 
control diets ( P < 0.01 ) and in those fed 
the low-calcium, high-phosphorus diet and 
was greater in rats fed the control diets 
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than in rats fed the high-phosphorus diets 
(P < 0.01). Absorption was markedly in-
fluenced by the dietary Ca/P ratio: during 
both periods values were higher in rats fed 
the high-phosphorus diets than in those fed 
the control diets ( P < 0.01 ) ; and in rats 
fed the former diets absorption was higher 
when the calcium content of the diet was 
low than when it was normal ( P < 0.01 ). 
Bone parameters (tables 5 and 6) 
Bone volume. Rats fed lactose tended to 
have higher values than did rats fed dex-
trose (P < 0.10), the difference being sig-
nificant only in rats fed the control diets 
( P < 0.05 ). Rats fed the high-phosphorus 
diets had higher values than rats fed the 
control diets (P< 0.01). 
Dry fat-free loeight. Rats fed lactose had 
higher values than did rats fed dextrose 
(P < 0.01), the difference being significant 
in rats fed the control diets ( P < 0.01 ) 
and the normal-calcium, high-phosphorus 
diets (P < 0.05). Of the rats fed the high-
phosphorus diets, those fed low dietary 
calcium tended to have lower values than 
those fed normal dietary calcium ( P < 
0.10). 
Total ash. Regarding the effect of lactose 
versus dextrose, results were similar to 
those for dry fat-free weight. Rats fed the 
low-calcium, high-phosphorus diets had sig-
nificantly lower values than rats fed either 
type of other diet (P < 0.01). The effect 
tended to be more marked in lactose-fed 
animals than in dextrose-fed ones (P < 
0.10). 
Derived bone parameters. Dry fat-free 
weight/volume, total ash/volume and total 
ash/(dry fat-free weight—total ash) were 
similar in lactose-fed rats and in dextrose-
fed rats. Values for these parameters were 
lower in rats fed either type of the high-
phosphorus diet than in rats fed the control 
diets ( P < 0.01 ), the difference being most 
marked between rats fed the control and 
those fed the low-calcium, high-phosphorus 
diets. 
TABLE 5 
Bone quantity parameters {right femur) 
Diets 
Lactose 
Dextrose 
SEM 
ANOV 
Main 
contrast 
Interaction 
contrast' 
CC 
CH 
LH 
CC 
CH 
LH 
CHO 
Ca/P 
CHO X Ca/P 
CC -
CC -
CC -
CH -
CC -
CC -
CC -
CH -
CH 
LH 
i(CH + LH) 
LH 
CH 
LH 
è(CH + LH) 
LH 
Volume 
cm'/kg BW 
1.38 
1.52 
1.43 
1.276 
1.44« 
1.43 
0.04 
P < 0.10 
P < 0.01 
N.S. 
-0.16±0.04> 
-0.11 ±0.04' 
-0.13±0.04> 
0.05±0.04 
— 
Dry fat-free 
weight 
g/kg BW 
1.59 
1.59 
1.49 
1.42' 
1.506 
1.45 
0.03 
P < 0.01 
P < 0.10 
N.S. 
-0.04±0.03 
0.07 ±0.03 
-0.01±0.03 
0.08±0.03a' 
— 
Total ash 
g/kg BW 
1.04 
1.01 
0.93 
0.92' 
0.96b 
0.91 
0.02 
P < 0.01 
P < 0.01 
P < 0.10 
-0.01 ±0.02 
0.06±0.02' 
0.03±0.02 
0.07±0.02' 
0.07 ±0.04 
0.10±0.04<l 
0.09±0.03d 
0.03±0.04 
1
 See footnotes to table 2. * Difference between contrast on lactose and contrast on dextrose diets. 
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TABLE 6 
Bone quality parameters (right femur) ' 
Diets 
Lactose 
Dextrose 
SEM 
ANOV 
Main 
contrast 
CC 
CH 
LH 
CC 
CH 
LH 
CHO 
Ca/P 
CHO X Ca/P 
CC -
CC -
CC -
CH -
CH 
LH 
i(CH + LH) 
LH 
Dry fat-free 
weight/volume 
g/cm3 
1.15 
1.05 
1.05 
1.12 
1.05 
1.02 
0.02 
N.S. 
P < 0.01 
N.S. 
0.09 ±0.02/ 
0.10±0.02' 
0.09 ±0.02' 
0.02±0.02 
Total ash/volume 
g/cm3 
0.75 
0.67 
0.65 
0.73 
0.67 
0.64 
0.02 
N.S. 
P < 0.01 
N.S. 
0.07±0.02' 
0.10±0.02' 
0.08±0.02' 
0.03 ±0.02 
Total ash/fat-free 
organic matter 
1.89 
1.76 
1.70 
1.89 
1.76 
1.70 
0.03 
N.S. 
P < 0.01 
N.S. 
0.13±0.03' 
0.19±0.03' 
0.16±0.03' 
0.06 ±0.03 
1
 See footnotes to table 2. 
Bone ash Ca/P ratio. The Ca/P ratio in 
the bone ash of rats fed either the control 
or the normal-calcium, high-phosphorus 
diets was 2.03±0.02 and was not influenced 
by the dietary treatments. In rats fed the 
low-calcium, high-phosphorus diets there 
was a wide variation in the bone ash Ca/P 
ratio: mean values were 1.98 (range: 1.69-
2.54) and 1.88 (range: 1.46-2.17) for rats 
fed lactose and those fed dextrose, respec-
tively. 
Calcium content of soft tissues (table 7). 
There was a marked calcification of renal 
tissue in rats fed the high-phosphorus diets, 
although with a variable response. These 
rats also showed a slightly but not signifi-
cantly increased calcium content of the 
heart. Soft-tissue calcification was not sig-
nificantly influenced by the type of dietary 
carbohydrate or by the dietary calcium 
content. 
DISCUSSION 
Body weight gain and food consumption. 
The lower body weight gain and food con-
sumption in rats on the high-phosphorus 
diets possibly indicate a low degree of 
toxicity of these diets. That the body 
weight gain in lactose-fed rats was lower 
than that in dextrose-fed rats must be due 
to a higher fecal loss of dietary energy in 
the former, since food intake was equal in 
both groups of rats. An increased loss of 
protein and fat in post-weanling lactose-fed 
rats, the consequence of low intestinal lac-
tase levels, has been reported by Leichter 
and Tolensky (14). 
Effects of high-phosphorus diets. As 
might be expected from the literature, 
feeding high-phosphorus diets to rats would 
induce nutritional secondary hyperpara-
thyroidism (NSH). Depending on experi-
mental conditions, inconsistent and variable 
results have been reported in this disease 
with respect to plasma calcium, phosphorus 
and alkaline phosphatase (5) . Henrikson 
( 4 ) stressed the importance of appreciation 
of compensatory mechanisms in the evalu-
ation of single determinations. The present 
experiment shows that in rats fed the high-
phosphorus diets plasma phosphorus was 
lower than in those fed the control diets. 
Laflamme and Jowsey (15) also observed 
depressed plasma phosphorus concentra-
tions in dogs that received oral acid potas-
sium phosphate supplements, and these 
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Diets 
Lactose 
Dextrose 
SEM 
Kruskal-
Wallis 
test 
ANOV 
Main 
contrast 
TABLE 
Calcium content 
cc 
CH 
LH 
CC 
CH 
LH 
CHO 
Ca/P 
CHO 
Ca/P 
CHO X Ca/P 
CC -
CC -
CC -
CH -
CH 
LH 
i(CH + LH) 
LH 
7 
of kidneys and heart1 
Kidneys (range) Heart 
mg/kg dry tissue 
0.33 (0.23-0.46) 0.41 
0.47 (0.45-0.62) 0.43 
0.87 (0.41-1.64) 0.46 
0.36 (0.26-0.44) 
1.50 (0.45-4.17) 
0.60 (0.51-0.85) 
— 
N.S. 
P < 0.01 
— 
-0.64° 
-0.39 
-0.52 
0.25 
0.42 
0.46 
0.46 
0.02 
— 
N.S. 
P < 0.10 
N.S. 
-0.03±0.02 
-0.05±0.02 
-0.04±0.02 
-0.02 ±0.02 
1
 See footnotes to table 2. " P ^ 0.01 by Kruskal-Wallis test. 
concentrations were negatively correlated 
with the bone resorption rate and with the 
plasma parathyroid hormone (PTH) level. 
We did not measure PTH levels but 
using the creatinine clearance which 
amounts to about 2.6 ml/minute in this 
strain of rats 1 as a measure of glomerular 
filtration, it can be estimated that tubular 
reabsorption of phosphate, which is known 
to be inhibited by PTH (16), was about 
81 and 12% in rats fed the control and 
high-phosphorus diets, respectively. Con-
sistent with NSH is also the decreased uri-
nary calcium excretion (6, 16), the slightly 
increased activity of plasma alkaline phos-
phatase after 17, 30 and 42 weeks, the in-
creased urinary excretion of hydroxyproline 
after 17 and 42 weeks, the calcification of 
renal tissue and the maintenance of normal 
plasma calcium concentrations in rats fed 
the high-phosphorus diets. The observed 
increase in plasma alkaline phosphatase 
and urinary hydroxyproline indicates PTH 
mediated accelerated bone remodeling 
(17). 
Like the results of other studies con-
cerned with rats ( 2, 7 ) as well as with man 
(18, 19), calcium retention as measured by 
the balance technique was not negatively 
influenced by feeding the high-phosphorus 
diets. This harmonizes with the quantity 
of bone ash and dry fat-free weight of 
femurs that did not differ between rats fed 
the control and those fed the high-phos-
phorus diets. However, in rats fed these 
latter diets bone quality parameters 
(amount of ash and dry fat-free weight 
per unit of bone volume and amount of ash 
per unit of fat-free organic matter) were 
significantly reduced. In rat studies carried 
out by Draper and co-workers (2, 6) just 
the reverse was observed, but our results 
are in line with a rabbit study conducted 
by Jowsey and Balasubramanian (20), who 
reported increased porosity of bones asso-
ciated with increased bone turnover in 
phosphate-supplemented animals without 
any effect on the bone calcium content. 
Differences in experimental conditions ( age 
and strain of the rats, length of feeding 
period and dietary composition) might ex-
plain the discrepancy between our results 
1
 Schaafsma, G. (1978) Unpublished results. 
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and those of the group of Draper. In one 
study (2) they used 8-month-old rats. An 
average urinary excretion of hydroxypro-
Iine of 0.15 mg/24 hours, which is far be-
low the values we observed, was reported 
and no significant differences in hydroxy-
proline excretion between rats fed either 
0.3, 0.6 or 1.2% dietary phosphorus were 
observed. Since hydroxyproline is a mea-
sure of collagen breakdown and bone turn-
over, it is attractive to postulate that quan-
titative loss of bone induced by feeding 
high-phosphorus diets will occur only in 
older animals in which bone turnover is low 
and stimulated bone resorption is not easily 
balanced by increased bone formation. 
To increase the phosphorus content of 
the diets, acid potassium phosphate was 
used as a supplement and no attempts were 
made to adjust potassium levels in the con-
trol diets. This is why the observed effects 
cannot theoretically be attributed to phos-
phate alone. However, we have no infor-
mation available as to whether differences 
in the dietary potassium content might ex-
plain any of the observed effects. 
Effects of dietary calcium. Since the ef-
fects of high-phosphorus diets on bone and 
soft tissue are attributed to the high phos-
phate flow through the plasma, the intesti-
nal absorption of phosphate is a critical 
parameter in NSH. Intestinal absorption 
and urinary excretion of phosphate were 
significantly higher when the calcium con-
tent of the diet was low than when it was 
normal. An inverse relationship in rats be-
tween phosphate absorption and the dietary 
calcium content has been reported by Clark 
(7) and was also apparent from studies of 
Draper and co-workers (2, 6 ). The inhibit-
ing effect of dietary calcium in this regard 
is probably related to the formation of in-
soluble calcium phosphates in the intestinal 
tract. In the present study the observed 
effects of feeding high-phosphorus diets 
were—with the exception of renal calcifi-
cation and depressed urinary calcium— 
more marked when the calcium content of 
the diet was low than when it was normal, 
stressing the importance of the dietary 
Ca/P ratio at high phosphorus intake levels. 
In addition to an inhibiting effect on phos-
phate absorption, dietary calcium also in-
hibits intestinal magnesium absorption (7) 
This might explain why high levels of di-
etary calcium do not fully counteract the 
effects of high-phosphorus diets on bone 
(2). Low levels of dietary magnesium nol 
only predispose to renal stone formation 
(21) but probably also reduce bone for-
mation, as Lai et al. (22) reported a de-
creased activity of bone alkaline phospha-
tase in magnesium deprived rats. 
Effects of lactose versus dextrose. With 
the exception of slightly higher plasma 
phosphorus values in rats fed lactose after 
30 weeks, for which we have no satisfactory 
explanation, there were no significant ef-
fects of the type of dietary carbohydrate 
on plasma parameters and on the urinary 
hydroxyproline excretion. During body 
weight gain, but not thereafter, rats fed 
lactose absorbed and retained more calcium 
and phosphorus, and this anabolic effect 
was reflected by higher bone values for 
dry fat-free weight and amount of ash. 
Throughout the study the urinary excretion 
of calcium was higher in lactose-fed rats. 
This probably reflects a continuing positive 
action of lactose on calcium absorption, 
which could not be detected by the balance 
method that does not allow the measure-
ment of endogenous fecal calcium. The en-
dogenous fecal route is used by the rat as a 
regulatory way of calcium excretion (9) . 
The precise mechanism by which lactose 
stimulates intestinal calcium absorption is 
not understood as yet. Recent evidence 
( 23 ) suggests that lactose and several other 
carbohydrates are able to increase the ac-
tivity of an intestinal brush border alkaline 
phosphatase, which is associated with cal-
cium transport, by a facilitated diffusion 
mechanism. The enzyme stimulation occurs 
predominantly in the ileum where, accord-
ing to classical observations (24), the ef-
fect of lactose on calcium absorption is 
most marked. 
The failure of lactose to diminish the 
change in bone quality and plasma param-
eters, in urinary hydroxyproline excretion 
and renal calcification produced by feeding 
the high-phosphorus diets, indicates that 
enhancement of calcium absorption does 
not interfere with the detrimental effects 
of high-phosphorus diets. This observation 
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is in harmony with a study conducted by 
Bell et al. (25) who showed that high-
protein diets promoted calcium absorption 
but did not prevent an increased loss of 
calcium from the bones of rats fed high-
phosphorus diets. 
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Chapter 8 
Effect of dietary calcium and phosphorus on calcium and 
phosphorus metabolism, bone parameters and renal function 
in rats 
8.1 Introduction 
Several investigators have pointed to a low dietary Ca/P-ratio as a factor in the 
pathogenesis of hyperparathyroidism and osteoporosis (Section 5.10). However, 
it is not clear whether in this respect similar ratios at different (absolute) levels of 
the elements have the same physiological significance. Therefore it was found 
necessary to investigate the effect of the dietary Ca/P-ratio on calcium and 
phosphorus metabolism and on bone parameters at different levels of both ele-
ments. This was the first objective of the study. 
The development of nephrocalcinosis in rats fed high-phosphorus diets is 
considered to be one of the effects of hyperparathyroidism on the kidney. Ne-
phrocalcinosis may impair renal function and further aggravate the hyperpara-
thyroidism. In the previous study (Chapter 7) nephrocalcinosis was found in male 
lean Zucker rats which were fed, from the age of three months onwards, 
high-phosphorus diets for 42 weeks, but renal function was not measured. No 
information is available as to whether the length of the experimental period has 
any influence on the development of nephrocalcinosis in rats fed high-phospho-
rus diets. Furthermore, results of studies on the effect of dietary calcium on this 
phosphate-induced nephrocalcinosis are inconsistent (Section 5.10) Therefore, it 
was found necessary to investigate the effects of dietary calcium and the length of 
the experimental period on nephrocalcinosis and renal function in rats fed 
high-phosphorus diets. This was the second objective of the study. 
In two experiments, which only differed in the duration of the experimental 
period, it was tried to find answers to the two objectives of the study. A short-term 
experiment (experiment A) was designed particularly to obtain information about 
the effects of the diet on calcium and phosphorus metabolism, which can be 
obtained fairly quickly. A long-term experiment (experiment B) was designed 
particularly to obtain information about the effects of the diet on bone parameters, 
which requires more time to establish. In both the long-term and short-term 
experiment the effect of the diet on nephrocalcinosis and renal function was 
studied. The difference between the results of these experiments would provide 
information about the effect of the duration of the feeding period in this respect. In 
order to be able to compare the results of this study with those of the previous one 
(Chapter 7), rats of the same strain, sex and age were used. From weaning until 
the time that the rats were used for the experiments, they were fed a commercial 
diet (RMH-B, Hope Farms N.V., Woerden). This diet contained 1.03% calcium and 
0.78% phosphorus. 
8.2 Methods 
8.2.1 Experiment A (short-term) 
Thirty-two male lean Zucker rats, three months old and weighing about 220 g, 
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were divided into eight groups of four. The animals were given either low-phos-
phorus control diets (0.15% P; L-diets) or high-phosphorus diets (1.20% P; 
H-diets). These diets had Ca/P-ratios of either 0.25, 0.50, 1.00 or 2.00. The 
composition of these diets was similar to that reported in Chapter 7, except that 
wheat starch and lactose were substituted for dextrose, that CaC03 and KH2P04 
were added to obtain Ca/P-ratios as described above and that Cr203 was added 
at a level of 0.5% as a non-absorbable faecal marker. The diets were fed for a 
period of four weeks during which the animals were kept individually in metabolic 
cages under the conditions described in Chapter 7. In order to reduce differences 
in the amount of food consumed, each rat was provided with 15 g food daily. Food 
consumption was recorded daily and body weights were measured bi-weekly. 
After 6 and 24 days, 72-hour collections of faeces and urine were made and in the 
morning of days 10 and 28, after an overnight fast, blood was drawn by orbita 
puncture under light ether anaesthesia. After the last bleeding the animals were 
sacrificed and femora, tibiae and kidneys were removed from the bodies. Total 
ash, dry fat-free weight and volume of the left femur and calcium, phosphorus, 
plasma alkaline phosphatase and urinary hydroxyproline were estimated as de-
scribed in Chapter 7. The left kidneys and samples of faeces and food were 
wet-ashed (with nitric acid and perchloric acid). After wet-ashing, the chromium 
content of faeces and food was estimated according to the method of Clarkson 
(1967). For the purpose of balance studies, food intake was estimated by using 
the following formula: 
food intake (g/24 hours) = c o n C ' Cr2°3 ™ faeces
 x f a g c e s Q u t p u t ( g / 2 4 h ) 
cone. Cr203 in food 
In plasma and urine, urea was estimated enzymatically and creatinine was 
estimated by the Jaffé-reaction according to the method designed by the Dutch 
Normalization Institute (Design NEN 2416,1972). PTH in plasma was estimated by 
Dr. R. Bosch, as described in Section 6.2.3. 
For bone histology, tibiae (right side) were removed from the bodies, and 
cleaned of adhering tissue. Cross-sections were made by using a thin-bladed 
diamond saw which was cooled with physiological water. The bone pieces were 
fixed in a solution according to Burkhardt. This solution consists of a mixture of 
formalin, methanol and a glucosephosphate-buffer (pH 7.4). After fixation and 
dehydration, the proximal parts of the tibiae were embedded in methyl metacry-
late. With a heavy Jung-K microtome undecalcified 3-6 fim thick sections were 
made and stained according to Olah (pentachrome). Osteoblasts, osteoclasts, 
osteoid and mineralized bone could be distinguished most satisfactorily in this 
way. 
8.2.2 Experiment B (long-term) 
With the exception of the following modifications, the design of experiment B was 
similar to that of experiment A. The diets were fed for a period of 16 weeks. The 
rats were housed in stainless steel cages with'wired bottoms. No collections of 
urine and faeces were made. Blood was drawn after 6, 44 and 111 days of feeding 
the experimental diets. 
8.2.3 Statistics 
Analysis of variance and/or of covariance was applied to test the significance of 
main and interaction effects. The statistical procedures were those described by 
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Snedecor & Cochran (1973). Differences between group means were further 
investigated using Student's t-test (one-sided, unless otherwise indicated). Three 
levels of significance were used: P < 0.01, P < 0.05 and P < 0.10. This last level 
was used as indicative of a statistical trend. If variances differed significantly, as 
indicated by an F-test, logarithmic transformation was applied before subjecting 
the data to further statistical treatment. 
8.3 Results 
8.3.1 Experiment A 
8.3.1.1 Body weight gain and food consumption (Table 21) 
In the previous study (Chapter 7) it was observed that rats fed high-phosphorus 
diets consumed slightly less food than those fed the control diet. In the present 
study we fed to all rats a restricted amount of food. It was expected that this 
amount would be consumed completely. However, it was observed that three 
groups of rats fed the high-phosphorus diets (H-diets) yet consumed slightly less, 
Table 21. Body weight gain (g/4 weeks) and average food consumption (g/24 
hours) in experiment A. 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM3) 
ANOV4) 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca/P(F3,24) 
body 
L-diets2) 
41.5 
49.0 
46.2 
44.4 
weight gain') 
5.1 
22.68* 
1.48 
2.06 
H-diets2) 
38.5 
30.5 
21.2 
16.5 
** 
food 
L-diets 
14.1 
14.4 
14.3 
14.4 
consurr 
— 
— 
— 
— 
ption') 
H-diets 
14.2 
13.6 
13.6 
13.1 
1) Values are the means for four rats. 
2) L-diets: 0.15% phosphorus; H-diets: 1.20% phosphorus. 
3) SEM derived from pooled error variance (df = 24). 
4) Analysis of variance; F-test values are given 
* = P < 0.10; ** = P < 0.05, * ** = P < 0.01. 
because they spilled more food. A change-over to paired-feeding was considered 
but this idea was abandoned, since the spillage appeared to be independent of 
the amount of food provided. The reduced consumption in rats fed H-diets was 
closely associated with a lower body weight gain. The mean difference ( ± SEM) in 
body weight gain between rats fed the low- and those fed the high-phosphorus 
diets was 17.1 ± 3.6 g after the four weeks of duration of this experiment ( P < 
0.01). 
8.3.1.2 Plasma parameters and urinary hydroxyproline 
Calcium (Table 22). There were no significant main effects of dietary variables on 
the plasma calcium concentrat ion. After six days a significant (P < 0.05) diets x 
Ca/P-interact ion was observed: with an increase in the dietary Ca/P-rat io, plas-
ma calcium tended to increase in rats fed the low-phosphorus control diets 
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Table 22. Plasma calcium (mg/100 ml) in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca/P(F3,24) 
after 6 days 
L-diets 
9.5 
9.4 
9.6 
9.8 
0.18 
0.20 
0.39 
3.18** 
H-diets 
9.9 
9.7 
9.6 
9.3 
after 28 days 
L-diets 
10.3 
10.5 
10.5 
10.5 
0.10 
1.49 
1.05 
0.53 
H-diets 
10.5 
10.4 
10.6 
10.6 
') See footnotes to Table 21. 
Table 23. Plasma phosphorus (mg/100 ml) in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca/P(F3,24) 
after 6 days 
L-diets H-diets 
9.0 
8.8 
7.9 
8.6 
0.37 
29 .04* * * 
1.41 
0.87 
7.5 
6.8 
7.1 
7.3 
after 28 days 
L-diets 
8.5 
8.5 
8.4 
8.4 
0.36 
39 .59* : 
0.63 
0.73 
H-diets 
7.2 
6.3 
6.8 
7.1 
1
 ) See footnotes to Table 21. 
Table 24. Tubular reabsorption of phosphate as a ratio to the glomerular filtra-
tion rate (TRP/GFR; / imol/ml)1) after 28 days in experiment A2). 
L-diets H-diets 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,3) 
Ca/P(F3,3) 
2.68 
2.68 
2.68 
2.68 
0.153) 
78.97*** 
1.14 
1.58 
1.58 
1.67 
2.05 
, . _ _ _ _ _ _ _creatinine clearance (ml/min)x plasma Pdumol/ml) — urinary P(|umol/min) 
creatinine clearance (ml/min) 
2) Values are group means obtained from analyses in samples pooled per group. 
3) df = 3 
* * * = P < 0.01 
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(L-diets) whereas it tended to decrease in rats fed the H-diets. After 28 days 
plasma calcium values were consistently higher than those after 6 days (mean 
difference: 0.89 mg/100 ml). The cause of this difference is probably of method-
ological origin, since it was not observed in the long-term experiment (see results 
of experiment B). 
Total protein. No significant differences were observed between the groups in the 
plasma total protein concentration after 28 days. The overall mean value ( ± SEM) 
was 61.9 ± 0.3 g/ l . No values can be given after 6 days, since insufficient plasma 
was available for this assay. The absence of effects of dietary variables on the 
concentration of total protein in plasma indicates that it is not necessary to 
correct plasma calcium values for differences in plasma total protein. 
Phosphorus (Table 23). Both after 6 and 28 days the plasma phosphorus con-
centrations were consistently lower in rats fed H-diets than in those fed L-diets 
(mean differences ± SEM: 1.40 ± 0.26 and 1.59 ± 0.25 mg/100 ml respectively; 
both P<0.01) . 
Parathyroid hormone. The plasma concentration of PTH was estimated in sam-
ples, drawn after 28 days. Unfortunately in most samples there was no clear 
cross-reaction and the assay was lacking the specificity to estimate PTH in Zucker 
rats. To estimate parathyroid activity, the tubular reabsorption of phosphate, 
expressed as a ratio to the glomerular filtration rate (TRP/GFR), was computed. 
The results are shown in Table 24. TRP/GFR was invariably 2.68 ftmol/ml in rats 
fed L-diets. In rats fed H-diets TRP/GFR increased from 1.58 to 2.05 ftmol/ml if the 
Ca/P ratio was raised from 0.25 to 2.00. These data indicate that PTH activity was 
higher in rats fed H-diets than in those fed L-diets, and that in rats on the former 
diets this activity decreased with an increase of the Ca/P-ratio. 
Alkaline phosphatase (Table 25). Both after 6 and 28 days, but particularly after 6 
days, the activity of alkaline phosphatase in plasma was significantly lower in rats 
fed H-diets than in those fed L-diets. The mean difference ( ± SEM) after 6 days 
was 7.5 ± 1.8 U / I (P< 0.01, two-tailed) and after 28 days it was 5.4 ± 2.2U/I(P< 
0.05, two-tailed). After 6 days, the activity of alkaline phosphatase on either diet 
was the lowest if the dietary Ca/P-ratio was 0.5. The significance of this obser-
vation is obscure since enzyme activity did not change consistently with the 
dietary Ca/P-ratio. The observations indicate that bone turnover in rats fed 
H-diets was lower than that in rats fed L-diets. This difference in bone turnover is 
not attributable to the high phosphorus content of the H-diets but must be related 
to the higher average calcium content of these latter diets. This conclusion can be 
derived from a comparison of alkaline phosphatase activity between rats fed diet 
L2.00 a r |d those fed diet H025. which differ only in their phosphorus content 
(calcium content 0.3%). Enzyme activities between these groups are not signifi-
cantly different. 
Urinary hydroxyproline (Table 26). Both after 6 and 28 days, the urinary excretion 
of hydroxyproline which, like plasma alkaline phosphatase, is an indicator of the 
bone turnover rate, was lower in rats fed H-diets than in those fed L-diets (mean 
differences ± SEM: 0.11 ± 0.06 mg/24 h; P < 0.10, two-tailed and 0.13 ± 0.04 
mg/24 h; P< 0.01, two-tailed, after 6 and 28 days respectively). Excretion de-
creased in rats fed H-diets with an increase in the dietary Ca/P-ratio after 6 days. 
This decrease was observed on both L- and H-diets after 28 days and at that time 
the mean difference ( ± SEM) between rats fed the lowest and those fed the 
highest Ca/P-ratio was 0.14 ± 0.08 mg/24 h on L-diets (P < 0.05) and 0.18 ± 
0.08 mg/24 h (P < 0.05) on H-diets. 
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Table 25. Plasma alkaline phosphatase (U/ l ) in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P (F3,24) 
diets x Ca/P(F3,24) 
after 6 days 
L-diets 
50.0 
42.6 
53.2 
54.8 
2.6 
16.90* 
5.36* 
2.07 
H-diets 
48.6 
37.7 
41.9 
42.4 
.* 
«=* 
after 28 days 
L-diets 
47.1 
47.1 
45.1 
42.0 
3.1 
6.10* 
0.72 
1.80 
H-diets 
43.2 
34.5 
38.8 
43.4 
,.* 
1
 ) See footnotes to Table 21. 
Table 26. Urinary hydroxyproline in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca/P 
(F3.24) 
hydroxyproline 
after 6 days 
L-diets 
0.83 
1.02 
0.90 
0.88 
H-diets 
1.00 
0.74 
0.76 
0.70 
0.08 
3.43* 
0.90 
2.88* 
(mg/24 hours) 
after 28 days 
L-diets H-diets 
0.75 
0.75 
0.69 
0.61 
0.69 
0.59 
0.47 
0.51 
0.05 
11.70*** 
3.63** 
0.80 
hydroxyproline/creati-
nine 
(mg/g)2) after 28 days 
L-diets H-diets 
52.2 52.7 
52.0 46.8 
47.7 41.0 
42.6 41.8 
2.43) 
F1,3 = 3.13 
F3,3 = 7.35* 
— 
1
 ) See footnotes to Table 21. 
2) Values of hydroxyproline/creatinine are group means obtained from analyses in sam-
ples pooled per group. 
3) df = 3. 
Table 27. Plasma urea (mg/100 ml) in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P (F3,24) 
diets x Ca/P(F3,24) 
after 6 days 
L-diets 
31.8 
32.0 
27.4 
31.3 
2.3 
15.41*** 
0.09 
1.52 
H-diets 
37.0 
36.4 
40.0 
35.2 
after 28 days 
L-diets 
30.2 
29.5 
28.3 
29.6 
2.0 
39.15* 
0.28 
1.07 
H-diets 
37.0 
36.8 
41.5 
37.8 
** 
1
 ) See footnotes to Table 21. 
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To account for differences in body weight, hydroxyproline excretion was com-
puted as the ratio to creatinine excretion. Values of this ratio decreased with an 
increase of the dietary Ca/P-ratio. Rats fed diet L2.00 nac ) a significantly lower 
urinary hydroxyproline/creatinine-ratio than did rats fed diet Ho.25 (mean differ-
ence ± SEM: 10.1 ± 3.45 mg/g; P < 0.05). Since the calcium content of these 
diets was equal (0.3%), this difference can be attributed to dietary phosphorus 
(0.15 versus 1.20%). 
8.3.1.3 Parameters on renal function 
Plasma urea (Table 27). Both after 6 and 28 days the plasma concentrations of 
urea were significantly higher in rats fed H-diets than in those fed L-diets and this 
difference tended to increase with the duration of the experiment (mean differ-
ences ± SEM after 6 and 28 days: 6.5 ± 1.6 and 8.9 ± 1.4 mg/100 ml respectively; 
both P < 0.01). Since similar differences were observed between rats fed diet 
L2.00 a r |d those fed diet Ho.25 (the Ca content of these diets is equal) the 
difference in plasma urea values is attributable to the phosphorus content of the 
diets. No significant main effect of the Ca/P-ratio was observed. 
Table 28. Creatinine and urea clearance (ml/min) after 28 days in experiment 
A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets 
Ca/P 
diets x Ca/P 
creatinine clearance2) 
L-diets 
2.85 
2.90 
2.87 
3.09 
F(1,3) = 
F(3,3) = 
0.113) 
H-diets 
2.55 
2.77 
2.43 
2.63 
18.99*** 
1.79 
— 
urea clearance 
L-diets 
2.12 
2.49 
2.53 
2.44 
F(1,24) = 
F(3,24) = 
F(3,24) = 
H-diets 
1.74 
1.61 
1.58 
1.63 
0.14 
55.43*** 
0.34 
1.62 
1
 ) See footnotes to Table 21. 
2) Values of creatinine clearance are group means obtained from analyses in plasma and 
urine samples pooled per group. 
3) df = 3. 
Urea and creatinine clearances (Table 28). Clearances of urea and creatinine 
were only estimated after 28 days. They were found to be significantly lower in rats 
fed the H- than in those fed the L-diets (mean differences ± SEM: 0.33 ± 0.16 
ml/min; P < 0.05 and 0.76 ± 0.10 ml/min; P < 0.01, for the creatinine and urea 
clearance respectively). No significant main effect of the dietary Ca/P-ratio was 
observed: however, the lowest clearance values (and the highest plasma urea 
values) were those in rats fed diet H-| oo-
8.3.1.4 Calcium metabolism (Table 29) 
In rats fed L-diets, retention and faecal excretion of calcium increased with the 
dietary Ca/P-ratio (and thus with Ca-intake) during both week 2 and week 4 and 
this was associated with an increase in urinary calcium, particularly during week 
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Table 29. 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM2) 
Ca/P 
0.25 
Parameters of calcium 
week 4 
intake 
5.9 
10.3 
17.4 
34.8 
— 
4.2 
in exper 
faeces 
3.6 
5.3 
9.8 
23.2 
1.2 
0.8 
metabolism (mg/24 hours) during 
ment A1). 
L-diets 
urine 
0.38 
0.41 
0.56 
0.50 
0.03 
0.31 
retention intake 
2.0 
4.7 
7.0 
11.1 
0.6 
3.1 
week 2 
33 
58 
113 
233 
week 4 
32 
faeces 
24 
50 
103 
218 
9 
21 
H-diets 
urine 
0.47 
0.46 
0.53 
0.73 
0.03 
0.38 
week 2 and 
retention 
8.2 
7.9 
9.2 
14.8 
2.2 
10.6 
0.50 9.7 1.9 0.36 7.5 68 52 0.37 15.1 
1.00 18.8 7.3 0.45 11.2 136 124 0.40 11.2 
2.00 35.7 24.1 0.52 11.1 248 233 0.85 13.9 
SEM2) - 0.6 0.30 0.8 - 7 0.05 1.3 
1
 ) Values are the means for four rats. 
2) SEM derived from pooled error of analysis of variance of data on L-diets and H-diets 
separately. 
Table 30. Parameters of phosphorus metabolism (mg/24 hours) during week 2 
and week 4 in experiment A1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
intake 
19.3 
17.9 
18.1 
17.6 
-
14.0 
16.8 
19.7 
18.1 
-
faeces 
6.3 
5.2 
6.0 
7.3 
0.7 
3.0 
3.7 
4.9 
7.7 
0.4 
L-diets 
urine 
16.1 
13.5 
11.3 
5.8 
0.8 
7.0 
5.0 
5.5 
2.8 
0.6 
retention intake 
week 2 
- 3 . 1 
- 0 . 8 
0.8 
4.1 
1.0 
134 
128 
122 
124 
-
week 4 
4.0 
8.1 
9.3 
7.6 
1.2 
130 
149 
146 
130 
-
H-diets 
faeces urine 
26 
37 
53 
60 
3 
25 
38 
73 
82 
4 
158 
118 
92 
61 
10 
78 
49 
46 
21 
4 
retention 
- 5 1 
- 2 7 
- 2 3 
2 
7 
26 
61 
27 
26 
5 
1
 ) See footnote to Table 29. 
82 
4. At that time, but not yet during week 2, the increase in calcium retention with 
calcium intake flattened to a dietary Ca/P-ratio over 1. The phenomenon that 
calcium retention on the dietary Ca/P-ratios below 1 was lower during week 2 
than that during week 4, shows that the adaptive response to diets low in calcium 
was not yet complete during week 2. 
In rats fed H-diets, faecal calcium increased with the dietary Ca/P-ratio. On this 
diet, urinary calcium increased with the dietary Ca/P-ratio only if this ratio ex-
ceeded the value 0.5. Calcium retention increased very slightly with the dietary 
Ca/P-ratio during week 2 but this increase was no longer observed during week 4. 
During week 2, calcium retention on diet 1-2.00 w a s superior to that on the diets 
Ho.25. Ho.50 and H-| oo> i n s P i t e o f a similar or higher calcium content of these 
latter diets. This difference in calcium retention was not observed during week 4. 
At that time the urinary calcium excretion on the H-diets was lower than that on 
diet 1-2.00-
The results with respect to calcium metabolism indicate that dietary phospho-
rus excess did not adversely influence either intestinal absorption or retention of 
calcium to a significant extent. They also indicate that calcium retention in rats fed 
L-diets is significantly decreased if the dietary Ca/P-ratio is 0.25 or 0.50. More-
over, the results indicate that the urinary calcium excretion is decreased in rats 
fed H-diets. 
8.3.1.5 Phosphorus metabolism (Table 30) 
On both L- and H-diets, the urinary excretion of phosphorus decreased and the 
faecal excretion of phosphorus increased when the dietary Ca/P-ratio was rais-
ed. As a consequence, net intestinal phosphorus absorption decreased with an 
increase in this ratio. For instance, during week 4 the absorption, expressed as a 
percentage of phosphorus intake, was 91 % on diet Ho.25 whereas it was only 37% 
on diet H2.00-
During week 2, phosphorus retention on both L- and H-diets increased with the 
dietary Ca/P-ratio as did calcium retention. However, at that time phosphorus 
retention was found to be markedly negative in rats fed the H-diets with Ca/P-ra-
tios between 0.25 and 1.00. The cause of this negative retention is probably an 
artefact. Since urinary phosphorus excretion on these diets is high, small inac-
curacies in the collection time of urine have substantial effects on the phosphorus 
balance. Anyhow, retention values were clearly positive during week 4. 
8.3.1.6 Bone parameters and kidney calcium content 
Results on bone parameters and kidney calcium content will be reported in 
conjunction with those of experiment B. 
8.3.2 Experiment B 
8.3.2.1 Body weight gain and food consumption (Table 31) 
Body weight gain and food consumption were slightly lower in rats fed H-diets 
than in those fed L-diets. The mean difference in body weight gain ( ± SEM) 
between these rats was 13.6 ± 5.3 g/16 weeks. These results compare favour-
ably with those of experiment A, although the differences in body weight gain and 
food consumption were smaller in experiment B. 
8.3.2.2 Plasma parameters 
Calcium (Table 32). There were no significant differences in the plasma calcium 
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Table 31. Body weight gain (g/16 weeks) and average food consumption (g/24 
hours) in experiment B1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca/P(F3,24) 
body weight gain 
L-diets 
80.8 
100.8 
80.5 
78.8 
7.5 
6 . 5 4 " « 
2.50 
0.65 
H-diets 
74.0 
78.3 
74.8 
59.3 
food 
L-diets 
14.7 
14.8 
14.5 
14.2 
consumpt ion 
— 
— 
— 
— 
H-diets 
14.4 
14.6 
14.3 
14.1 
1
 ) See footnotes to Table 21. 
Table 32. Plasma calcium (mg/100 ml) in experiment B1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca /P(F3 ,24) 
diets x 
after 6 days 
L-diets 
10.5 
10.1 
10.4 
10.3 
Ca/P(F3,24) 
H-diets 
10.5 
10.3 
10.6 
10.6 
0.12 
3.70* 
3.30** 
0.30 
after 44 days 
L-diets H-diets 
10.5 
10.0 
10.1 
10.7 
10.2 
9.9 
10.5 
10.5 
0.27 
0.02 
1.89 
0.66 
after 111 days 
L-diets 
10.1 
10.0 
10.2 
9.8 
H-diets 
10.0 
9.8 
10.1 
10.0 
0.12 
0.09 
1.96 
1.15 
1
 ) See footnotes to Table 21. 
Table 33. Plasma phosphorus (mg/100 ml) in experiment B'). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
after 6 days 
L-diets 
7.7 
7.6 
7.3 
7.5 
diets x Ca /P (F3.24) 
H-diets 
7.0 
7.2 
6.7 
7.6 
0.24 
4 .83** 
1.83 
0.96 
after 44 days 
L-diets H-diets 
7.5 
7.0 
7.0 
7.3 
6.0 
5.4 
6.2 
6.3 
0.32 
2 6 . 3 1 * * * 
1,40 
1.43 
after 111 days 
L-diets 
6.6 
6.0 
6.3 
6.0 
H-diets 
4.6 
5.1 
5.4 
5.7 
0.28 
25 .96 * * * 
0.61 
3.16** 
1
 ) See footnotes to Table 21. 
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concentration between groups after 44 and 111 days. After 6 days, values in rats 
fed L-diets tended to be lower than those in rats fed H-diets (mean difference ± 
SEM: 0.16 ± 0.08 mg/100 ml; P< 0.10, two-tailed). Although analysis of variance 
indicated a statistically significant main effect of the dietary Ca/P-ratio, no sys-
tematic changes in plasma calcium could be observed in this respect. Since 
results on plasma calcium after 6 days in experiment A were different, it seems 
unlikely that differences in plasma calcium between groups are attributable to 
diet. 
Total protein. No significant differences in the plasma total protein concentration 
were observed after 44 and 111 days. The overall mean values ( ± SEM) were 62.4 
± 0.7 and 63.8 ± 1.5 g/l respectively. No values can be given after 6 days since 
insufficient plasma was available for the estimation. 
Phosphorus (Table 33). During the whole of the study the concentration of 
phosphorus in plasma was significantly lower in rats fed H-diets than in those fed 
L-diets. Mean differences ( ± SEM) after 6,44 and 111 days were 0.38 ± 0.17 (P < 
0.05), 1.23 ± 0.23 (P < 0.01 ) and 1.03 ± 0.20 mg/100 ml (P < 0.05) respectively. 
After 111 days, but not at earlier times, plasma phosphorus showed a slight but 
clear-cut increase with the dietary Ca/P-ratio in rats fed H-diets. In this respect 
the mean difference ( ± SEM) between rats fed the H2.0O" a n c l those fed the 
Ho.25-diet was 1.08 ± 0.40 mg/100 ml (P < 0.01). 
Alkaline phosphatase (Table 34). The activity of alkaline phosphatase in plasma 
was found to be slightly lower in rats fed H-diets than in those fed L-diets. After 6, 
44 and 111 days, the differences ( ± SEM) were 6.3 ± 2.0 (P < 0.01, two-tailed), 
4.0 ± 1.08 (P < 0.01, two-tailed) and 2.8 ± 1.5 U/l (P < 0.10, two-tailed) 
respectively. These differences thus tended to fade away with advancing age. On 
both L- and H-diets, alkaline phosphatase showed a slight decrease with an 
increase of the dietary Ca/P-ratio after 6 and 44 days. This effect was no longer 
observed after 111 days. 
As in experiment A, these results indicate that the bone turnover, as measured 
by alkaline phosphatase activity in plasma, was slightly lower in rats fed H-diets 
than in those fed L-diets. This difference is attributable to the higher average 
calcium content of the H-diets. This conclusion can be drawn from a comparison 
of alkaline phosphatase activity between rats fed the L2.oo_diet and those fed the 
Ho.25-diet. Enzyme activities on these diets, which differ only in their phosphorus 
content, are not significantly different. 
Urea (Table 35). Both after 44 and 111 days the plasma urea concentration was 
significantly lower in rats fed L-diets than in those fed H-diets. Mean differences 
( ± SEM) were 5.2 ± 1.3 and 9.7 ± 1.8 mg/100 ml (both P < 0.01). The highest 
plasma urea concentration was observed in rats fed the H-| oO'diet. After 111 
days, this concentration (46.3 mg /100 ml) was significantly higher than that in rats 
fed the other diets. In rats fed the H-diets the plasma concentration of urea 
increased with the duration of the experiment. 
8.3.2.3 Kidney calcium content (experiments A and B, Table 36) 
There was a wide variation in the kidney calcium content of rats fed H-diets in both 
experiments A and B. Values ranged from 120 to 1520 ,ug/g fr.esh tissue. The 
kidney calcium content in rats fed L-diets was lower and much less variable 
(range: 70 to 180 jug/g). Because of the high variability on H-diets, values were 
transformed into their ' "log-derivations for statistical treatment. In Table 36 it can 
be observed that the transformed values were significantly higher in rats fed H-
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Table 34. Plasma alkaline phosphatase (U/ l ) in experiment B1). 
Ca/P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1.24) 
Ca/P(F3.24) 
diets 
atte 
L-diets 
66.9 
62.0 
59.8 
58.6 
x Ca/P(F3,24) 
r 6 days 
H-diets 
61.1 
58.3 
49.4 
53.0 
2.8 
10 .02** * 
4 .55** 
0.50 
after 44 days 
L-diets H-diets 
31.0 
29.0 
26.7 
27.3 
26.6 
25.0 
22.9 
23.6 
1.5 
13 .56* * * 
2.73* 
0.02 
after 111 days 
L-diets 
33.4 
33.5 
32.4 
32.9 
H-diets 
29.6 
27.6 
34.2 
30.0 
2.1 
3.67* 
0.61 
1.28 
1
 ) See footnotes to Table 21. 
Table 35. Plasma urea (mg/100 ml) in experiment B1). 
Ca /P 
0.25 
0.50 
1.00 
2.00 
SEM 
ANOV 
diets (F1,24) 
Ca/P(F3,24) 
diets x Ca /P (F3,24) 
after 44 days 
L-diets 
30.1 
28.4 
27.7 
28.9 
1.9 
15.70* 
0.34 
1.83 
H-diets 
30.7 
34.3 
36.9 
34.1 
* * 
after 111 days 
L-diets 
31.3 
31.6 
27.0 
27.8 
2.6 
2 6 . 7 3 " 
1.05 
3.78* ' 
H-diets 
34.0 
38.3 
46.3 
38.1 
,* 
1
 ) See footnotes to Table 21. 
Table 36. Kidney calcium content in experiments A and B (1 "log-derivations of 
fig/g fresh tissue1). 
Ca /P 
0.25 
0.50 
1.00 
2.00 
SEM2) 
ANOV 
experiment A 
L-diets 
2.13 
2.09 
2.14 
2.15 
diets (F1,48) 
Ca/P(F3,48) 
experiments (F1,48) 
Ca /P x diets (F3.48) 
experiments x diets (F1,48) 
experiments x Ca/P(F3,48) 
experiments x diets x Ca /P (F3,48) 
H-diets 
2.70 
2.56 
2.98 
2.24 
0.09 
18.28** 
9.24** 
1.69 
10.69** 
3.55* 
3.35** 
4 . 3 1 * * 
experirr 
L-diets 
2.03 
1.98 
1.97 
1.98 
ent B 
H-diets 
2.26 
2.79 
3.00 
2.53 
1) See footnotes to Table 21. 
2) SEM derived from pooled error variance (df = 48). 
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than in those fed L-diets in both experiments A and B. The mean difference ( ± 
SEM) was 0.58 ± 0.04 /xg/g (P < 0.01, experiments A and B combined). The 
dietary Ca/P-ratio significantly, but not systematically, influenced the kidney 
calcium content: as with plasma urea, peak values were observed in rats fed the 
Hi oo"die*- l n r a t s fecl L-diets, the kidney calcium content was significantly lower 
in experiment B than in experiment A (mean difference of 1 "log-values ± SEM: 
0.14 ± 0.06 iug/g; P < 0.05, two-tailed). This phenomenon was not observed in 
rats fed H-diets (mean difference ± SEM: —0.02 ± 0.06 /^g/g; n.s.). From a 
comparison of values in rats fed the L2.oo-diet with those in rats fed the 
Hn.25-diet, it must be concluded that the higher values on the latter diet can be 
attributed to dietary phoshorus, since the calcium content ot both diets was equal 
(0.3%). 
The higher kidney calcium content in rats fed H-diets was associated with an 
increased relative weight of this organ. In experiment A the weight of the left 
kidney, expressed as a percentage of the body weight ( ± SEM) was 0.396 ± 
0.09% on L-diets and 0.452 ± 0.09% on H-diets. In experiment B these values 
were 0.391 ± 0.08 and 0.449 ± 0.07% respectively. The differences in relative 
kidney weight between rats fed the L- and those fed the H-diets were statistically 
significant (P < 0.01). 
The kidney calcium content in rats fed H-diets was significantly correlated with 
the phosphorus content of this organ. In experiment A the correlation between 
these variables (x = Cain mg/g fresh tissue; y = Pin mg/g fresh tissue) could be 
described as: y = 0.42 x + 2.56 (r = 0.83; P < 0.01 ) and in experiment B as: y = 
0.44 x + 2.34 (r = 0.92; P < 0.01 ). The slopes of these lines are very close to the 
weight ratio between P and Ca in apatite (Ca10 (PO„) 6- (OH)2) which is 0.46. 
There was a significant positive correlation (r = 0.74; P < 0.01) between 
'°log-values of the kidney calcium content and the plasma urea concentration in 
rats fed H-diets in experiment B. In experiment A this correlation was not statisti-
cally significant (r = 0.33; P < 0.10). In rats on L-diets in both experiments A and 
B, plasma urea varied independently of the kidney calcium content. 
8.3.2.4 Bone parameters (experiments A and B) 
Bone quantity (left femur, Table 37). Since the bone mass is related to the body 
weight and since differences between groups in body weight gain occurred, bone 
quantity parameters were adjusted to the overall final mean body weight in 
experiment A and that in experiment B. This was done by regression of body 
weight on these bone parameters. The regression coefficients (the bs) were 
obtained from analyses of covariance. For the adjustments the following formula 
was used: . . _. 
Yadj = yobs- D (xobs - *) 
with y = bone parameter and x = body weight. 
In rats fed L-diets, values on dry fat-free weight and total ash increased mar-
kedly with the Ca/P ratio in both experiments. This increase also occurred in rats 
fed H-diets, though to a lesser extent. For instance in experiment A and in exper-
iment B, the differences ( ± SEM) in femur ash between rats fed the Ln.25- a n d 
those fed the L2.oo_diet w e r e 34 ± 8 and 72 ± 8 mg respectively (both P < 0.01 ) 
and between rats fed the Hrj.25- a n d those fed the H2.00-diet. these respective 
differences were 10 ± 8 (P < 0.10) and 21 ± 8 mg (P < 0.01 ). 
In both experiments A and B, values on dry fat-free bone weight and total bone 
ash were higher in rats fed H-diets than those in rats fed L-diets. These differences 
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were mainly caused by the low values in rats fed the Ln.25- and Ln 50-diets. The 
marked increase in total ash and dry fat-free weight of the femur with the dietary 
Ca/P-ratio in rats fed L-diets as well as the low values of these parameters in rats 
fed the Ln.25- a n d Lrj.50-diets, indicate that these latter animals suffered from 
calcium deficiency. As is indicated in Table 37, values on total ash and dry fat-free 
weight were slightly higher in rats fed the L2.nn-diet than those in rats fed the 
H0.25-diet, in both experiments A and B. These differences were not statistically 
significant. Since the calcium content of these latter diets was similar (0.3%), this 
observation indicates that dietary phosphorus excess did not adversely influence 
the bone mass to a significant extent. 
Bone quality (left femur, Table 38). Bone quality parameters increased with the 
dietary Ca/P-ratio in rats fed the L-diets. In rats fed the H-diets this increase was 
Table 37. Bone quantity parameters (mg, left femur) in experiments A and B1 2). 
experiment A 
L-diets, Ca/P 
H-diets, 
0.25 
0.50 
1.00 
2.00 
Ca/P 
0.25 
0.50 
1.00 
2.00 
experiment B 
L-diets, Ca/P 
H-diets, 
SEM3) 
ANOV 
0.25 
0.50 
1.00 
2.00 
Ca/P 
0.25 
0.50 
1.00 
2.00 
diets (F1,46) 
Ca/P(F3,46) 
experiments (F1,46) 
Ca/P x diets (F3.46) 
experiments x diets (F1,46) 
experiments x Ca/P(F3,46) 
experiments x diets x Ca/P (F3.46) 
dry fat-free 
weight 
345 
351 
376 
388 
381 
381 
394 
395 
406 
447 
474 
496 
484 
494 
507 
508 
8.2 
52.81*** 
20.33*** 
44.49*** 
3.93** 
0.00 
1.99 
3.11** 
total 
ash 
215 
224 
245 
249 
245 
246 
258 
255 
258 
289 
312 
330 
320 
327 
336 
341 
5.6 
74.50*** 
26.94*** 
49.92*** 
4.53*** 
0.17 
2.03 
2.97** 
fat-free org. 
matter 
130 
127 
131 
139 
137 
135 
136 
139 
148 
158 
162 
166 
164 
168 
172 
167 
3.3 
12.23*** 
5.98*** 
21.23*** 
3.23** 
0.23 
2.05 
6.14*** 
1
 ) See footnotes to Table 21. 
2) Values are adjusted to the overall mean body weight of 242.5 g in experiment A and of 
280.7 g in experiment B. Regression coefficients ( ± SEM) for the respective bone 
parameters are 0.58 ± 0.25,0.29 ± 0.16 and 0.28 ± 0.11 in experiment A (all P < 0.05), 
and 1.71 ± 0.20,1.22 ± 0.14 and 0,50 ± 0.08 in experiment B (all P < 0.01 ). 
3) SEM derived from pooled error variance (df = 46). 
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only slight. The overall mean values of bone quality parameters in rats fed the 
H-diets were superior to those in rats fed the L-diets in both experiments A and B. 
This superiority is attributable to low values in rats fed the Lrj.25- and Ln.50-diets. 
These rats suffered from calcium deficiency. Bone quality parameters in rats fed 
the L-| 00' o r L2.00_c'iet did not differ significantly from those in rats fed the 
H-diets, neither in experiment A nor in experiment B. This observation indicates 
that dietary phosphorus excess did not adversely influence the bone quality 
parameters to a significant extent. 
In general, values for bone quality parameters in experiment B were higher than 
those in experiment A. This reflects the maturation of the bone tissue. For in-
stance the mean value ( ± SEM) for the ratio total ash/fat-free organic matter in 
rats fed L-diets increased from 1.76 ± 0.02 in experiment A to 1.85 ± 0.02 in 
experiment B. 
Table 38. Bone quality (left femur) in experiments A and B1). 
experiment A 
L-diets, 
H-diets, 
Ca/P 
0.25 
0.50 
1.00 
2.00 
Ca/P 
0.25 
0.50 
1.00 
2.00 
experiment B 
L-diets, 
H-diets, 
SEM 
ANOV 
Ca/P 
0.25 
0.50 
1.00 
2.00 
Ca/P 
0.25 
0.50 
1.00 
2.00 
diets (F1,48) 
Ca/P (F3.48) 
experiments (F1,48) 
Ca/P x diets (F3.48) 
experiments x diets (F1,48) 
experiments x Ca/P (F3.48) 
dry fat-free weight 
volume 
0.91 g/cm3 
0.96 
1.00 
1.01 
0.94 
1.04 
1.03 
1.06 
1.00 
1.02 
1.04 
1.03 
1.03 
1.06 
1.03 
1.07 
0.015 
28.02*** 
18.51*** 
24.95*** 
6.05*** 
1.32 
2.36 
experiments x diets x Ca/P (F3, 48) 0.86 
total ash 
volume 
571 g/cm 
611 
650 
653 
641 
655 
684 
668 
602 
677 
683 
693 
682 
701 
678 
717 
12 
34.41*** 
17.62*** 
36.95*** 
4.93*** 
0.59 
2.15 
0.95 
total ash 
fat-free organic matter 
s
 1.67 
1.74 
1.86 
1.78 
1.79 
1.83 
1.91 
1.87 
1.77 
1.88 
1.94 
1.88 
1.94 
1.94 
1.95 
2.01 
0.031 
32.29*** 
11.13*** 
49.54*** 
2.39 
0.12 
0.99 
0.58 
1
 ) See footnotes to Table 21. 
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Bone histology (right tibia, Table 39). Sections from tibiae from all rats fed diets 
Lrj.25' L2.00' H0.25 a r |d H2.00 were judged by Dr. W. Visser, who is an experi-
enced investigator in bone histology, and by the writer of this thesis. The area of 
interest was uniformly that beneath the epiphyseal line in the metaphyseal trabe-
cular bone. Semi-quantitative estimations were made of the number and size of 
the trabeculae, the bone turnover rate (lines of osteoclastic activity along the 
trabeculae) and of the amount of osteoid. The procedure was as follows. Dr. 
Visser selected one of the sections that showed a histologic picture that was not 
different from that of a normal rat and this section was used as a reference. All 
sections were studied without knowledge of the experimental situation. When the 
investigators had come to agreement about a particular section, it was judged in 
terms of signs. These were (in decreasing order) + + , + ± , + , ± , —, ± —, and 
( ± = normal) 
In experiment A the amount of trabecular bone was considered to be below 
normal in all groups. It tended to be higher in rats fed a Ca/P-ratio of 2.00 than in 
those fed a ratio of 0.25. Bone turnover was found to be normal in rats fed L-diets, 
but in rats fed H-diets bone turnover was slightly increased. 
In experiment B the amount of trabecular bone was found to be slightly below 
normal in all groups except in the group fed diet H2.00 where it was normal. Bone 
turnover and amount of osteoid were slightly elevated in rats fed diet Ln.25- ln t n e 
other groups these parameters were normal. 
In addition to the observations with respect to the bone mass and bone density, 
it can be concluded from these histological results that rats fed the low-phos-
phorus control diets developed osteoporosis as a consequence of calcium defi-
ciency if the dietary Ca/P-ratio was low (either 0.25 or 0.50). 
Table 39. Bone histological parameters (right tibia) in experiments A and B. 
L-diets 
H-diets 
Ca /P 
0.25 
2.00 
0.25 
2.00 
rat No. 
102 
130 
140 
037 
mean 
123 
132 
009 
112 
mean 
103 
131 
042 
051 
mean 
124 
143 
080 
085 
mean 
experiment A 
trabeculae 
+ — 
+ 
-
— 
+ 
_ 
+ 
± 
— _ 
— 
+ 
— 
± 
-
turnover 
+ 
+ 
± 
± 
+ 
+ 
± 
± 
± 
+ 
+ 
— 
-f 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
osteoid 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
_ 
+ 
± 
— 
— 
± 
+ 
+ — 
+ 
— 
— 
+ 
+ 
rat No. 
360 
376 
380 
092 
mean 
377 
385 
372 
373 
mean 
345 
002 
086 
095 
mean 
378 
397 
087 
094 
mean 
exper ment B 
trabeculae turnover 
— 
_ 
— 
+ — 
-
— 
+ — 
+ 
-
— 
+ 
± 
-
+ 
± 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
± 
— 
± 
± 
± 
± 
+ 
± 
± 
± 
+ 
+ 
+ 
osteoid 
+ 
+ 
+ 
± + 
± + 
+ 
+ 
+ 
+ 
+ 
+ 
— 
± 
+ 
+ 
+ 
+ 
+ 
± 
± 
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Fig. 6. Cross-sections of the proximal part of the tibia, magnified 320 times. The upper 
photograph (rat No. 345) shows a reduced amount of trabecular bone below the epiphyseal 
line. The lower photograph (rat No. 397) shows a normal number of trabeculae; the epiphy-
seal line and a trabecula are indicated by (a) and (b) respectively. 
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8.3.3 Abstract of results 
8.3.3.1 Body weight gain and food consumption 
In both the short- and long-term experiment, body weight gain was significantly 
lower (P < 0.01) in rats fed the high-phosphorus diets (H) than in those fed the 
low-phosphorus control diets (L). This difference in body weight gain was attrib-
utable to a reduced food intake. 
8.3.3.2 Biochemical parameters 
Plasma concentrations of calcium and total protein were not systematically or 
significantly influenced by dietary variables. Plasma phosphorus was significantly 
(P < 0.01 or P < 0.05) decreased in rats fed the H-diets during the whole of the 
experiments. At the end of the long-term experiment, the severity of this hypo-
phoshataemia decreased with an increase of the dietary Ca/P-ratio. In the 
short-term experiment, PTH activity, as measured by the tubular reabsorption of 
phosphate per ml glomerular filtrate (TRP/GFR), was higher in rats fed the H-diets 
than in those fed the L-diets. On these former diets, PTH activity decreased with 
an increase of the dietary Ca/P-ratio. The activity of alkaline phosphatase in 
plasma was significantly (P < 0.01 or P < 0.05) lower in rats fed the H-diets than in 
those fed the L-diets in both experiments. This difference in alkaline phosphatase 
activity was attributable to the lower calcium content of the latter diets. A slight 
decrease in enzyme activity with an increase of the dietary Ca/P-ratio was ob-
served on both diets during the first part of the long-term study. The observed 
differences in alkaline phosphatase activity decreased with the duration of the 
long-term experiment. In the short-term experiment, the urinary hydroxyproline 
excretion was lower (P < 0.10 or P < 0.01 ) in rats fed the H-diets than in those fed 
the L-diets. This difference was attributable to the lower calcium content of these 
latter diets. On either diet the excretion of hydroxyproline decreased with an 
increase of the dietary Ca/P-ratio. The hydroxyproline/creatinine ratio in urine 
was significantly (P < 0.05) higher in rats fed the H-diets than in those fed the 
L-diets if the calcium content of these diets was similar (0.3%). 
8.3.3.3 Calcium and phosphorus metabolism 
An increase in the Ca/P-ratio of either the H-diets or the L-diets inhibited the 
intestinal absorption and decreased the urinary excretion of phosphorus. The 
urinary calcium excretion was found to be depressed in rats fed the H-diets. With 
an increase of the dietary Ca/P-ratio, intestinal absorption and retention of cal-
cium markedly increased in rats fed the L-diets. In rats fed the H-diets, this 
increase in absorption and retention of calcium was only slight. Dietary phos-
phorus excess did not adversely influence either calcium absorption or calcium 
retention to a significant extent. 
8.3.3.4 Bone parameters 
Parameters of bone quantity as well as those of bone quality increased clearly 
with the dietary Ca/P-ratio in rats fed the L-diets. 
In rats fed the H-diets, this increase was only slight. In rats on the L-diets, 
osteoporosis developed as a consequence of calcium deficiency if the Ca/P-ratio 
of the diet was low (either 0.25 or 0.50). It was found that dietary phosphorus 
excess did not adversely influence either the quality or the quantity of the bone to 
a significant extent. Histologically, only small differences between groups were 
observed. In the short-term experiment, bone turnover was slightly increased in 
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rats fed the H-diets. On either diet, the amount of trabecular bone tended to be 
higher if the dietary Ca/P-ratio was 2.00 than when it was 0.25. In the long-term 
experiment, bone turnover and amount of osteoid were slightly elevated in rats fed 
the L-diet with a Ca/P-ratio of 0.25. 
8.3.3.5 Renal function 
In both experiments, feeding the H-diets resulted in a rapid (within one week) but 
moderate loss of renal function, as measured by the clearance rates of urea and 
creatinine and/or the plasma urea concentration. The loss of renal function 
which increased slowly with the duration of the studies was attributable to the 
deposition of calcium apatite in the kidneys (nephrocalcinosis). The extent of 
renal calcification varied with the calcium content of the diet. It increased if the 
calcium content was raised from 0.3 to 1.2% (Ca/P from 0.25 to 1.00), but de-
creased when the calcium content of the diet was raised to 2.4% (Ca/P to 2.00). 
8.3.4 Discussion of results 
According to the outline in Figure 5 (Section 5.11), either a low-calcium diet, a 
high-phosphorus diet or a diet with a low Ca/P-ratio decreases the plasma-ioniz-
ed calcium concentration (temporarily) so that the parathyroid glands are stim-
ulated to secrete parathyroid hormone (PTH). This hormone acts on bone and 
kidney in order to restore the plasma-ionized calcium concentration and this may 
proceed at the expense of skeletal calcium so that osteoporosis develops. It was 
explained (Figure 5) why the stimulation of PTH secretion by the diet occurs 
particularly when renal function is decreased. In the present experiments rats 
were given high-phosphorus diets (H) and low-phosphorus diets (L). These diets 
were provided with four different Ca/P-ratios (0.25, 0.50, 1.00 and 2.00) during 
either a long- or short-term experiment. By these experiments we were able to 
investigate the effect of dietary phosphorus excess and that of the dietary 
Ca/P-ratio (at different levels of both elements) on the metabolism of calcium, 
phosphorus and bone. We were also able to investigate the effect of dietary 
calcium on nephrocalcinosis and subsequent loss of renal function, induced by 
feeding high-phosphorus diets. 
8.3.4.1 Dietary phosphorus 
As could have been expected, the plasma calcium concentration was not clearly 
influenced by dietary phosphorus excess. On the other hand, it was observed that 
in rats fed the H-diets the tubular reabsorption of phosphate (TRP/GFR), the 
plasma phosphorus concentration and the urinary calcium excretion were de-
creased. Moreover, in these rats nephrocalcinosis developed. These biochemical 
changes in rats fed the H-diets reflect the effect of hyperparathyroidism on the 
kidney. The urinary excretion of hydroxyproline (expressed as a ratio to creatin-
ine) was significantly higher in rats fed the H-diet with 0.3% calcium (Ca/P = 
0.25) than in those fed the L-diet with the same calcium content (Ca/P = 2.00). 
Histologically, bone turnover was found to be slightly higher in rats fed the H-diets 
than in those fed the L-diets. These observations reflect the effect of hyperpara-
thyroidism on bone. The intestinal calcium absorption, calcium retention and 
parameters of bone quantity and bone quality were not adversely influenced by 
dietary phosphorus excess to any significant extent. However, these bone para-
meters were slightly (but not significantly) lower in rats fed the H-diet with 0.3% 
calcium (Ca/P = 0.25) than in those fed the L-diet with the same calcium content 
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(Ca/P = 2.00). This observation, which is consistent with the calcium retention 
values in the short-term experiment, may indicate a small negative effect of dietary 
phosphorus excess on calcium utilization. 
8.3.4.2 Dietary Ca/P-ratio 
On both the L- and H-diets, the urinary excretion of hydroxyproline decreased 
with an increase of the dietary Ca/P-ratio. The activity of alkaline phoshatase in 
plasma and the urinary excretion of hydroxyproline were lower in rats fed the 
H-diets than in those fed the L-diets. These effects on the parameters of the bone 
turnover were attributable to differences in the calcium content of the diets. The 
secretion of PTH and the bone turnover rate are known to be inhibited by dietary 
calcium. The activity of alkaline phosphatase in plasma did not decrease so 
clearly with the amount of calcium in the diets as did the excretion of hydroxy-
proline in urine. 
This may indicate that the activity of alkaline phosphatase in plasma is not such 
a sensitive indicator of the bone turnover rate as is the urinary excretion of 
hydroxyproline. Plasma alkaline phosphatase activity declined with the duration 
of the long-term experiment as did the difference in this activity between rats fed 
the L-diets and those fed the H-diets. This probably reflects a decrease in the 
bone turnover rate and calcium need with further maturation when body growth 
diminishes. 
The observation, at the end of the long-term study, in rats fed the H-diets, that 
the severity of the hypophosphataemia decreased with an increase of the dietary 
Ca/P-ratio, probably reflects the inhibiting effect of dietary calcium on PTH se-
cretion. This explanation is consistent with the observation that PTH activity, as 
measured by the tubular reabsorption of phosphate, decreased with an increase 
of the dietary Ca/P-ratio in rats fed the H-diets in the short-term experiment. 
The inhibition of the intestinal absorption and decrease of the urinary excretion 
of phosphorus, which were observed if the dietary Ca/P-ratio of either the L- or 
H-diets was raised, can be explained in two ways: 
1. dietary calcium inhibits the intestinal phosphorus absorption by the formation 
of insoluble calcium phosphates in the intestinal tract and 
2. dietary calcium inhibits PTH secretion, which is followed by a reduction in the 
urinary phosphorus excretion. Further research is needed to establish the relative 
importance of these mechanisms. 
The positive relation between the dietary Ca/P-ratio and calcium retention in 
rats fed the L-diets was reflected by the bone parameters. If the Ca/P-ratio of the 
L-diets was low (either 0.25 or 0.50), osteoporosis developed: bone mass and 
bone density were decreased, particularly in the long-term experiment; histolo-
gically, the amount of trabecular bone was found to be reduced, whereas bone 
turnover and amount of osteoid were normal (short-term experiment) or slightly 
increased (long-term experiment). In rats fed the H-diets, a positive trend between 
the dietary Ca/P-ratio and calcium retention was also reflected by the bone 
parameters. In these rats osteoporosis did not develop if the dietary Ca/P-ratio 
was low. 
8.3.4.3 Renal function 
In the long-term as well as in the short-term experiment, renal function, as mea-
sured by the plasma urea concentration and/or the renal clearances of urea and 
creatinine, was decreased in rats fed the H-diets. This decrease in renal function 
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was the consequence of nephrocalcinosis as indicated by the significant corre-
lation between plasma urea values and extent of renal calcification. Since plasma 
urea was already increased after 6 days of feeding the H-diets and slightly in-
creased further with the duration of the experiments, it can be concluded that loss 
of renal function by dietary phosphate-induced renal calcification is caused rap-
idly and progresses slowly. This calcification is known to comprise the deposition 
of von Kossa-positive particles (probably calcium apatite) in the interstitial tissue 
of the outer zone of the medulla; this deposition is associated with tubular cell 
damage involving the distal portions of the proximal convoluted tubules; these 
renal lesions have been shown to be irreversible (McKay & Oliver, 1935; Hitchman 
etal., 1979). 
On the low-phosphorus diets renal calcium and phosphorus contents were on 
average 137 and 2640 /xg/g fresh tissue in experiment A and 99 and 2468 MQ/Q 
fresh tissue in experiment B respectively. These contents compare favourably 
with those reported by Goulding & Malthus (1969) for the normal rat kidney (75 fig 
calcium and 3250 jug phosphorus per gram wet tissue). If compared with values of 
the renal calcium content on the low-phosphorus diet, values were increased 
eight-fold in rats fed the high-phosphorus diet if the dietary Ca/P-ratio was 1.0 
and four-fold if the Ca/P ratio was 0.25 in experiment A. These figures were 
fourteenfold and two-fold respectively in experiment B. These increases are 
rather small if compared to those reported by Hitchman et al. (1979). These 
investigators observed a fifty-fold increase in the renal calcium content (from 67 
to 3250 /Ltg/g wet tissue) in the female rat if the phosphorus content of a semi-
synthetic diet which contained 1% calcium was raised from 0.2 to 1.0% during a 
feeding period of 6 weeks. 
The cause of the observed nephrocalcinosis is undoubtedly hyperparathyroi-
dism. Anderson & Draper (1972) have found that nephrocalcinosis in rats fed 1.2% 
dietary phosphorus can be prevented by removal of the parathyroid glands. 
Moreover, the decreased plasma phosphorus values and the decreased tubular 
reabsorption of phosphate in rats fed the H-diets also point to hyperparathyroi-
dism. Although this was not reported explicitly in their publication, Hitchman et al. 
(1979) observed significantly lower plasma phosphorus values in female rats fed a 
semi-synthetic diet which contained 1 % calcium and 1 % phosphorus than in rats 
fed a commercial diet which contained 1 % calcium and 0.72% phosphorus. Rats 
on the former diet developed severe nephrocalcinosis whereas those on the latter 
diet did not. 
In rats fed the L-diets, the kidney calcium content and the renal function were 
not influenced by the dietary Ca/P-ratio. On the other hand, in rats fed the H-diets 
the extent of nephrocalcinosis and loss of renal function was most severe if the 
calcium content of the diet was 1.2% (Ca/P = 1.0). Either an increase of the 
dietary calcium content to 2.4% (Ca/P = 2.0) or a decrease to 0.3% (Ca/P = 
0.25) was associated with a marked reduction in the extent of renal calcification 
and in the loss of renal function. Since the intestinal phosphorus absorption 
decreased with an increase of the calcium content (and thus of the Ca/P-ratio) of 
the diets, these observations indicate that the extent of nephrocalcinosis is not 
simply a function of the availability of dietary phosphorus as has been suggested 
by van Beek et al. (1974) and Hitchman et al. (1979). In fact in the present study the 
lowest degree of nephrocalcinosis on the H-diets was observed in the group 
where the availability of dietary phosphorus was the highest. Thus other factors 
also play a role. In this respect the inhibiting effect of dietary calcium on the 
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intestinal absorption of magnesium may be recalled. Low levels of dietary mag-
nesium have been shown to predispose the rat to nephrocalcinosis (Goulding & 
Malthus, 1969). 
Whether the diminished renal function in rats fed the H-diets has had any 
influence on parameters of the bone metabolism is difficult to evaluate. In the 
short-term experiment the creatinine clearance was decreased by about 17% in 
rats that had the highest plasma urea concentration. It is not likely that such a 
decrease in the glomerular filtration rate causes significant disturbance. The 
decreased plasma phosphorus concentration in rats fed the H-diets might be a 
reflection of a diminished tubular reabsorption caused by tubular cell damage, 
but this would be in contrast with the observation that at the end of the long-term 
experiment plasma phosphorus was the lowest in rats that had the lowest degree 
of nephrocalcinosis and the lowest urea concentration. Therefore it is more 
logical to attribute the decrease in plasma phosphorus to hyperparathyroidism. 
Plasma urea values in rats fed the high-phosphorus diets slowly increased with 
the duration of the experiments and this reflects a gradual loss of renal function. It 
is therefore clear that experimental periods exceeding those of the present study 
in this respect might cause problems in the maintenance of the bone mineral 
metabolism. 
8.3.4.5 Conclusions 
From the results of the experiments, the following conclusions can be drawn: 
1. Similar dietary Ca/P-ratios at different levels of the elements do not have the 
same physiological significance. Low ratios (either 0.25 or 0.50) in low-
phosphorus diets produce osteoporosis whereas the same low ratios in high-
phosphorus diets do not. 
2. High-phosphorus diets produce hyperparathyroidism, the effect of which on 
the kidney is more marked than that on bone. In the kidney the hyperparathy-
roidism reduces the tubular reabsorption of phosphate, increases that of cal-
cium and induces nephrocalcinosis. In the bone, the hyperparathyroidism 
slightly accelerates the bone turnover but it does not adversely influence to a 
significant extent either the bone mass or the bone density. With an increase of 
the dietary Ca/P-ratio the hyperparathyroidism is reduced. 
3. Nephrocalcinosis, induced by excess of dietary phosphorus, results in a rapid 
loss of renal function which increases slowly with the duration of feeding the 
high-phosphorus diet. With a rise of the dietary calcium content to a Ca/P-ra-
tio of 1.0 the renal lesion increases, while with a further rise of the dietary 
calcium content to a Ca/P-ratio of 2.0 the lesion decreases. 
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Chapter 9 
General discussion 
9.1 Literature review 
It was deduced from the literature that the diet might contribute to the pathogen-
esis of osteoporosis according to a mechanism in which secondary hyperpara-
thyroidism plays a leading role. A calcium-deficient diet, a phosphate-rich diet or a 
diet with a low Ca/P-ratio depresses the concentration of ionized calcium in 
plasma, which in its turn leads to stimulation of the secretion of PTH. This hor-
mone acts on bone and kidney in order to restore the plasma calcium concen-
tration, which may proceed at the expense of skeletal calcium. 
A model was composed (Figure 5, Section 5.11) according to which hyperpa-
rathyroidism by the diet occurs particularly under conditions of a diminished renal 
function (decreased GFR and synthesis of 1,25-DHCC) and/or a low vitamin D 
status. By measuring the plasma PTH concentration, a good impression of the 
activity of the parathyroid glands can be obtained. This can also be accomplished 
indirectly by estimating biochemical parameters in plasma and urine, which re-
flect the action of the hormone on the bone (stimulation of bone turnover) and on 
the kidney (stimulation of tubular reabsorption of calcium, inhibition of tubular 
low vitamin D status renal function I diet 
(due to aging process) P-excess Ca-deficiency low Ca/P ratio 
(Ca-malabsorption) 
,25-DHCC synthesis I glomerular 
serùm"Ca++l 
(temporarily) 
serum PTH ) 
bone 
resorption \ 
turnover t 
" k idney 
Ca-reabsorptiont 
P-reabsorption j 
loss of bone t serum P \ 
urinary hydroxyproline ( urinary Ca \ 
serum alkaline phosphatase f urinary P \ 
Fig. 5. Outline of the pathogenesis of secondary hyperparathyroidism. 
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reabsorption of phosphate, and stimulation of 1,25-DHCC synthesis). In this re-
spect the urinary excretion of hydroxyproline can be used as an indicator of the 
bone turnover rate, and the tubular reabsorption of phosphate (TRP) as an indi-
cator of PTH activity on the kidney. With this model as a guide, the possible 
relationships between dietary calcium and phosphorus on the one hand and bone 
mass and bone metabolism on the other were investigated in an observational 
cross-sectional study in elderly people and in three experimental studies with rats. 
9.2 Cross-sectional study in elderly people 
The many limitations which are inherent in the design of this study are such that 
the results cannot be explained as a conclusive confirmation of the hypothesis 
that secondary hyperparathyroidism contributes to the pathogenesis of osteo-
porosis. Nevertheless, several observations were indeed in line with this hypo-
thesis and add to its probability. 
They may be compared with the relationships outlined in Figure 5, Section 5.11. 
As regards the women, the following results suggest that dietary phosphorus 
stimulates the secretion of PTH, accelerates the bone turnover rate and brings 
about a loss of cortical bone: 
— a negative correlation between dietary phosphorus and bone mineral content, 
corrected for bone width (BMC/BW), if any effects of other parameters (age, 
body size, calcium intake) on the bone mineral content are taken into account; 
— a negative correlation between the BMC/BW-ratio and the urinary excretion of 
phosphorus (the latter parameter reflects the phosphorus intake); 
— a positive correlation between dietary phosphorus and the urinary excretion of 
hydroxyproline (the latter parameter is considered to reflect the bone turnover 
rate); 
— a positive correlation between urinary phosphorus and hydroxyproline; 
— the absence of any significant correlation between plasma calcium and either 
dietary or urinary phosphorus. 
As regards the men, the following results suggest that dietary phosphorus 
stimulates the secretion of PTH and accelerates the bone turnover rate, but does 
not bring about any loss of cortical bone: 
— no significant correlation between dietary phosphorus and the bone mineral 
content, corrected for bone width (BMC/BW); 
— no significant correlation between the BMC/BW-ratio and the urinary excre-
tion of phosphorus; 
— a positive correlation between dietary phosphorus and the urinary excretion of 
hydroxyproline; 
— a positive correlation between urinary phosphorus and hydroxyproline; 
— a negative correlation between urinary phosphorus and serum phosphorus 
(this correlation reflects a decrease of the tubular reabsorption of phosphorus 
in the kidney with an increase of phosphorus intake, as a result of a raised 
production of PTH); 
— the absence of any significant correlation between plasma calcium and either 
dietary or urinary phosphorus. 
It should be recognized that these results in men and women were not sup-
ported by significant positive correlations between either dietary or urinary 
phosphorus and the serum concentrations of PTH and alkaline phosphatase 
(bone fraction). These correlations might have been expected to occur, accor-
ding to Figure 5, Section 5.11. However, it is plausible that the large inter-indivi-
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dual variation in the serum concentrations of PTH and alkaline phosphatase, 
which, at least in part, is the consequence of the rather large variation coefficient 
in the biochemical determination of these parameters, obscure relations within 
the range of normal values. Moreover, the activity of alkaline phosphatase in 
serum might not be such a sensitive indicator of the bone turnover rate as is the 
urinary secretion of hydroxyproline. As was to be expected in a population of 
elderly people, serum values of PTH as well as those of creatinine (renal function) 
were at the upper limit of normality. 
In both the men and the women, the serum 25-HCC concentration, which 
reflects the vitamin D status, correlated positively with the BMC/BW-ratio, despite 
the fact that the serum concentrations of this vitamin D metabolite were within 
normal limits. This positive correlation might reflect a decreased production of 
1,25-DHCC in elderly people consequent on either a low vitamin D intake, a low 
degree of skin exposure to sunshine, or both. A decline in the production of the 
active vitamin D metabolite is compatible with the observation that in the women 
the urinary calcium excretion decreased with age, probably reflecting a decline of 
the intestinal calcium absorption and/or an increase of the tubular reabsorption 
in the kidney, the latter being brought about by a raised production of PTH. The 
observation that in the men the BMC/BW-ratio correlated negatively with the 
serum alkaline phosphatase activity is also compatible with a decreased produc-
tion of 1,25-DHCC, because it has been shown that the activity of this enzyme is 
increased in vitamin D-deficiency. In our opinion these observations indicate that 
elderly people may need a larger quantity of vitamin D. 
In spite of the observation that the mean calcium intake exceeded the Dutch 
recommended allowance for adults, a positive correlation between calcium intake 
and the BMC/BW-ratio was found in the women, if allowance was made for 
differences in age, body size and phosphorus intake. In the men, but not in the 
women, a positive correlation was found between body height and calcium intake. 
Since loss of body height, which is a sign of trabecular bone loss, occurred 
particularly in the men, these correlations in women and men might reflect a 
protective action of dietary calcium against aging bone loss. 
9.3 Studies with rats 
The results of the three experiments with rats are consistent with the-induction of 
hyperparathyroidism by feeding high-phosphorus diets. This appeared from bio-
chemical changes in serum and urine (hypophosphataemia, decreased tubular 
reabsorption of phosphate and urinary calcium excretion, increased urinary hy-
droxyproline excretion) and from the occurrence of nephrocalcinosis. Feeding 
rats high-phosphorus diets resulted in decreased bone density after a period of 
forty-two weeks, but did not do so after shorter periods (either four or sixteen 
weeks). This difference in the response of bone might be related to differences 
between the experiments in the level of dietary phosphorus used and the amount 
of food that the rats consumed. In the experiment that lasted 42 weeks, the dietary 
phosphorus content was 1.3% and the diets were fed ad libitum. In the experi-
ments that lasted either four or sixteen weeks, the dietary phosphorus content 
was slightly lower (1.2%) and the diets were fed in restricted amounts. However, 
the response of bone to hyperparathyroidism is more likely to depend on the 
duration of the intake of high-phosphorus diets, since it is to be expected that 
quite some time must elapse before the effect of moderate hyperparathyroidism 
on bone becomes observable. 
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Dietary calcium tended to reduce not only the biochemical changes in serum 
and urine induced by high-phosphorus diets, but also the adverse influence of 
these diets on bone density. These 'protective' effects of dietary calcium were 
associated with an inhibition of the net intestinal phosphorus absorption. It should 
be recognized, however, that addition of calcium to the high-phosphorus diets up 
to a level of a Ca/P-ratio of 1.0, increased the severity of nephrocalcinosis. 
It was observed that maturing rats fed a low-phosphorus diet with Ca/P-ratios 
of 0.25 or 0.50 developed osteoporosis as a consequence of calcium deficiency, 
whereas rats fed a high-phosphorus diet with similar Ca/P-ratios did not. This is 
an indication of the limited effect that the dietary Ca/P-ratio has on bone meta-
bolism. 
The decrease of renal function which was associated with the induction of 
nephrocalcinosis continued slowly during the course of the studies. Although no 
effect of this process on bone metabolism could be demonstrated, it should be 
recognized that loss of renal function in the long run will contribute to hyper-
parathyroidism. 
9.4 Final view, a new hypothesis 
With respect to the influence of dietary phosphorus on bone metabolism, some 
remarkable parallels can be observed between the results of the cross-sectional 
study of elderly people and those of the studies with rats. These parallels have 
given rise to the construction of a theory which accounts for the difference in 
physiological response to dietary phosphorus between the postmenopausal 
women on the one hand and the elderly men and the male rat on the other. In 
Table 40 it is shown that an increase of phosphorus intake is accompanied with an 
Table 40. Outline of changes of parameters regarding bone metabolism and 
bone mass, associated with an increase of phosphorus intake. 
elderly women elderly men male rats 
urinary phosphorus + + + 
urinary hydroxyproline + + + 
BMC/BW or femur mass — + ± 
serum phosphorus ± — — 
increase in the urinary excretion of phosphorus and hydroxyproline in the post-
menopausal women, the elderly men and the male rats. The increase in the 
excretion of hydroxyproline reflects an increase in the bone turnover rate, 
brought about by PTH. The secretion of this hormone, which is triggered by a 
depressed plasma-ionized calcium concentration consequent on an increased 
flux of phosphate through the blood, acts on bone and kidney in order to restore 
the plasma calcium concentration. As was expected, in all groups plasma calcium 
concentration did not change with either the phosphorus content of the diet or 
with the urinary phosphorus excretion. In the postmenopausal women the skele-
ton is liable to the action of PTH because of oestrogen deficiency, which action 
results in bone loss and thus in a net release of phosphorus into the circulation. By 
the Phosphaturie action of PTH on the kidney in these women, the plasma 
phosphorus concentration will not change to any significant extent. In the elderly 
man as well as in the male rat, on the other hand, the net result of the action of PTH 
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on bone is that no phosphorus is liberated into the circulation, since the 
stimulated bone resorption is balanced by bone formation, so that bone loss does 
not occur. The Phosphaturie action of PTH on the kidney leads to a decrease of 
the plasma phosphorus concentration. 
9.5 Conclusions 
To the questions which were posed in Chapter 1, the following answers have been 
formulated: 
Question 1. Are there any relations between dietary calcium and phosphorus on 
the one hand and bone mass and bone metabolism on the other in normal, 
healthy, elderly people, who subsist on their own customary diets? 
a. In elderly women, a positive correlation between dietary calcium and bone 
mass and a negative one between dietary phosphorus and bone mass was 
observed. These correlations, which were significant (P < 0.05), could be 
demonstrated only if the effects of other factors which influence the bone mass 
(age, body size and dietary calcium or phosphorus) were taken into account. 
b. In elderly men, no significant correlation between either calcium or phospho-
rus intake and bone mass was detected, but body height and calcium intake 
showed a significant positive correlation (P < 0.05). 
c. In elderly women as well as in men, correlations between dietary phosphorus 
and biochemical parameters of the bone metabolism were found, which sup-
ports the hypothesis that high-phosphorus diets cause hyperparathyroidism. 
Question 2. What influence have dietary calcium and phosphorus on bone mass 
and bone metabolism under controlled conditions in rats? 
a. Excess of dietary phosphorus caused hyperparathyroidism, as shown by a 
reduced tubular reabsorption of phosphate in the kidney, hypophosphatae-
mia, increased urinary hydroxyproline excretion and nephrocalcinosis. 
b. The hyperparathyroidism, induced by dietary phosphorus excess, did not 
significantly influence either the bone mass or the bone quality in the maturing 
animal fed the high-phosphorus diet for either four or sixteen weeks, but it 
reduced the bone density if this diet was fed for forty-two weeks. 
c. The hyperparathyroidism, induced by dietary phosphorus excess, and its 
effect on bone, were reduced if the dietary calcium content was raised. 
d. In rats fed a high-phosphorus diet, the extent of nephrocalcinosis increased if 
the calcium content of the diet was raised to a Ca/P-ratio of 1.0. 
e. The nephrocalcinosis, induced by dietary phosphorus excess, was associated 
with a loss of renal function which continued slowly with the duration of 
feeding the phosphorus excess. 
f. In maturing animals, fed diets with a low Ca/P-ratio, osteoporosis developed if 
the calcium content of the diet was insufficient but not if the calcium content of 
the diet was adequate. 
9.6 Dietary prevention of osteoporosis 
With regard to the high prevalence of osteoporosis, particularly among post-
menopausal women, it is absolutely necessary to utilize all possibilities which 
might contribute to the prevention of this disease. It is very likely that the diet plays 
a role in the etiology of osteoporosis. Four main factors emerge: calcium, 
phosphorus, vitamin D and protein. As yet, the available data do not allow us to 
make scientifically based, exact recommendations of the optimum levels of these 
nutrients in the diet. Nevertheless, current knowledge points to dietary measures 
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which may be considered as useful for the maintenance of bone health in elderly 
people living in western communities. These measures are: 
— ensure a proper vitamin D status; 
— restrict intake of phosphorus; 
— take ample calcium; 
— restrict intake of protein. 
Whether supplementary dietary vitamin D is necessary, depends on the extent 
to which the skin is exposed to sunshine. In our moderate climate the endogenous 
synthesis of vitamin D is probably limited, particularly in people who have a 
pigmented skin, in night-workers and in those who are house-bound (elderly 
people, sick persons). For these people, vitamin D supplementation (200 — 400 IU 
per day = 5 — 10 ^ g) is necessary. 
The average western diet contains an abundance of (animal) protein and is rich 
in phosphorus. A 20%-reduction in the intake of these nutrients would be com-
pletely without risk in terms of nutrient deficiency. For instance, in the Nether-
lands such a reduction would bring down the protein intake to about 70 g per head 
per day and that of phosphorus to about 1.3 g per head per day. These levels are 
still in excess of the USA recommended daily allowances for male adults (70 kg 
body weight) with regard to these nutrients (56 and 0.8 g respectively). 
Table 41. Estimated amount (g per head per day) of calcium, phosphorus and 
protein in Dutch diets1). 
Ca 
P 
Ca/P 
protein 
vegetable 
animal 
1950-1960 
1.00 
1.48 
0.68 
79.3 
35.7 
43.6 
period 
1970 
0.93 
1.54 
0.60 
82.1 
28.0 
54.1 
1975 
0.94 
1.63 
0.58 
87.9 
28.7 
59.2 
') Derived from market data of foods available for human consumption, as reported by 
Bosman (1979), Bosman & Kosten-Zoethout (1978), and Mulder (1962). 
Table 41 shows that a slight decrease in the consumption of calcium and an 
increase in that of phosphorus and protein have taken place in the Netherlands 
between the fifties and the seventies. The dietary Ca/P-ratio has declined from 
0.68 to 0.58 in that period. The increase in the consumption of phosphorus and 
protein is almost completely attributable to a higher consumption of meat and 
poultry. It should be remembered that the hypercalciuric action of dietary protein 
is related particularly to the sulphur-containing amino-acids which are present in 
the protein (Section 5.4). Since the content of these amino-acids in animal protein 
generally exceeds that in vegetable protein, it is not only the rise in the intake of 
protein but also the shift from vegetable to animal protein that has to be taken into 
consideration. In fact, the ratio of vegetable to animal protein decreased from 0.82 
in the fifties to about 0.50 in the seventies. The increase in the consumption of 
phosphorus, mentioned above, is probably an underestimation, as the use of 
phosphate and polyphosphate additives by the food-processing industry has 
been left out of account. These compounds are used for such purposes as 
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increasing the water-binding capacity, fat emulsif ication, acidif ication, protein 
stabilization and others. It has been estimated that in the USA the contr ibut ion of 
these additives to the total phosphorus intake is more than 25% (Sie et al., 1974). 
The sodium salts of ortho-, pyro- and tripoly-phosphates as well as those of the 
cyclic trimeta- and linear hexameta-phosphate are of particular commercial sig-
nificance. Unfortunately, only few data are available about the current use of 
phoshate additives by the Dutch food-processing industry. 
In order to decrease the intake of animal protein and phosphorus, a reduction in 
the consumption of dairy products and meat and poultry may be suggested for 
consideration. These food groups together account for more than 50% of the 
intake of phosphorus and for more than 90% of the intake of animal protein (see 
Table 42). However, a reduction in the consumption of dairy products would be 
Table 42. Relative contribution (%) of dairy products, meat and poultry to the 
intake of calcium, phosphorus and animal protein in Dutch diets in 
1975'). 
dairy products2) meat and poultry 
Ca 75 2 
P 31 23 
animal protein 36 55 
1) Derived from market data of foods available for human consumption, as reported by 
Bosman (1979). 
2) Milk and milk products, excluding butter. 
unwise, since these foods are by far the most important sources of dietary cal-
c ium. Moreover, the Ca/P-rat io of dairy products (between 1.0 and 1.5) is 
favourable and exceeds that of almost all other foods. On the other hand, an 
excessive consumption of dairy products should also be avoided, because of 
their high content of animal protein and phosphorus. In addition to the fact that 
excess of protein raises the calcium requirement due to its hypercalciuric action, 
it is also suspect by reason of the high frequency of nephrocalcinosis in western 
societies (Section 5.4). Furthermore, our results indicate that dietary calcium may 
aggravate nephrocalcinosis in rats fed high-phosphorus diets. Although it is not 
permissible to extrapolate this effect to man without observing the greatest res-
ervation, it can be used as a warning to those who think that a high phosphorus 
intake does not do harm as long as the dietary Ca/P-rat io is kept within accept-
able limits. If, for therapeutical reasons, more than a normal amount of calcium in 
the diet is required, calcium tablet supplementation (for instance as calcium 
lactate or as calcium carbonate) is indicated. 
Considering the matters discussed above, a reduction in the intake of phos-
phorus and animal protein should be brought about by a decrease in the con-
sumption of meat, poultry and meat products. These foods do not contr ibute to 
any significant extent to the intake of calcium, and their Ca/P-rat io is extremely 
low (1 /20). A further reduction in the intake of phosphorus can be achieved by 
limiting the consumption of processed foods to which phosphates have been 
added. A list of these products with their content of added phosphates should be 
made available for nutritionists, dietitians and others. It is also recommended that 
the use of phosphate additives should be limited as much as possible. 
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Chapter 10 
Summary 
By means of this study it was attempted to obtain a better insight into the possible 
influence of the diet on the development of human osteoporosis. This disease, 
which is a consequence of decalcification of the bones, occurs frequently in 
elderly people, particularly in postmenopausal women. 
On the basis of data from the literature a model was composed describing a 
mechanism according to which either a low-calcium diet, a high-phosphorus diet 
or a diet with a low calcium-to-phosphorus ratio (temporarily) decreases the 
plasma-ionized calcium concentration, so that the parathyroid glands are stimu-
lated to secrete parathyroid hormone (PTH). This hormone acts on bone and 
kidney in order to restore the plasma-ionized calcium concentration, which may 
proceed at the expense of skeletal calcium, so that osteoporosis develops. The 
model explains why the dietary stimulation of PTH secretion occurs especially 
when the renal function has decreased and/or when a suboptimal vitamin D 
status is prevalent. In an observational cross-sectional study in elderly people and 
in three experimental studies with three month old male rats, the influence of 
dietary calcium and phosphorus on bone metabolism was investigated. 
The cross-sectional study was carried out among 89 healthy eldery people (53 
women and 36 men), whose age ranged from 57 to 89 years (mean: 70 years). It 
was investigated whether relationships could be demonstrated which fitted in the 
proposed model. For this purpose the calcium and phosphorus intake was esti-
mated by the cross-check method. The bone mineral content (BMC) and the bone 
width (BW) were measured on the distal third of the radius (cortical bone) by 
means of ,25l-photon absorptiometry. In addition, parameters of the bone meta-
bolism in serum and urine were estimated. Because of the observational nature of 
the study, which lacked an experimental basis, it was stressed that the results had 
to be interpreted with caution. The mean daily calcium intake of the women was 
1.04 g and that of the men 1.22 g. These amounts largely exceeded the current 
Dutch recommended allowance for adults of 0.8 g per day. Phosphorus intake 
was considered to be high: 25% of the men and women had an intake of more than 
1.6 and 2.0 g per day respectively. In the men as well as in the women the serum 
concentrations of PTH and creatinine were at the upper limit of normality. The 
level of this latter parameter pointed to a slightly decreased renal function such as 
could be expected in people of this age group. 
In the women the amount of cortical bone, corrected for bone width 
(BMC/BW-ratio) showed a significant negative correlation with age, and the 
regression corresponded with an annual bone loss of about 0.8%. This loss of 
bone was associated with a decrease of body height of about 0.35 cm per year, 
which was considered to be, at least in part, the consequence of vertebral col-
lapse. The BMC/BW-ratio correlated positively with calcium intake and negatively 
with phosphorus intake, if differences in age, body size and either calcium or 
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phosphorus intake were taken into account. The excretion of phosphorus with the 
urine also showed a negative correlation with the BMC/BW-ratio, and dietary 
phosphorus correlated positively with the urinary excretion of phosphorus as well 
as with that of hydroxyproline. The possibility was discussed that these correla-
tions are in line with the concept that high-phosphorus diets contribute to bone 
loss in that they stimulate the secretion of PTH. 
In the men, loss of cortical bone with advancing age was not observed, and no 
relations were found between dietary calcium or phosphorus and the amount of 
this bone. However, a marked loss of height with age (0.45 cm per year) was 
established and a positive correlation between dietary calcium and body height 
was found. It was considered that this correlation might reflect a 'protective' 
action of dietary calcium against loss of trabecular bone from the vertebrae. The 
urinary excretion of phosphorus showed a negative correlation with the serum 
phosphorus concentration, and dietary phosphorus correlated positively with the 
urinary excretion of phosphorus as well as with that of hydroxyproline. The 
possibility was discussed that these correlations are in line with a concept ac-
cording to which high-phosphorus diets stimulate the secretion of PTH and in-
crease the bone turnover rate, but do not bring about loss of cortical bone. 
In the men as well as in the women, the serum concentration of 25-hydroxy-vi-
tamin D (25-HCC) correlated positively with the BMC/BW-ratio, despite the fact 
that serum values of this metabolite (the serum 25-HCC concentration is used as 
an indicator of the vitamin D status) were within normal limits. The possibility was 
discussed that this positive correlation might indicate that elderly people require 
larger amounts of vitamin D as a consequence of diminished renal synthesis of the 
active vitamin D metabolite. 
The experiments with rats, which lasted either four, sixteen or forty-two weeks, 
showed that high-phosphorus (1.2 or 1.3%) diets did not significantly influence 
calcium retention and /or bone mass, as opposed to diets with either a low (0.15%) 
or a normal (0.45%) phosphorus content. From histological and chemical analy-
ses of bone samples, it was concluded that the quality of the bone was not 
obviously affected by the phosphorus content (0.15 versus 1.20%) of the diet in 
experiments which lasted four or sixteen weeks. However, in the experiment 
which lasted forty-two weeks, bone density was found to have been reduced in 
rats fed 1.3% dietary phosphorus, as opposed to those that had been fed 0.45% 
dietary phosphorus. It was suggested that the effect of high-phosphorus diets on 
bone depends either on age or on the duration of feeding these diets. There were 
consistent and strong indications that the function of the parathyroids and the 
bone turnover rate were stimulated in rats fed high-phosphorus diets. In addition 
to the diminished bone density after forty-two weeks, these indications were: 
decreased renal tubular reabsorption of phosphate, hypophosphataemia, de-
creased urinary calcium excretion, increased urinary phosphorus excretion, 
nephrocalcinosis and increased urinary excretion of hydroxyproline. With the 
exception of nephrocalcinosis and decreased urinary calcium, these biochemical 
changes were reduced if the calcium content of the-diet was elevated. This was 
associated with an inhibiting effect of dietary calcium on the intestinal phospho-
rus absorption. In the experiments which lasted four or sixteen weeks, the cause 
and consequence of nephrocalcinosis were studied in more detail. It was found 
that nephrocalcinosis was attributable to the deposition of calcium apatite and 
that it resulted in a clear but moderate loss of renal function. This loss appeared to 
increase slowly during the course of the experiments. The extent of nephrocalci-
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nosis and loss of renal function depended on the calcium content of the diet. 
When the diet contained 1.2% phosphorus, the extent of renal calcification and 
loss of renal function increased if the calcium content of the diet was raised from 
0.3 to 1.2%, but these parameters decreased if the calcium content of the diet was 
further raised to 2.4%. There were no indications as to whether the loss of renal 
function had any influence on the composition or metabolism of the bone. In rats 
fed the low-phosphorus control diets, but not in those fed the high-phosphorus 
diets, osteoporosis developed when the dietary Ca/P-ratio was low (0.25 or 0.50). 
It was concluded that this stresses the importance of indicating absolute levels of 
calcium and phosphorus in the diet and that reporting only the ratio between 
these nutrients should be avoided. 
The results of the cross-sectional study of elderly people and those of the 
experiments with rats gave rise to the framing of a hypothesis. This hypothesis 
explains why hyperparathyroidism, induced by excess of dietary phosphorus, 
brings about a decrease in the plasma phosphorus concentration in the elderly 
man and in the rat, whereas no such effect is seen in the postmenopausal woman. 
Finally, recommendations were made regarding dietary measures which are 
considered to be useful in the prevention of osteoporosis in western societies. 
These measures are: (1 ) ensure a proper vitamin D status, (2) restrict the intake of 
phosphorus, (3) take ample calcium, and (4) restrict the intake of protein. In order 
to reduce the intake of phosphorus and protein, it was suggested that the con-
sumption of meat and poultry should be decreased and the consumption of 
products which contain added phosphates should be limited. A further discussion 
was concerned with a regular consumption of dairy products which is necessary 
to ensure a sufficient intake of calcium. 
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Samenvatting 
Door middel van het hier beschreven onderzoek werd getracht een beter inzicht 
te verkrijgen in de mogelijke invloed die de voeding heeft op het ontstaan van 
osteoporose bij de mens. Deze ziekte, die het gevolg is van een verlies van kalk uit 
het skelet, komt bij de oudere mens veelvuldig voor, vooral bij de vrouw na de 
menopauze. 
Aan de hand van literatuuronderzoek werd een model opgesteld dat een me-
chanisme beschrijft volgens hetwelk een voeding die arm is aan calcium, of veel 
fosfaat bevat of een lage Ca/P-verhouding heeft, het gehalte aan geïoniseerd 
calcium in het bloedplasma (tijdelijk) verlaagt, zodat de bijschildklieren worden 
gestimuleerd tot het uitscheiden van parathormoon (PTH). Dit hormoon werkt in 
op botten en nieren, met als doel de plasmaconcentratie aan geïoniseerd calcium 
weer te verhogen; de hiervoor benodigde kalk kan aan het skelet worden ont-
trokken, zodat osteoporose ontstaat. Het model verklaart waarom de afscheiding 
van PTH die door de voeding is geïnduceerd, vooral wordt gestimuleerd wanneer 
er sprake is van een verminderde nierfunctie en/of van een suboptimale vitami-
ne-D-status. In een observationeel transversaal onderzoek bij bejaarden en in drie 
experimenten met drie-maanden-oude mannelijke ratten werd de invloed onder-
zocht die het calciumgehalte en het fosfaatgehalte van de voeding op de bot-
stofwisseling hebben. 
Het transversale onderzoek werd verricht bij 89 gezonde bejaarden (53 vrou-
wen en 36 mannen), die in leeftijd varieerden van 57 tot 89 jaar (gemiddeld 70 
jaar). Er werd onderzocht of er relaties konden worden aangetoond die pasten in 
het voorgestelde model. Hiertoe werd de opneming van calcium en fosfaat be-
paald door middel van de kruis-vraagmethode. Het botmineraalgehalte (BMC) en 
de botbreedte (BW) werden gemeten aan het distale derde deel van de radius 
(corticaal bot) door middel van 125l-fotonabsorptiometrie. Daarnaast werden pa-
rameters van de botstofwisseling bepaald in bloedserum en urine. Er werd met 
nadruk gesteld dat de interpretatie van de resultaten met voorzichtigheid moet 
geschieden, omdat het onderzoek observationeel van aard was zonder dat er een 
experimentele basis aan ten grondslag lag. De gemiddelde dagelijkse calcium-
opneming bedroeg 1,04 g bij de vrouwen en 1,22 g bij de mannen. Deze hoe-
veelheden overschrijden ruimschoots de huidige in Nederland aanbevolen hoe-
veelheid voor volwassenen van 0,8 g per dag. De opneming van fosfor werd hoog 
bevonden: 25% van de mannen en vrouwen hadden een dagelijkse opneming van 
meer dan 1,6, respectievelijk 2,0 g. Zowel bij de mannen als bij de vrouwen waren 
het gehalte aan PTH en aan creatinine in het bloedserum hoog-normaal. Het 
niveau van deze laatste parameter wees op een licht verminderde nierfunctie, 
zoals overigens verwacht mocht worden bij mensen uit deze leeftijdscategorie. 
Bij de vrouwen vertoonde de hoeveelheid corticaal botmineraal, gecorrigeerd 
voor de botbreedte (de BMC/BW-verhouding), een significant negatieve corre-
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latie met de leeftijd en de regressie kwam overeen met een botontkalking van 
ongeveer 0,8% per jaar. Deze botontkalking ging samen met een jaarlijkse ver-
mindering van de lichaamslengte van ca. 0,35 cm. Deze vermindering in lengte 
werd, althans ten dele, toegeschreven aan het inzakken van de rugwervels. De 
BMC/BW-verhouding correleerde positief met de calciumopneming en negatief 
met de fosfaatopneming, indien verschillen in leeftijd, lichaamsafmetingen en 
calcium- of fosfaatopneming in aanmerking werden genomen. De uitscheiding 
van fosfaat in de urine vertoonde eveneens een negatieve correlatie met de 
BMC/BW-verhouding, en de fosfaatopneming met de voeding correleerde posi-
tief met de uitscheiding van fosfaat in de urine evenals met die van hydroxyproli-
ne. De mogelijkheid werd besproken dat deze correlaties in overeenstemming zijn 
met het concept dat een fosfaatrijke voeding botontkalking bevordert doordat 
deze voeding de afscheiding van PTH stimuleert. 
Bij de mannen werd met het klimmen der jaren geen ontkalking van corticaal 
bot waargenomen, en bij hen bestond ook geen verband tussen de hoeveelheid 
calcium en fosfaat in de voeding en de hoeveelheid van dit bot. Er werd echter wel 
een duidelijke vermindering van de lichaamslengte waargenomen (0,45 cm per 
jaar), en de lichaamslengte had een positieve correlatie met de calciumopneming. 
Er werd verondersteld dat deze correlatie een afspiegeling zou kunnen zijn van 
een beschermende werking die calcium in de voeding uitoefent tegen verlies van 
trabeculair bot uit de rugwervels. De uitscheiding van fosfaat in de urine ver-
toonde een negatieve correlatie met de serum-fosfaatconcentratie, en de hoe-
veelheid fosfaat in de voeding correleerde positief met zowel de uitscheiding van 
fosfaat in de urine als met die van hydroxyproline. De mogelijkheid werd bespro-
ken dat deze correlaties in overeenstemming zijn met een concept volgens het-
welk een voeding met veel fosfaat de afscheiding van PTH stimuleert en de 
botstofwisseling versnelt zonder ontkalking van corticaal bot te bewerkstelligen. 
Bij zowel de mannen als de vrouwen was er een positieve correlatie tussen de 
BMC/BW-verhouding en de concentratie aan 25-hydroxy-vitamine D (25-HCC) in 
bloedserum ondanks het feit dat de serumwaarden van deze metaboliet — de 
25-HCC-concentratie in serum wordt gebruikt als een indicator van de vitami-
ne-D-status — in het normale gebied lagen. De mogelijkheid werd besproken dat 
deze positieve correlatie erop zou kunnen wijzen dat de oudere mens een hogere 
behoefte aan vitamine D heeft als gevolg van een verminderde synthese van de 
actieve vitamine-D-metaboliet in de nier. 
Uit de resultaten van proeven met ratten, die vier, zestien of tweeënveertig 
weken duurden, bleek dat fosfaatrijke voeders (1,2 of 1,3% P) geen significante 
invloed hadden op de calciumretentie en/of op de hoeveelheid bot, ten opzichte 
van controlevoeders die een lage (0,15% P) dan wel een normale (0,45% P) 
hoeveelheid fosfaat bevatten. Het histologisch en chemisch onderzoek van bot-
monsters toonde aan dat de kwaliteit ervan niet duidelijk door het fosfaatgehalte 
van het voer was beïnvloed (0,15 t.o.v. 1,20% P), althans niet bij de proeven die 
vier of zestien weken duurden. Na afloop van het experiment dat tweeënveertig 
weken duurde, werd bij ratten die 1,3% P in het voer hadden een geringere 
botdichtheid vastgesteld dan bij die welke voer kregen met 0,45% P. Er werd 
verondersteld dat de invloed die voeders met veel fosfaat uitoefenen op het bot 
afhankelijk kan zijn van de leeftijd van de rat of van de tijd gedurende welke deze 
voeders worden verstrekt. Er waren consistente en sterke aanwijzingen dat de 
bijschildklierfunctie en de botstofwisseling werden gestimuleerd door de voeders 
met veel fosfaat. Naast een verminderde botdichtheid na tweeënveertig weken 
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waren deze aanwijzingen: een vermindering van de tubulaire reabsorptie van 
fosfaat, hypofosfatemie, een verminderde calciumuitscheiding met de urine, een 
toegenomen uitscheiding van fosfaat in de urine, nierverkalking en een ver-
hoogde uitscheiding van hydroxyproline in de urine. Met uitzondering van de 
nierverkalking en de verminderde calciumuitscheiding in de urine, werden deze 
biochemische veranderingen tegengegaan indien het calciumgehalte van het 
voer werd verhoogd; dit ging samen met een remmend effect dat het calcium in 
het voer op de absorptie van fosfaat in de darm bleek te hebben. Bij de proeven 
die vier tot zestien weken duurden, werden de oorzaak en het gevolg van de 
nierverkalking meer gedetailleerd onderzocht. Er werd waargenomen dat het 
verkalken van de nieren was toe te schrijven aan de afzetting van calciumapatiet, 
en dat deze afzetting een zekere vermindering van de nierfunctie ten gevolge had. 
De mate van de nierverkalking en van de verminderde nierfunctie bleken afhan-
kelijk te zijn van het calciumgehalte van het voer. Indien het voer 1,2% P bevatte, 
namen de mate van nierverkalking en de vermindering in nierfunctie toe als het 
calciumgehalte van het voer van 0,3 tot 1,2% werd verhoogd, maar deze para-
meters namen af als het calciumgehalte van het voer verder werd verhoogd tot 
2,4%. Er werden geen aanwijzingen gevonden dat de vermindering in nierfunctie 
enige invloed zou hebben op de botstofwisseling. Bij ratten die het controlevoer 
kregen met een laag fosfaatgehalte ontstond osteoporose wanneer de 
Ca/P-verhouding van het voer laag was (0,25 of 0,50) maar dit gebeurde niet bij 
ratten die voer kregen met een hoog fosfaatgehalte. Hieruit werd geconcludeerd 
dat het van groot belang is de absolute gehalten aan calcium en fosfaat van de 
voeding te vermelden, en dat men zich niet moet beperken tot het aangeven van 
de verhouding tussen deze nutriënten. 
De resultaten van het transversale onderzoek bij de bejaarden en die van de 
proeven met de ratten gaven ons aanleiding een hypothese op te stellen. Deze 
hypothese verklaart waarom hyperparathyreoïdie, die is geïnduceerd door een 
teveel aan fosfaat in de voeding, een daling van de plasmafosfaatconcentratie 
kan bewerkstelligen bij de oudere man en bij de rat, terwijl dit effect bij de vrouw 
na de menopauze niet wordt waargenomen. 
Ten slotte werden adviezen gegeven over voedingsmaatregelen die als nuttig 
kunnen worden beschouwd om het optreden van osteoporose in westerse sa-
menlevingen te voorkomen. Deze maatregelen zijn: (1) zorg voor een behoorlijke 
vitamine-D-status, (2) beperk de opneming van fosfaat, (3) neem een ruime hoe-
veelheid calcium, en (4) beperk de opneming van eiwit. Ten einde de opneming 
van fosfaat en eiwit te beperken, werd in overweging gegeven de consumptie van 
vlees en gevogelte te verminderen en de consumptie van produkten waaraan 
fosfaten zijn toegevoegd te beperken. Ook werd erop gewezen dat een regelma-
tige consumptie van melkprodukten noodzakelijk is om verzekerd te zijn van een 
voldoende opneming van calcium. 
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